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A Modified Mathematical Model for HIV Transmission, AIDS and 
Intervention Strategies in Ireland.
Mary Dunne
Abstract
The aim of this project was to modify transmission models previously developed to 
describe HIV transmission in Ireland through more precise estimates of parameters 
delineating sexual and needle sharing behaviour and AIDS related mortality, with a view 
to examining the extent of spread from IVDUs to the general heterosexual population 
To provide predictions on HIV transmission and AIDS cases up to the year 2010 and to 
examine the sensitivity of the predictions to changes in the key parameters under 
different assumptions on intervention strategies
Essential data of relevance to HIV transmission were acquired (through the co­
operation of the Department of Health, the AIDS Resource Centre, the Drug Treatment 
Centre, the Ana Liffey Drug Project, and St James’s Hospital, Dublin) and analysed 
The parameters obtained from the descriptive and survival analyses were used in a 
refined deterministic model of HIV transmission which was solved numerically An 
attempt at a solution using perturbation methods was undertaken ^
Results provided a plausible range of projected new HIV infections and AIDS 
cases up to the year 2010. The model projects that if present behaviour continues, 
approximately 1009 new infections may be expected in Dublin by the year 2000, and 
1496 new infections by 2010 Small changes in the values of key parameters induce 
significant changes in projected trends, particularly in the longer term However all 
projections point to the fact that
•Non-IVDU women are particularly susceptible to HIV infection 
•Early introduction of behaviour change makes a significant difference to the 
growth of the epidemic
•Expanding the Drug Treatment System could help to significantly reduce the 
spread of HIV
•Central collation of data is essential if rational implementation of intervention 
plans is to be achieved
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Chapter 1
AIDS in Ireland
'The HIV/AIDS pandemic is entenng a new, more dangerous phase 
As the global threat increases, there are many signs of growing 
complacency, persistent denial, and resurgent discrimination '
(Mann, Tarantola, and Netter, 1992)
1.1 Introduction
1.1.1 The HIV/AIDS pandemic
In 1981, a new syndrome, the acquired immunodeficiency syndrome 
(AIDS), was first recognised among homosexual men in the USA (Centres for 
Disease Control 1981) By 1982 the features of the disease had been 
attributed to a deficiency of the immune system, its transmissibility had been 
recognised and its viral origin was suspected This was confirmed through the 
identification of the aetiological agent — the human immunodeficiency virus 
(HIV) — in 1983 (Barre-Sinoussi et a l , 1983 and Gallo et a l , 1983) and a 
serological test for antibodies was available shortly afterwards Since that time, 
HIV- disease has been defined primarily on the criterion of the presence of 
antibodies to the antigenic components of the virus By the mid 1980s it 
became clear that the virus had spread, largely unnoticed and unsuspected, 
throughout the world since the mid- to late 1970s and that its effects had 
reached truly global — or 'pandemic' — proportions A comprehensive 
understanding of the disease-process, expressed in review articles (Curran et 
al and Wong-Staal et a l) was available by 1985
The HIV/AIDS pandemic consists of thousands of smaller, complicated 
epidemics, both separate and interdependent (in many cases there are many 
epidemics even within a single country) Each epidemic has its own distinct 
origin, in terms of geography and specific populations affected, each has its 
own rate of spread, intensity, and special characteristics, and each involves
different types and frequencies of risk behaviours and practices — for example, 
having unprotected sex with multiple partners or sharing intravenous drug 
injection equipment
The virus is being transmitted on all continents and is spreading to new 
communities all the time As of mid 1994, more than 17 million HIV infections 
(over 1/2 million of which are in Western Europe) are estimated to have 
occurred since the beginning of the pandemic, with over 16 million of them in 
adults (WHO July 1994) The WHO estimates and projections of HIV infection 
and AIDS should furthermore be viewed as very conservative since they use 
the lower value of the possible range of estimates
The HIV/AIDS pandemic was initially centred in urban locations but in 
most countries is now thought to be present in rural areas as well The precise 
nature and extent of HIV spread in rural areas varies between, and even within, 
individual countries In Ireland for example, the situation outside Dublin varies 
considerably, with most seropositive individuals living in the Southern Health 
Board Area, (see Table 1) No community or country in the world already 
affected by AIDS can claim that HIV spread has stopped In Europe alone, 
75,000 to 100, 000 new HIV infections are estimated to have occurred in 1991, 
(Mann et a l , 1992)
There is increasing evidence that women are more at risk of HIV infection 
when considered either on a per contact or per partnership level Initially, in 
developed countries, men were more exposed to HIV than women, primarily as 
a result of homosexual intercourse or IV drug injecting, but the difference in the 
numbers of men and women infected with HIV has gradually narrowed as 
heterosexual transmission has become more common Between 1990 and 
1993 there was a significant increase (from 40 9% to 45 4%) in the proportion 
of female cases in the European heterosexual contact group, (European Centre 
for the Epidemiological Monitoring of AIDS, March 1994) In Western Europe, 
the sex ratio among all HIV-infected adults was 5 7 1 in 1993, (WHO, 1993)
In other parts of the world, where heterosexual transmission 
predominated from the outset, the difference between the sexes is even less 
World-wide, with heterosexual transmission being the most common mode of 
HIV dissemination, there are 3 men already infected for every 2 women and by 
the year 2000 the number of new infections among women is expected to 
approach that among men (Chin 1990) The rising infection rates in women are 
accompanied by a corresponding rise in the number of children born with HIV 
infection To date, it is estimated that about 1 million children have been 
infected with HIV through mother-to-child transmission Most of these children
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rapidly develop AIDS and die — usually before the age of 5 (WHO 1993) By 
April 1994 in Ireland for example, 101 children at risk had been confirmed 
seropositive, 10 of these have developed AIDS, of whom 6 have already died
Mirroring the trend for women, upward seroprevalence trends have been 
noted in IVDUs in several countries, particularly those in Southern Europe, 
wheras a decline in HIV incidence has generally been noted in men who have 
sex with men
The interval between infection with HIV and the onset of clinical
symptoms is unusually long compared with other communicable diseases, and 
varies considerably between individuals Reporting of AIDS was initially based 
on the clinical case definition established by the Centres for Disease Control in 
1982 (Centers for Disease Control, 1982) In 1985 the Walter Reed Staging 
Classification of HIV was introduced (Redfield et a l , 1986), dividing HIV 
infection into a hierarchy of stages of clinical immunological dysfunction In 
1986 the CDC introduced an alternative classification system (Centers for 
Disease Control, 1986) which includes pathological confirmation of the 
presence of opportunistic disease and which was revised in 1987 (Centers for 
Disease Control, 1987) The CDC classifies those with the HIV virus into four 
groups Group I, seroconversion, Group II, asymptomatic, Group III,
progressive generalised lymphadenopathy and Group IV, patients with clinical 
manifestations of HIV infection designated by assignment to one or more 
subgroups (A-E) Subgroup IV B, C1, and D defines an AIDS case Included 
are patients with symptomatic or invasive disease due to one of a number of 
specified secondary infectious diseases, patients with neurological disease 
such as dementia and patients with secondary cancers such as Kaposi's
sarcoma Approximately 50% of those infected become ill within ten years of
initial infection Current evidence suggests that, in the absence of other 
causes of death, almost all HIV-infected people will ultimately die of AIDS 
Once an individual develops AIDS, the average survival time appears to be 
between one and three years (WHO 1993)
The spread of HIV and the occurrence of AIDS are therefore separated by 
years, and so, at any specific moment in any area, these two epidemics may be 
evolving in very different ways
From 1992 to 1995, it is estimated that a total of 3 8 million people will 
develop AIDS, which is 150 percent more than have developed AIDS during the 
entire history of the pandemic through January 1,1992, ( Mann et al 1992) As 
of 30 June 1994, 985, 119 AIDS cases have been reported to the World Health 
Organisation Global Programme on AIDS since the onset of the pandemic
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This represents a 37% increase since 30 June 1993 However WHO estimates 
that as of mid 1994, allowing for under-diagnosis, under-reporting, and delays 
in reporting, and based on the available data on HIV infections around the 
world, there have been around 4 million AIDS cases world-wide since the 
pandemic began This represents a 60% increase over the estimated 2 5 
million cases as of July 1993, (WHO 1994) By the end of June 1994, a 
cumulative total of 122,059 AIDS cases have been reported in the WHO 
European region, (European Centre for the Epidemiological Monitoring of 
AIDS, June 1994) In Ireland, as of mid 1994, there have been 408 cases 
reported to the Department of Health since the epidemic began, (official 
Department of Health figures) This represents a 19% increase over the 
reported 344 cases as of mid 1993
1.1.2 Modes of HIV transmission
An understanding of the ways in which HIV can be transmitted is central 
to an understanding of the epidemiology of the pandemic It has now been 
established, as a result of laboratory and epidemiological investigations, that 
HIV is transmitted in three ways through sexual intercourse, through blood and 
from mother-to-child There are however individual differences in the ability to 
transmit and acquire HIV that remain unexplained (Padian et al 1991)
HIV transmission as a result of sexual intercourse accounts for about 
three-quarters of all HIV infection world-wide (WHO 1993) HIV is therefore a 
sexually transmitted disease (STD) Although transmission through intercourse 
between men occurs in most parts of the world, the majority of the world's 
infections have been acquired through intercourse between men and women 
(heterosexual transmission) Studies have shown that the likelihood of being 
infected increases statistically with the number of sexual partners and with anal 
receptive intercourse (European Study Group, 1989, Padian et a l , 1987 and 
1991, Goedert et al , 1984, De Vincenzi, 1988) Heterosexual transmission 
continues to grow in importance world-wide (WHO 1993)
As with some other STDs, HIV infection can also be transmitted through 
blood, for example as a result of the medical transfusion of infected blood or 
blood products or from the use of contaminated injection equipment by 
intravenous drug users
The transmission of HIV from mother to child includes transmission during 
pregnancy, during delivery and through breast-feeding
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1.2 Methods of estimating and projecting HIV/AIDS
1.2.1 Models in current use
Despite considerable advances in understanding the basic biology of HIV, 
the human immune deficiency virus, which is the aetiological agent of the 
acquired immune deficiency syndrome (AIDS), medical, public health and 
health education planning is still inevitably subject to uncertainties The 
problems are world-wide and many questions of an epidemiological nature 
currently remain to be answered, e g the likely magnitude of the epidemic, the 
period of peak incidence, the extent of the spread in the heterosexual 
community, the necessary behaviour changes required to affect the magnitude 
of the epidemic, the sexual and drug sharing habits of intravenous drug users 
(IVDUs), the inter-relationships of at risk populations, and the effects of 
intervention policies
An obvious way to predict the future course of any epidemic is to fit a 
smooth curve through the disease incidence (or cumulative AIDS case) data 
and extrapolate this line into the future on the supposition that previous trends 
will continue (Gail and Brookmeyer, 1988) Such empirical predictions are 
useful only up to two or three years into the future, after which they become too 
imprecise since they assume no change in observed trends and do not 
incorporate knowledge about disease progression or transmission dynamics or 
intervention policies where these exist In addition the extrapolations assume 
that the number of AIDS cases has been reported with the same accuracy over 
time Projections of HIV prevalence or incidence are not possible with this 
method AIDS incidence is also subject to a number of uncertainties, including 
delays in reporting cases, under reporting, and changes in the surveillance 
definition
Back-calculation methods also have been used to project new cases 
based on AIDS case data in a semi -empirical way and to obtain estimates of 
the incubation period (Brookmeyer and Damiano, 1989, Brookmeyer, 1991, 
Rosenberg et a l , 1991, Comiskey & Ruskin, 1992) However back-calculation 
projects AIDS cases only from infections that have already occurred and AIDS 
is notoriously under-reported (Rosenberg and Gail, 1990, Mann et a l , 1992) 
The methods therefore yield some information on the incidence of infection 
more than 2 or 3 years in the past, very little information on the incidence within 
the last 2 years, and no information on the future incidence of infection In 
addition, back-calculation is increasingly difficult to use because of the evident 
need to stratify by risk, age, treatment e tc , and the complications that this
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stratification involves The principal aim of epidemic models must be to learn 
about the underlying course of new infections in order to provide adequate 
resources taking these factors into account
As a third approach dynamic models, which use information required by 
back-calculation methods and information about modes of transmission, 
transmission probabilities, and behaviour associated with the spread of HIV, 
have been used Given the availability of data, these models should be 
preferred to back-calculation In the medium term, mathematical models of the 
dynamics of HIV transmission and its progression to AIDS can facilitate the 
indirect assessment of the essential epidemiological parameters and clarify 
relations between them Furthermore, such models can indicate gaps in our 
knowledge, clarify what data must be collected in order that better predictions 
can be obtained, assess the effects of future intervention policies, eliminate 
hypotheses put forward to explain observed trends, and importantly, provide 
predictions for several decades ahead In general mathematical models can 
provide a framework to guide the interpretation of observed trends ( May and 
Anderson, 1987, Anderson et a l , 1986)
There are other methods also in use, e g the more recently developed 
Automata network SIR models for modelling the spread of AIDS in populations 
of moving individuals (Boccara and Cheong, 1992) Automata networks are 
discrete dynamical systems which consist of graphs with a discrete variable at 
each vertex Each vertex variable evolves in discrete time steps according to a 
definite rule involving the value of neighbouring vertex variables The vertex 
variables may be updated from the application of a local rule of automation, 
which consists of a number of subrules One of these subrules might describe 
e g the different types of sequential moves that an individual may perform 
Another might determine which susceptibles become mfectives and which 
infectives are removed in a synchronous manner These are flexible models 
and may be applied to both closed and open populations to include births, 
deaths by other causes, immigrations, or emigrations.
Research on mathematical models of HIV transmission has to date 
concentrated mainly on the homosexual population In many parts of Western 
Europe and North America the majority of early cases of the virus were 
identified within this group and survey analyses to date have reflected this 
situation However, current work employs the insights gained from these more 
restricted models to model the spread of the disease within the heterosexual 
population Intravenous drug users have been recognised as a significant risk 
group for HIV and play a major role in transmission of the virus in many parts
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of the world in particular for the heterosexual epidemic in the United States and 
Europe (Friedland & Klein, 1987, Moss, 1987, Curran et a l , 1988; France et 
a l , 1988, des Jarlais et a l , 1989) In southern Europe, particularly Spain and 
Italy, IVDUs make up 66% of reported AIDS cases (European Centre for the 
Epidemiological Monitoring of AIDS, 1994) Understanding long term trends in 
the spread of HIV among intravenous drug users is therefore critical to 
controlling the AIDS epidemic
From the beginning of the AIDS epidemic in Ireland it was observed that 
we are unlike most of the rest of Western Europe in that the major spread is 
through drug users rather than homosexuals We therefore found it necessary 
to proceed directly to the difficult problem of modelling the spread of the HIV 
virus from within the IVDU group (Comiskey, 1991) Seropositive IVDUs can 
transmit HIV to non-seropositive intravenous drug users through sharing 
injecting equipment, and to both non-seropositive IVDUs and non-IVDU sex 
partners through sexual intercourse In addition seropositive female IVDUs are 
a source for perinatal transmission
In Ireland to date, there has been little analysis of the rate of spread of 
HIV, or attempts to model the future course of the disease at a national level 
(see however, Comiskey, 1991) It is the aim of this work to develop a 
deterministic mathematical model of HIV transmission from IVDUs to the 
general population under different assumptions of social and sexual mixing A 
survey of intravenous drug users is used to provide detailed information on the 
extent of needle use and sharing, the rate of change of sexual partners (both 
IVDUs and non-IVDUs) and the extent of spread to non-IVDU partners In 
conjunction with the mathematical models, we hope to provide more precise 
estimates of the incidence of HIV infection and AIDS in the heterosexual 
population of Dublin
1.2.2 Global estimates and projections of HIV/AIDS
Uncertainties about the potential spread of HIV and the ultimate 
dimensions of the HIV/AIDS pandemic have existed since the initial recognition 
of AIDS in the early 1980s The major uncertainties include
• when, and at what level, HIV prevalence will peak in different populations at 
risk in the various geographical areas
• the rate at which HIV-infected children and adults will ultimately develop 
AIDS and die
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Despite these uncertainties, a variety of methods and models have been 
developed for making future projections of the pandemic
The first step in making future projections is to gauge the current 
magnitude of the HIV pandemic Here, the major problem is that HIV infection 
is largely silent — AIDS cases are the only visible part of the epidemic 
Attempting to estimate the number of HIV infections from the number of AIDS 
cases has several major disadvantages with several problems inherent to such 
data, (Jager et a l , 1993) Firstly the number of AIDS cases is never complete 
and may be senously underestimated in some countries because of inadequate 
diagnostic facilities and poor reporting mechanisms Even in countries with 
relatively complete reporting, delays between AIDS diagnoses and case reports 
are inevitable. In Europe it is estimated that reporting is only 60 to 90 percent 
complete (Mann et a l , 1992) Indeed even if the true number of AIDS cases 
were known, estimating the number of HIV infections from this number is 
fraught with difficulty because of the long and variable time (asymptotic) 
between initial HIV infection and the onset of AIDS symptoms Moreover, 
because of the long interval between infection and illness, AIDS cases at best 
reflect the level and distribution of HIV infection 5-10 years earlier HIV 
infection is also silent because the assessment of HIV infection by available 
test procedures is complicated for social reasons
In making estimates of the current magnitude of HIV spread, WHO 
therefore draws on other sources of information, such as studies of HIV 
prevalence in specific population groups and areas, the estimated size of such 
groups, prevalence in neighbouring areas, and trends over time, for example 
the changes in prevalence from year to year in a given group
The ultimate long-term dimensions of the HIV/AIDS pandemic cannot yet 
be forecast with any degree of confidence However, on the basis of available 
data on the current global status of the pandemic and recent trends in its 
spread, WHO has generated a plausible range of projected new HIV infections 
during the 1990s In making projections of the future magnitude of the 
pandemic, WHO uses the lower limits of its estimated regional ranges of HIV 
prevalence The results of HIV/AIDS forecasting by WHO should thus be 
considered conservative During this decade, WHO projects that around 10-15 
million new HIV infections may be expected in adults, mostly in developing 
countries During the same period, WHO projects that as many as 5-10 million 
children will be HIV- infected at birth or through breast-feeding, the majority of 
them in sub-Saharan Africa By the year 2000, the cumulative number of HIV- 
related deaths m adults is predicted to rise to more than 8 million from its mid
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1993 total of 2 million, (WHO 1993) Therefore the number of AIDS deaths 
projected between 1993 and 2000 is four times the number that occurred 
during the entire pandemic through mid-1993
For the year 2000, the current WHO projection is that there will be a 
cumulative total of 30-40 million HIV infections in men, women and children, of 
which more than 90% will be in developing countries The projected cumulative 
total of adult AIDS cases is close to 10 million (WHO 1993) The impact of the 
AIDS pandemic goes far beyond these statistics however AIDS principally 
affects young and middle-aged adults The cost of medical care for each 
infected person — roughly estimated as equal to or greater than the annual per 
capita gross national product — overwhelms individuals and households, 
(Mann et al 1992)
1.3 The Irish situation
1.3.1 Background
The first case of AIDS in Ireland was identified in the homosexual/bisexual 
group in 1982 The first case of AIDS in an IVDU was not found until the 
second half of 1985 By the end of June 1994, 408 cases of AIDS had been 
reported Most cases occurred among IVDUs (177) and homosexual men 
(136) Heterosexual cases make up only 11% of all AIDS cases in Ireland, but 
they account for 31% of female AIDS cases indicating that heterosexual 
transmission is a particularly high risk acquisition route for females 49 per 
cent of all AIDS cases attributed to heterosexual transmission are women 
Heterosexual acquired AIDS increased from 29% of all women with AIDS in 
1993 to 31% in 1994 The proportion of cases due to heterosexual sex is rising 
far more rapidly than any other route of transmission The number of reported 
cases of people infected through heterosexual sex rose by 80% in the past 2 
years (June 1992-June 1994), (Department of Health Statistics) Many of these 
heterosexual cases were the sexual partners of HIV-infected IVDUs
A number of studies have shown that between 60% and 100% of 
heterosexually acquired HIV in the western world is related to intravenous drug 
use and that at least 40% of IVDUs are in relationships with non-users, (France 
et a l , 1988) It has indeed been suggested by a previous Minister for Health 
(O'Hanlon 1988) that Ireland's most serious problems with AIDS may result 
from IVDUs acting as a 'bridge' for the virus into the non-drug using 
heterosexual population
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The greatest percentage (57 8%) of Irish cases occur in the 25-34 year 
age group with 82 6% in males and 17 4% in females of all age groups This 
gives an overall male female ratio of 4 7 1
Up to the end of June 1994, 86,701 tests for antibodies to the human 
immunodeficiency virus had been carried out by the National Virus Reference 
Laboratory (NVRL) and 1494 individuals had been found to be seropositive 
(National Virus Reference Laboratory, June 1994) The 86,701 are not 
necessarily 86,701 individuals since some persons may have been tested more 
than once It should be noted that many other centres are also carrying out 
tests but when a positive result is identified it is sent to the NVRL to be 
confirmed There are no available statistics on the total number of tests carried 
out nationally A large proportion (46%) of the tests that the NVRL carry out 
are for insurance/visa purposes whereas other centres carry out the majority of 
their tests for a particular risk behaviour such as intravenous drug use
Figure 1 1 shows the cumulative number of HIV infections diagnosed at 
the Virus Reference Laboratory from 1985 (when the first tests were performed) 
to the end of 1993
The graph shows an almost linear increase in the numbers testing HIV 
antibody positive The highest number of positive tests occurred in 1992 with 
157 individuals testing positive
It is impossible to obtain the exact number of people who are infected with 
the virus as the above statistics refer only to those who have been tested 
Conservative estimates put the number of people with HIV at four to five times 
the official figure
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Figure 1 1 Cumulative HIV cases 1985-1993
1.3.2 The situation in Dublin
The majority (90%) of HIV seropositive individuals in Ireland are located
in the Dublin metropolitan area (National AIDS Strategy Committee, 1992)
Although appearing initially among homosexuals and intravenous drug users,
HIV infection is now spreading to the general heterosexual population HIV
infection here follows a pattern which is dissimilar to that of the U K but closely
resembles that of Spain and Italy (the only other European countries to have a
higher proportion of AIDS cases in the IVDU risk group (66%) than in the
Homosexual risk group (15-16%), European Centre for the Epidemiological
Monitoring of AIDS, March, 1994) 50 2% of those who are known to be
infected with HIV in Ireland have been exposed to it through the intravenous
use of drugs, 13 4% have acquired their status through heterosexual
transmission, and 19 5% have been infected through homosexual intercourse
The other 16 9% is made up of children, persons with haemophilia and others,
(National Virus Reference Laboratory, June 1994) In contrast, unprotected
homosexual intercourse accounts for the majority (60 5%) of those who are HIV
seropositive in the U K (Communicable Disease Report, 1994)
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Recent studies have however indicated that sexually-transmitted HIV 
infection may be the commonest mode of transmission outside Dublin 
(Department of Health, 1993), (see Dublin versus the Regions, below)
The male female ratio of HIV infections attributed to IVDU is
approximately 3 1 (National Virus Reference Laboratory, June 1994) Infected 
drug users provide one of the major driving forces for heterosexual
transmission of HIV in Ireland Their significance as a high risk group lies in
the large number of young people, particularly in Dublin, who have used 
intravenous drugs since heroin became widely available in the late 1970s and 
early 1980s (Dean et a l , 1983) Estimates of the total number of intravenous 
drug users are varied and impossible to confirm, they range from a low 
estimate of 3000 people to a high one of 15,000 (Bury 1989) The true number 
is probably somewhere between these figures but certainly involves thousands 
of people who have used drugs intravenously at some stage Ireland's drug 
problem is concentrated in Dublin and there is little evidence of a serious 
problem outside the city (Department of Health, 1991) Information on HIV 
positive IVDUs is essential to our understanding of the spread of the virus, and 
to the construction of any mathematical model for the transmission dynamics of 
the disease
Drug addiction and treatment services in Dublin are shared by the Drug 
Treatment Centre (whose emphasis is on abstinence), the AIDS Resource 
Centre in Baggot Street and its satellite clinics (emphasis is on harm 
reduction), and a number of non statutory/voluntary agencies like the Coolmme 
Therapeutic Community (based on abstinence), and those which include harm 
reduction treatments like the Ballymun Youth Action Project, the Ana Liffey 
Drug Project and the Merchants' Quay Project Co-operation between services 
can be rather intermittent, partly because of the different philosophies guiding 
the different services Primary care or satellite clinics of the Baggot St centre 
have been established in three locations (with plans for a further two) in the 
Dublin area The services available in these centres include methadone 
maintenance, condom distribution, and needle exchange
Our national statistics state that while 50 2% of Ireland's seropositive 
population have been infected through intravenous drug use, only 9 6% of all 
tests carried out by the NVRL with IVDU named as a nsk factor are seropositive 
(see earlier note on NVRL, section 1 3) However Bury (1989) suggests that 
many people who have tested positive or negative In the past have had the test 
repeated using other names or identifying numbers, and that therefore the 
apparent total number of IVDUs tested is inflated and thus the proportion of
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IVDUs who have tested seropositive is an underestimate In addition many 
drug users who have tested positive outside the country and have returned to 
Ireland will not be included in the statistics It is generally accepted too that a 
large number of potential HIV seropositive individuals have not been tested, for 
psychological, social and legal reasons In their study of 'Admissions for HIV-1 
related disease in a Dublin Hospital 1987-1990', Murphy et al (1991), found 
that 27 4% of patients were admitted with advanced disease (CDC4) who had 
not been previously diagTiosed HIV seropositive These findings suggest a 
sizeable reserve of undetected disease in the population The reasons for this 
are varied as pointed out by Murphy et al In Dublin, intravenous drug use is 
more common and more detectable in the lower socio-economic groups and 
IVDUs tend to be poorly motivated to seek medical attention Secondly, many 
socially disadvantaged IVDUs have spent time in prison where it has been the 
policy since 1985 to segregate HIV seropositive prisoners, and IVDUs were 
therefore reluctant to be tested for HIV (Harding, 1987, Dept of Justice, 1993) 
Thirdly, in the early years of the epidemic, many homosexuals were 
encouraged by various voluntary agencies not to have the HIV antibody test, 
and this advice may have filtered through to IVDUs Because of these reasons 
and others (such as fear of learning the result), it is probable that many 
individuals who are in high risk categories have still not been tested
Data published by the Department of Health in 1986 showed that 30 per 
cent of selected samples of IVDUs had tested positive for HIV (Department of 
Health, 1986) Indeed others have suggested seroprevalence levels of 27% 
(Dean et a l , 1987), 28 2% (Richardson et a l , 1993), and even as high as 39% 
(Bury, 1989) A survey of 120 clients of the Merchants' Quay drugs/HIV service 
found that 58 of the 107 (54%) clients who were tested were seropositive 
(McKeown et a l , 1993) In a study conducted in Edinburgh where the IV drug 
using situation is similar to that in Dublin it was found that 52% of IVDUs tested 
were seropositive (Brettle et al 1987) Estimating the prevalence of HIV 
infection among IVDUs is methodologically difficult because true random 
samples of the general population of drug injectors are not obtainable Studies 
have found that drug injectors with no experience of treatment had significantly 
lower rates of HIV-antibody testing, and significantly higher levels of HIV 
prevalence and of unreported HIV positivity than those previously or currently 
m treatment, (McKeown et a l , 1993, Donoghoe et al 1993, Rhodes et 
al ,1993b) It was pointed out by Robertson et al (1986) that young drug users 
are particularly at risk of AIDS because they rarely have their own equipment 
and have little contact with the medical services or access to health education
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These studies suggest that previous studies of HIV prevalence among drug 
users may be biased by drawing on samples primarily from treatment settings 
(see section 4 2)
Intravenous drug users are therefore a critical group in the AIDS epidemic 
in Ireland, and control of the AIDS epidemic here will thus require control of HIV 
infection among IVDUs An underestimate now of the total numbers infected by 
IVDU will lead to under resourcing of the services needed to cope with AIDS 
Accurate predictions and estimates of the level of HIV infection and spread are 
essential to enable planning by government authorities and health care 
personnel working within a system that is already overstretched
The first phase of an anonymous, unlinked HIV surveillance programme 
commenced in October 1992 in Maternity Hospitals and Maternity Units in 
General Hospitals throughout Ireland Pregnant women are especially 
important since they are by definition sexually active, and they represent one of 
the routes by which the epidemic can spread outwards from the high risk 
groups The government propose to extend this programme initially to hospital 
out-patients and then to hospital admissions during 1994 (Department of 
Health, Annual Report, 1993) With this in place we should have a more 
comprehensive and accurate estimate of the prevalence of HIV infection in the 
population and a reduction in some of the Uncertainty surrounding heterosexual 
contact transmission However, since HIV infection is not uniformly distributed 
within the population, and those persons attending maternity and other 
hospitals do not constitute a strictly representative sample of the general 
population, the seroprevalence of HIV antibody found in these samples may 
provide biased estimates However, if such a bias exists, it may not vary much 
over time and, thus, inferences on rates of change of HIV prevalence, regional 
differences, etc should be highly informative
1.3.3 Dublin versus the Regions
In November 1993, the Department of Health introduced a more 
comprehensive Notification Form for Cases of AIDS This requires details of 
the Postal District (Dublin) and the County (elsewhere) of residence of the 
person This will allow more focused monitoring of AIDS Under the revised 
Notification System cases of AIDS will now be reported first to the Regional 
AIDS Co-ordinator in a health board and then to the Department of Health 
(Department of Health, Annual Report, 1993) Figure 2 shows a map of Ireland 
detailing the Health Board Areas
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The Virus Reference Laboratory only began to classify HIV antibody tests 
into regions in June 1992, and therefore their statistics do not provide an 
adequate picture of the situation in Ireland outside Dublin Figures for the 
prevalence of HIV outside Dublin can currently only be arrived at by combining 
the results of personal communication with the AIDS co-ordinators from each of 
the Health Board areas with the results of a few limited studies These have 
included a retrospective study conducted by the Department of Gemto-Urinary 
Medicine, St James's Hospital, Dublin (Foreman et a l , 1994), on the profile of 
109 seropositive patients residing outside Dublin city, and a survey of Irish 
general practitioners, on contact with HIV positive patients (Bradley et a l , 
1993) Information which we have obtained from the AIDS co-ordinators 
includes only those cases known to them up to June 1993 The St James's 
Hospital study used data up to March 1994 and the Bradley study was 
conducted in June 1992 The following table shows the distribution of HIV 
positive individuals from outside Dublin city, obtained from a crude synthesis of 
the above information
Table 1.1 Distribution of HIV seropositive individuals outside Dublin City.
Health Board Area________Number
Eastern 45
Midland 17
Mid Western 9
North Eastern 7
North Western 4
South Eastern 14
Southern 100
Western 12
Total 208
The St James's Hospital study suggests that the transmission of HIV 
outside of Dublin city is primarily through sexual intercourse 69% of their 
cohort were infected through this route and 55% were infected through 
homosexual transmission This proportion differs substantially from that in the 
national statistics and that in the Department of G U M in St James's, where 
the majority of those who are seropositive, are or were IVDUs However it is
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still likely to be an underestimate of the true proportion of persons infected 
through sexual intercourse, since the St James's Hospital study included 
patients in the Dublin area but outside Dublin city Thus the 31% of 
seropositive subjects found by the study who were IVDUs, have probably 
biased the overall figure, since there is a higher proportion of IVDUs on 
Dublin’s periphery than in any of the other health board areas Supporting this 
view we note that the Virus Reference Laboratory have recorded the same 
number of seropositive tests from Co Dublin for IVDUs and bi/homosexual men 
since June 1994 (National Virus Reference Laboratory Statistics) Further, the 
AIDS co-ordinators, and the microbiologists from the regional hospitals in Cork 
and Galway (personal communication 1993), also agree that the vast majority 
of HIV infections have been acquired sexually and that up to 1993 most of 
these were homosexually transmitted However, it should be noted that the 
overall numbers involved at present are small, although these undoubtedly omit 
a percentage who have not yet been tested
An indicator of this last point lies in the fact that 40% of the patients in the 
St James's Hospital study (Foreman et a l , 1994) were CDC stage IV when 
they first presented to the hospital This is worrying and suggests a reservoir 
of undetected disease in rural Ireland
There is a need for a comprehensive linked picture of the situation 
regarding HIV infection, and its geographical distribution, which could be 
arrived at through conducting similar studies to those mentioned above in 
Dublin and the regions
1.4 The history of mathematical modelling/epidemiology
The application of mathematics to the study of infectious disease appears 
to have been initiated by the mathematician and physician Daniel Bernoulli in 
1760 He developed a method to calculate the gain in life expectancy if 
smallpox were eliminated as a cause of death The research of Henle (1809- 
85), Pasteur (1827-1875) and Koch (1843-1910) in the science of bacteriology 
gave a solid and important basis to epidemiology Hamer (1906), using post- 
germ-theory thinking suggested that the course of an epidemic depends on the 
number of susceptibles and the contact rate between the susceptibles and 
infectious individuals This set the stage for all future deterministic studies 
The people who pioneered work in this area were epidemiologists with an 
interest in mathematics which they used to study the transmission dynamics of
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epidemics The foundation was firmly laid by Sir Ronald Ross, who received 
the second Nobel prize in medicine in 1902 for his discovery that the mosquito 
is the vector of malaria Ross (1911) produced a deterministic mathematical 
model for the transmission of malaria This model predicts the future state of 
the epidemic given the initial numbers of susceptible and infectious individuals, 
together with the attack, recovery, birth and death rates Mathematical theory 
had made its debut as a research tool in epidemiology
Kermack and McKendnck (1927-39) developed this work further and 
Bailey's book "The Mathematical Theory of Infectious Diseases" (1957) 
became the handbook of epidemiologists and mathematicians working m the 
area
Ross and McKendnck (1912) noted that their equations for the prevalence 
of the malaria infection in the human and in the vector host could also be 
applied to females and males with respect to a sexually transmitted disease 
Bailey (1979) and Hethcote and Yorke (1984) provide an extensive list of 
references on modelling sexually transmitted diseases in general and for 
gonorrhoea in particular
In recent years there has been a great upsurge of interest in models for 
epidemics, partly generated by concern over the AIDS epidemic In fact the 
AIDS epidemic has tremendously stimulated the development of mathematical 
models of infectious diseases Much of the work on building mathematical 
models for the transmission dynamics of HIV infection is deterministic 
Anderson et al (1986) published the first comprehensive study of the 
transmission dynamics of HIV in 1986 and many more studies have followed 
since then The models are almost always described in stochastic terms even 
when a deterministic analysis is envisaged A deterministic model for the state 
of a system consists of a set of differential equations which, given assumed 
parameter values, can be solved numencally if not analytically to give a fixed 
temporal evolution of the system As Isham (1993) points out different 
realisations of a corresponding stochastic model can be simulated and results 
will, in general, exhibit considerable variability depending on the conditions 
involved Explicit solutions are not usually possible
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1.5 Scope of thesis
The aim of this work is to develop a mathematical model for the 
transmission of HIV from intravenous drug users to the general heterosexual 
population in Dublin which has been identified as being a problem of particular 
relevance (see section 1 3) We derive the parameters of the model using data 
collected in Ireland as far as possible To achieve our aim a system of non­
linear differential equations first proposed by Anderson et al (1986), and 
developed by Comiskey (1991), and Comiskey et al (1992), is adopted and 
adjusted to suit the present model In addition we explore the possibility of 
adopting other modelling approaches to this work
In Chapter 2 we review the literature on various deterministic models of 
the transmission dynamics of HIV and their numerical solutions
Chapter 3 looks at the role of statistical studies in providing parameter 
estimates Details of parameter choice in other studies are examined This 
chapter concentrates on HIV prevalence and incidence A Retrospective 
Survey of persons attending needle exchange centres, and a retrospective HIV 
Transmission Survey carried out in conjunction with the Drug Treatment Centre 
and the Ana Liffey Drug Project provide further input on the parameters of the 
sexual and drug using behaviour of intravenous drug users in Dublin
Chapter 4 examines current statistics of AIDS incidence, prevalence and 
deaths It includes a detailed survival analysis of AIDS patients which is used 
to estimate the survival parameter for the models
Chapter 5 uses a perturbation method to attempt an analytical solution of 
the system of non-linear differential equations which describe a deterministic 
model of HIV transmission, and describes the work to date on this method 
Chapter 6 applies the new parameters derived from studies described in 
chapters 3 and 4 to a deterministic mathematical model of HIV transmission It 
describes the construction and numerical evaluation of a predictive model 
under various assumptions covering model structure and parameter values, 
which are based in part on the results of our various studies It examines the 
sensitivity of the model to changes in parameters and evaluates potential 
intervention steps The model, which works in discrete annual time steps, is 
deterministic and provides predictions on the spread of HIV and AIDS from the 
IVDU population to the general male and female population of Ireland
Chapter 7 details the results, conclusions and recommendations based on 
the findings of the thesis
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Chapter 2
The Mathematical Modelling of AIDS
I have yet to see any problem, however complicated, which, when 
you look at it in the right way, did not become still more complicated
Poul Anderson (Science-fiction writer)
2.1 A definition of transmission models
Epidemiology is the study of the distribution of disease in human 
populations and of the search for determinants of disease encountered in 
different groups The study of epidemic models of various types is currently 
highly topical in a number of different disciplines Epidemiological 
mathematical models of HIV transmission consist of sets of simultaneous 
differential equations which are formulated based upon specific assumptions 
about the transmission dynamics of the virus
Numerous particular models have been introduced in recent years to 
explain various specific aspects of the dynamics associated with the spread of 
AIDS (see section 12 1) These provide useful results by a variety of means 
including analytical approaches, numerical approximation methods and 
simulation For example mathematical models based on the theory of Markov 
chains have been used to predict the spread of HIV/AIDS These models 
define a population's state at a particular point in time in terms of the states of 
the individuals m the population at that time The success of these models is 
dependent only on the availability of adequate data about the states of 
individuals in the population However data such as dates of diagnosis of AIDS 
disease stages in individuals are generally not known and impossible to 
determine precisely Fuzzy Arithmetic Techniques have been used to estimate 
such dates (Bielefeld, 1992)
Back-calculation methods have also been widely studied because they 
require few assumptions about the shape of the infection curve and require
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only AIDS incidence data and an estimate of the incubation period distribution 
However they provide no information on the future incidence of infection 
Automata network SIR models are a relatively recent development, which put 
the emphasis on the evolution of the disease
A detailed review of mathematical approaches to modelling HIV/AIDS can 
be found in Anderson (1989), Castillo-Chavez (1989) and Isham (1988) In 
what follows, we give the principal outlines of models we have used, indicating 
obvious limitations and desirable extensions
2.1.1 Stages in the course of HIV infection and AIDS
Figure 2 1 provides an illustration of the stages relating to the course of 
AIDS in a susceptible individual
Stages of AIDS
Seropositive
I 
I
Susceptible—>Onset of —>lnfectious—>Appearance of------> Death
infection symptoms (AIDS)
Infectious
Period
Time scale <------------------------------------->
Incubation Period
Figure 2 1 Stages of AIDS
Individuals infected with HIV pass through a series of progressive 
irreversible stages (at least 4), from infected but antibody negative to acquired 
immune deficiency syndrome diagnosis (Redfield et a l , 1986) The onset of 
infection is followed by an infectiousness period during which the individual is
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an infective and can pass on the disease to susceptibles A few weeks after 
infection (6-10, with an average of approx 65 days) (Anderson & May, 1991), 
antibodies to the virus are normally detectable in the blood and at this stage 
the individual is termed seropositive The time from infection until symptoms of 
disease occur is the incubation period It is thought that the incubation period 
can be described by three stages These correspond to an initial period of high 
HIV antigen concentration shortly after infection, the longer asymptomatic  y
stage, and the final symptomatic stage with high levels of antigenaemia (an 
antigen is a substance capable of stimulating the formation of an antibody), 
before the individual reaches fully developed AIDS (see section 1.1 1)
Studies suggest that infectiousness varies with disease stage, beginning 
with a highly infectious period immediately after becoming infected, followed by 
a longer period of low infectiousness and reaching a maximum shortly before 
the onset of AIDS (Pederson et a l , 1987, Goedert et a l , 1987 and 1988, 
Anderson & May, 1988) This could imply that the infectious period is much 
less than the incubation period In the absence of conclusive data, most 
published models assume that the infectious period is equal to the incubation 
period (e g Anderson et a l , 1986)
In modelling the epidemic it is usually assumed that all those infected with 
the virus will ultimately progress to AIDS and that, after AIDS is diagnosed, the 
individual concerned is effectively isolated (e g sexually inactive) and unable 
to infect further susceptibles This means that the infectious period is 
contained within the incubation period
2.2 Deterministic models of HIV transmission
Deterministic models involve the representation of individual risk 
behaviours, HIV transmission from infected to previously uninfected persons, 
and the development of the disease (AIDS) among those infected with HIV In 
this way the spread of HIV infection is modelled and future AIDS cases are 
projected These models incorporate principles of epidemic theory such as the 
distributed incubation and infectious periods, estimates of the transmission 
probabilities of HIV infection, an estimate of the initial' HIV prevalence, and 
estimates of the numbers of susceptibles recruited to the sexually active and 
drug using population They include features like heterogeneity in drug using 
and sexual activity (defined as the rate of needle sharing or sexual partner 
change per unit of time, or the percentage of non-drug-using heterosexuals
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who have sexual contact with IVDUs) and the effect of changes in sexual or 
needle-sharing habits
A complete model of the spread of the AIDS virus in the sexually active 
and IVDU community must account for the complicated interactions between 
people such as patterns of sexual mixing However, one must begin by 
understanding the behaviour of simple models with main features like 
incubation period, contact rates and transmission probabilities before going on 
to explore more complex ones Two different approaches to the modelling of 
sexually transmitted diseases have been developed
The first considers the behaviour of individuals as they form and break 
partnerships In this approach, paired individuals become infected when one 
partner is infected, but remain uninfected for the duration of the partnership if 
both are uninfected (Dietz & Hadeler, 1987) The second approach considers 
the risk to the individual and stratifies the population according to the amount of 
risk that individuals incur We will concentrate on the latter approach since we 
are primarily concerned with the models proposed for the spread of HIV in and 
from high-risk populations (Bailey, 1957, Anderson et a l , 1986)
2.2.1 Deterministic epidemic transmission models: basic approach
A deterministic model consists of a set of differential equations which, 
given assumed parameter values, can be solved numerically if not analytically 
to give a fixed temporal evolution of the system
In most countries in the developed world, spread of HIV infection was 
initially among the male homosexual population and this was the first situation 
to be modelled
A basic deterministic epidemic model divides a closed population of male 
homosexuals into three categories susceptible, infected and AIDS case 
individuals This is based on a SIR model where S represents the class of 
susceptible individuals, I the class of infected individuals, and R the class of 
removed (e g sexually inactive) or recovered individuals Suppose that at time 
t, a fixed population, of size n, can be separated into a group of X(f) 
susceptibles, Y(f) infectives and A(?) AIDS cases, where
X(i) + Y (t) +A(f) = n,
the latent period of the infection being regarded as negligible Suppose that 
each susceptible acquires new sexual partners at a rate s, that the population 
mixes homogeneously so that at time / the probability that such a partner is an
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infective is Y{t)/n (strictly Y(f)/(n-1) but n is assumed large), that p is the 
probability of infection from a sexual contact with an infected individual and that 
a is the rate of developing AIDS for infected individuals Then in a small time 
interval (f, f+8) there will be on average (3sX(f)Y(f)5/n new infectives A 
deterministic approximation to this stochastic process is therefore that X(f) 
satisfies
^  = - P  sX( , )Y( t ) /n  (2 1)
at
Infected individuals are assumed to go on to develop AIDS with a per 
infective being the mean rate of withdrawal from the infective class Therefore 
a second equation
<^ -  = $sX (it)Y(t)/n(t) -  aY(t)  (2 2)
dt
must be included in the deterministic model and n must be replaced by n(t) in 
(1) The appropriate form for n(t) depends on the assumptions made about the 
pool of possible sexual partners It could be the whole population so that n(t) = 
n, or one could assume that each withdrawn individual ceases to belong to the 
pool of possible sexual partners, and plays no further part in the spread of 
infection, in which case
n(t) = X(f) + Y(f)
Anderson et al (1986) proposed that on withdrawal from the class of infectives, 
each individual enters the class of AIDS patients In this case the incubation 
period for AIDS, a, is the same as the infectious period for HIV, and has 
expectation 1/a (i e 1/a denotes the average incubation period) We now have 
our third equation
= aY( t )  (2 3)
Thus an infective in an otherwise wholly susceptible population will pass 
on the infection to an average of R = fis/a susceptibles, where R is the 
reproductive rate of the infection
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2.2.2 The reproductive rate of infection
The potential for the spread of an epidemic such as HIV depends on the 
magnitude of the reproductive rate of the infection This rate denoted as Ro 
defines the average number of secondary cases of infections generated by one 
typical primary case in a population where almost everyone is susceptible to 
infection — as in the early stages of the epidemic Using data from the U K on 
rates of partner change, Anderson and May (1 9 8 8 ), suggest that Ro may be just 
above or below 1 If Ro is just above 1 then the doubling time of the 
heterosexual epidemic would be in the order of 8 -1 4  years, much longer than in 
the homosexual community Thus, viral spread may increase very slowly and, 
at the low prevalence outside high-risk populations, require large 
seroprevalence surveys to detect changes of a small magnitude With a 
deterministic model, if Ro is greater than one, each infection generates more 
than one secondary case and the result is a chain reaction or an epidemic If 
on the other hand Ro is less than one, the infection cannot develop or sustain 
itself The larger the value of Ro the shorter the time it takes for the number of 
cases to double
For HIV, Ro is a product of 3 factors the average probability that an 
infected person will infect a sexual or drug using partner over the period of the 
partnership, the average number of partners acquired per unit time and the 
average duration of infectiousness (as noted earlier in section 21 1 
infectiousness probably does not remain constant, but is often taken to be so 
for the sake of simplicity)
The reproductive rate of the infection can, however, differ between risk 
groups and can change over time as behaviour changes Much recent work, 
for example, has concentrated on the estimation of Ro for the heterosexual 
population (Dietz, 1 9 9 3 ) The nature of Ro suggests that the importance of the 
timing of behaviour changes cannot be underestimated Changes introduced 
early in the course of the epidemic have a disproportionately greater effect than 
similar changes introduced later (Peterson et a l , 1 9 9 0 )
2.2.3 Model for a population that is not closed
The basic model described above has assumed a closed population and 
has concentrated on the initial stages of the spread of infection For longer 
time periods it is necessary to allow immigration at rate X, to the class of 
susceptibles, and migration by all competing causes from all classes Suppose 
that migration, including deaths unrelated to AIDS occur in all classes at the 
same rate |i (to include the natural mortality rate) and that deaths due to AIDS
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occur within the class of AIDS patients at an additional rate v (where 1/v » the 
average survival time), v being large relative to [i Then the differential 
equations in section 2 2 1 are modified as follows
— —  = A, -  PsX(r)F(r)/«(i) -  j jX ( i)  (2 4)
d t
^ ^  = ^ s X { t)Y ( t) ln { t) - {a  + \i)Y {t) (2 5)
at
= a  Y(t) -  (p, +v)A (i) (2 6)
dt
Anderson et al (1986) describe numerical studies of the deterministic 
model described above, based on analyses of the available quantitative 
epidemiological data which assesses how various processes influence the 
course of the initial epidemic following the introduction of the epidemic
2.2.4 Heterogeneity
There are two broad types of heterogeneity which affect the spread of 
epidemics population heterogeneity (i e that due to differences between 
individuals, whether intrinsic or behavioural) and heterogeneity of mixing 
(contact patterns) So far the model described has assumed that the 
population under consideration is homogeneous, and the parameter s 
represents the constant rate at which individual members of the population 
acquire new sexual partners However this is an unrealistic assumption since 
individuals vary considerably in their levels of sexual activity The model can 
be modified to allow for this variation
May and Anderson (1987), describe one such modified model where it is 
assumed that the infection probability per partner does not depend on the 
number of contacts per partner They justify this assumption by reference to 
data by Peterman et al (1988) where no relationship could be found between 
the risk of HIV transmission and the number of contacts at risk
This modification is usually done by means of three types of matrices
contact matries, mixing or contact fraction matrices and transmission parameter
matrices A contact matrix, gives the number of contacts that persons in group /
make with persons in group j  per unit of time (i e the rate of making contacts
between different groups) The mixing matrix, gives the fraction of the contacts
of persons in group / that are made with persons in j  per unit of time The
transmission parameter matrix includes the effects of the probability of
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transmission per contact, and so, it gives the transmission rate to susceptibles 
in / resulting from contacts with infectious individuals in j
The coefficients within the matrices determine the links within and 
between the subgroups, these coefficients specify the probability that an 
individual in subgroup / 'mixes' (has sex or shares injecting equipment) with an 
individual in subgroup j  Therefore, the mixing matrices serve to allocate 
partnerships, they specify who has sex with whom and who shares needles 
with whom Transmission models can be used to determine such variables as 
which mixing pattern, sex or equipment- sharing, is the most crucial in 
determining the magnitude of the epidemic, and which parts of the mixing 
patterns (i e which links between which subgroups) are the most important to 
HIV epidemiology
There are two main lines of development in the attempts to take into 
account the effects on heterogeneity on disease transmission One line is 
empirical, the other is based on a model of mixing in the population
The empirical approach is to try to fill in the elements of a contact matrix 
directly from data The difficulty with this approach is that such information is 
not always available, particularly so with regard-to sexually transmitted 
diseases
There are somewhat different approaches to the development of mixing 
models The most common type of contact matnx in epidemic models of’ 
sexually transmitted diseases is built upon the assumption that individuals from 
different sub-groups mix randomly This leads to a proportionate mixing model 
in which the probability of contact between individuals from different groups is 
proportional to the size or amount of activity of the groups involved Hethcote 
and Yorke (1984) have developed a mathematical model for the transmission 
dynamics of Gonorrhoea to allow for the influence of population structure and a 
proportional mixing assumption, with sexual partners being weighted by their 
activity They have thus shown the importance of the existence of so-called 
core groups of individuals with much higher rates of partner change than the 
majonty of the population
Anderson et al (1986) have explored numencally the properties of the 
course of the AIDS epidemic using such a modified model '
Peto (1986) describes a simulation study using a simple AIDS 
transmission model in which he classifies the sexual activity parameter s into 
two groups, with a small minority of individuals having a very high activity rate 
while the majority of the population has a low rate
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V
Another possibility is that of restricted mixing, where individuals choose 
partners only from within their own sub-groups
However because the proportional and restricted mixing assumptions are 
not very realistic, especially for sexually transmitted diseases, Sattenspiel et al 
(1990), have relaxed some of the constraints on mixing patterns and developed 
a model based on a particular form of non-random mixing which they term 
preferred mixing In this form of mixing a certain proportion, p. of contacts are 
made between persons within the same group, while the remaining contacts, 
(1-pO occur between individuals from different groups and are made in 
proportion to the amount of sexual activity of the groups Sattenspiel et al 
explore the effects of varying the proportion of contacts restricted to within the 
group and show conclusively that lack of randomness in the choice of sexual 
partner can profoundly affect the course of the epidemic and is an important 
confounding factor to the levels of sexual activity
In contrast, Castillo-Chavez (1991), shows that preferred mixing (a convex 
combination of two mixing functions), contrary to the suggestions of some 
researchers, does not contain all reasonable possibilities
Jacquez et al (1989) and Koopman et al (1989) devised a mixing 
scheme (structured mixing) which allows the proportions of choices to be 
specified over all the subgroups In this scheme, choices are made in "contact 
classes" which can be thought of as locations (e g , geographical or social) in 
which the partner choices take place Alternatively, they could be determined 
by type of sexual activity or age group
With a heterogeneous model, the early exponential increase in the 
incidence of seropositivity or of AIDS will soon be replaced by a more slowly 
increasing function This is because after the initial period of rapid spread of 
infection through the highly active individuals, during which a large proportion 
of them will become infected, most of the subsequent infections will be of the 
less active individuals amongst whom the epidemic will progress at a slower 
rate Therefore a slowing of the rate of increase in the incidence curve is an 
inevitable consequence of heterogeneity in sexual activity and not necessarily 
a consequence of individuals changing their behaviour (Blower et a l , 1990, 
DeGruttola & Lagakos, 1989, May and Anderson, 1987) In such a situation 
the observed slowing may be only temporary and the seroprevalence/incidence 
level may soon begin to rise again
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2.2.5 The incubation period distribution
Attempts have been made to relate the number of reported cases of AIDS 
in a defined population to the proportion of that population infected with the 
virus as a specified point in time (Anderson et a l , 1986, May & Anderson,
1987) Non-parametric methods use only the information available from the 
observed data, but cannot therefore provide estimates of the progression to 
AIDS at durations greater than have been observed Parametric methods, 
which provide estimates of rates of progression to AIDS at durations greater 
than have yet been observed, require assumptions to be made about the form 
of the distribution of the incubation period of the disease Proper analysis of 
the distribution of incubation times for people infected with HIV can only be 
carried out by studying groups where the date of infection is known, or can be 
accurately estimated, and observing them over a long period, probably for 20 
years or more
Because we are presently in the relatively early stages of the HIV 
epidemic knowledge of the shape of the incubation time distribution is limited 
Medley et al (1987, 1988 a, b) analysed 297 cases of transfusion-associated 
AIDS known to have been diagnosed in the U S A before 1986 and for whom 
date of diagnosis and date of AIDS were known Assuming exponential growth 
(because it fitted the data better than linear growth) in the number of infected 
individuals and a Weibull distribution (because it best described the data) for 
the incubation time, Medley et al estimated a mean incubation time of 8 23 
years for adults The Weibull distribution, which is widely used in survival 
studies, is equivalent to supposing that some power of incubation time is 
exponentially distributed
The simple model described in section 2 2 3 assumes that the infectives 
who develop AIDS are withdrawn into the class of AIDS patients at a constant 
rate a However it is more probable that the chance of withdrawal depends on 
the time since infection A simple deterministic model describing the incubation 
of AIDS is as follows Let a(t) denote the proportion of a cohort of patients (all
of whom were infected with HIV at time t = 0) who have AIDS at time t If we 
assume that the rate of conversion from seropositivity to 'full blown' AIDS is a(f) 
at time f from the point of infection, then the rates of change of a [t) and y(i)
(the proportion who do not have AIDS, y + a = \) are given by
^  = -a ( t ) y ( t ) ,  (2 7)
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(2 8)
The initial condition is, of course, ;y(0) = 1 and a(0) = 0 We assume for
simplicity that all infected members of the cohort eventually develop AIDS 
Because the progressive impairment of the patient's immune system through 
time from the point of infection with HIV results in a linear rise with time in the 
probability that an opportunistic infection or cancer develops in that patient, a 
simple assumption concerning the form of the function a(t) is that it is linear 
with an intercept at zero (a(i) = cf) The solutions of equations (2 7) and (2 8) 
are
Equation (9) is identical to the 'hazard function' of the Weibull distribution 
The incubation period for AIDS should have an increasing hazard function, 
representing progressive deterioration of the infective's immune system In 
order to take this into account one must subdivide the class of infecteds at time 
t by time of infection and by sexual activity Anderson et al (1986) describe 
numerical studies of a model modified to include the incubation period 
distribution
It seems clear, however that the incubation periods for men and women 
may differ as may those for different age groups (see Medley et a l , 1987 and 
1988, Longini et a l , 1991, Mientjes et a l , 1993, and references therein)
2.2.6 Stages of infectiousness
In order to differentiate between stages of infectiousness, Billard and 
Zhen Zhao (1994), have established a mathematical framework for a multiple 
stage Markov model in which a population of fixed size N is divided into five 
categories susceptible, infected seronegative, seropositive asymptomatic, pre- 
AIDS and AIDS case individuals This division of overall infectiousness into 
these different stages was first proposed in the Walter Reed study (Redfield et 
a l , 1986), which divided the infective stage into six different components This 
was developed by Longini et al (1989) who partitioned the infective period into
(2 9)
(2 10)
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four progressive stages and distinguish between individuals diagnosed with 
AIDS who are alive and those who have died
Blythe and Anderson (1988a, b), proposed a deterministic model to 
account for the effect of varying infectivity by allowing the transmission 
probability to vary from stage to stage Their model is simplified by assuming 
that the rate of infection in the second stage of infection is 0 In their models in 
which the incubation parameter values reflect two peaks in infectiousness, 
Blythe and Anderson show how temporal variation in infectivity (the contact 
transmission probability) can influence the qualitative shape of the epidemic, 
and suggest that infectiousness is of shorter duration but of greater intensity 
than has previously been envisaged In this model no allowance is made for 
variable susceptibility of individuals to infection by an infected partner
Isham (1993) has shown that predictions depend crucially on the actual 
levels over time of the infectiousness
2.3 The heterosexual epidemic
The models described in section 2 2 have concentrated on a male 
homosexual population For transmission between heterosexuals the model 
has to be made more complicated, since there are two groups of individuals 
with the infectives in one group spreading the infection to the susceptibles in 
the other If we denote the numbers of female susceptibles, infectives and 
AIDS cases at time f by Xf (t),Yf (t) and Af (t), with Xm(t),Ym(t) and Am(t) being
the corresponding numbers for males, then a two group model corresponding 
to the simple homogeneous mixing model (see equations 4, 5 and 6) can be 
described by the following equations
= Xf -  $*SfXf(t)Y4t)ln4t) -  M/X/(r)
at
(2 1 1 )
dt
(2 13)
(2 14)
(2 12)
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at
=aY f( t ) - ( \ i f  +v)Af(t) (2 15)
= a Ym(t) -  (jlm  + V )Am(t) (2 16)
where X f{t) + Y f{t) + A f{t) = n f(t) and Xn(f) + Ym(t) + Am(t) -  nm(t) the
total number of females -and males in the sexually active age groups The 
mean incubation period and the rate of deaths due to AIDS is assumed to be 
the same for females and males but the transmission coefficients fV,(3m for 
spread of infection from female to male and from male to female are not 
assumed to be the same May and Anderson (1987) suggest that p/<J3m<J3,, 
where (3 is the corresponding coefficient for homosexual males Similarly, the 
rates for partner change sr,sm of females and males are probably not the same, 
and are likely to be substantially smaller than the male homosexual rate, and 
the rates of migration (to include natural mortality) are assumed to be different 
for females and males
In equations 11-16, the spread of HIV infection and the incidence of AIDS 
in a heterosexual population is modelled However it is of particular interest to 
us to investigate the effect on the heterosexual population of the current 
epidemic in male and female IVDUs as IVDUs may also be expected to transfer 
the infection to their non-IVDU sexual partners (see section 1 1), and for this 
the model must be extended still further Comiskey et al (1992) describes a 
numerical study of such an extended model in which the migration rate (to 
include mortality) and the rate of change of sexual partners are assumed to be 
constant
Comiskey (1992) denotes the four different groups within the population 
by the subscripts 1, 2, 3 and 4 for male and female drug users and male and 
female non drug users respectively Hence the population of male drug users 
at time t is denoted by P^t), the population of female drug users at time t is 
denoted, P2(t) and so on The nonlinear differential equation model to 
describe the rate of change in the number of susceptible, infectious and AIDS 
patients in the male and female intravenous drug using and non IV drug using' 
populations is given by
(2 17)
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g!>
dt " ,  p ,(.) %  p (0 - ( a + n . K W  (21fi)
(2 19)
where
x,(i)+3',W+AW = P.W
Py is the probability of transmission during a single needle sharing act from an
infectious in group yto a susceptible in group / The rate of needle sharing for 
members in group / with members in group j  is per unit time
Williams and Anderson (1994) describe a model for England and Wales 
which mimics transmission within and between different sexual activity classes 
(or needle sharing classes in the case of intravenous drug users) and within 
and between different risk groups such as male homosexuals, intravenous drug 
users and heterosexuals However they make no distinction between males 
and females and so fail to allow for differing probabilities of the transmission of 
HIV from males to females and vice versa
A factor that plays an important role in HIV transmission, especially in the 
initial phase of the epidemic, is the phenonomen of pair formation Pair 
formation markedly decreases the number of contacts involved in general 
transmission by concentrating the contacts within pairs Dietz (1988) and Dietz 
and Hadeler (1988) have developed models of the transmission of HIV infection 
for populations in which long-lasting partnerships are common In these 
models the population is divided into single males, single females and female- 
male pairs These models introduce explicitly a pairing rate and a separation 
rate The infection transmission dynamics depends on the contact rate within a 
pair and the duration of a partnership Dietz and Hadeler assuming that a new 
partnership can only start after the termination of the previous one, found that 
endemic equilibria can only exist if the separation rate is sufficiently large in 
order to ensure the necessary number of sexual partners The classical 
models are recovered if one lets the separation rate tend to infinity This 
approach highlights the importance of sexual pair formation, but, some of these 
models can prove quite complicated as can be seen from that of Dietz (1988) 
Dietz has 29 variables, the equations for which involve 42 parameters 
Reliable information does not in fact exist for many of the parameter values
33
The model would become even more complicated if it was extended to consider 
the progression of infectives to AIDS Daykin (1990) and Wiley et al (1989) 
furthermore note recent studies which indicate variation in the infectivity of HIV 
among heterosexual couples (P) Wiley et al represent this heterogeneity by 
modelling p as a random vanable
Blower et al (1991) used a transmission model as an explanatory tool to 
clarify the relationship between heterosexual and IVDU transmission They 
used a computer simulation to examine the gender-specific risks of 
heterosexual transmission in IVDUs Their results showed that the effect of the 
heterosexual transmission risk factor on increasing the risk of HIV infection 
depends upon the level of risk of drug injecting behaviour They also 
demonstrated that the addition of the heterosexual transmission risk factor to 
an individual with a very risky drug-injecting behaviour does not increase the 
individual's risk of HIV infection, whereas the addition of the same risk factor to 
an individual with a less risky drug injecting behaviour can significantly 
increase the individual's risk of HIV infection Another variation of a 
transmission model has been used as an explanatory tool by Kaplan (1989), to 
identify which factors determine the transmission speed of the virus among a 
community of needle-sharers
2.3.1 Demographic factors
Age structured models have also been proposed These may allow for 
more realism since it is known that the length of the incubation period tends to 
decrease with increasing age in adults Bongaarts (1989) proposed a staged 
computer simulation model in which he divides the infectious period into four 
infectious substates He stratifies his population by age, sex, sexual 
behaviour, marital status and infection/disease status
Anderson and May (1991) developed a series of age structured models 
and concluded that three realistic refinements, concerning sexual behaviour 
and the likelihood of transmission between the two sexes, produced a higher 
likelihood of the disease AIDS inducing a severe demographic impact These 
are age dependency in sexual activity (from high to low as people age), male 
preference for female sexual partners younger than themselves, and a higher 
likelihood of transmission from males to females and vice versa The reasons 
for the increased severity of the epidemic with these refinements are that all 
three factors enhance the chance that females are infected and die from AIDS 
during their years of high fertility. They modelled the situation when each of 
the three factors were taken independently and when all three were taken
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together The most severe independent impact results when the effective rate 
of sexual partner change is highest in young men and women
2.3.2 Changes in behaviour
Changes in behaviour can be incorporated into the model by letting 
individuals move from one sexual/drug-using activity subgroup to another 
Another sort of behaviour change is the adoption of safer sexual/needle- 
sharing practices as the epidemic progresses or publicity campaigns are 
mounted In the models for AIDS described so far, it has been assumed that 
infected individuals will take steps not to transmit HIV infection once they have 
progressed to full AIDS However, it is possible that many individuals who are 
aware of their infected status will cease transmission of infection at an earlier 
stage
This change could be introduced to the model by taking the transmission 
probability p to be a function of real time t (as well as the time x since infection) 
Alternatively, in a staged model one could suppose that the mean period of the 
third infectious stage is cut short even though full AIDS will not develop for the 
number of years by which it is shortened
A discrete-time model such as that for AIDS incidence, developed by 
Pickering et al (1986) would be appropnate to model such changing behaviour 
In a similar vein it will be necessary to allow for the temporal evolution of the 
model by incorporating treatment effects (Schechter et a l , 1989)
2.4 Summary
The major goal of modelling the AIDS epidemic is to gain insight into its 
dynamics which in turn will assist policy decisions This insight can best be 
gained by first using simple models and then developing these by the gradual 
inclusion of more complex features However the penalty attached to models 
incorporating greater realism is clearly the increased number of parameters 
about whose values and distributions there is considerable uncertainty As 
stated by Davis and Hersh (1981) a model is "a 'sometime thing', a convenient 
approximation to a state of affairs rather than an expression of eternal truth" 
The essence of modelling is to capture the main processes at work
We need to understand how the dynamics of a model depend on its basic 
components, and how sensitive they are to the way in which these are 
incorporated into the model Numerical studies of the models described in this
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chapter have been made to judge the effects of changes in assumptions and 
parameter values, and to gauge which of these have a critical influence on the 
course of the epidemic and conversely to identify those to which it is 
reasonably robust Many of these studies have used estimates of parameter 
values based on observational or survey data for particular populations (see 
e g Comiskey, 1991, Comiskey et a l , 1992)
However one must J)e careful here, since, as the epidemic progresses 
and attracts publicity, the underlying parameter values relating to sexual or 
drug using behaviour may change (see for example Noone et a l, 1993)
By identifying critical points in the transmission chains it may also be 
possible to identify places for intervention in the process that would not 
otherwise be obvious Therefore, mathematical models could be used to 
identify which subgroup and /or type of behaviour it is most important to target 
for behavioural change or for treatment In addition, by investigating the 
effectiveness of particular strategies in model form one can examine the impact 
on the total epidemic (Peterson et a l , 1990)
The use of mathematical models to provide reliable predictions on the 
future course of the AIDS epidemic requires the collection and analysis of many 
more data sets than are currently available In Ireland there is a particularly 
strong need for data regarding IVDUs and for data that will clarify the 
parameters involved in heterosexual spread Nevertheless, by critical 
consideration of the assumptions made in the modelling process, by using such 
data as are available and, in particular, by exploring the effects of alternative 
assumptions, mathematical models have a crucial role to play in predicting the 
future course of the disease
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Chapter 3
Revised Parameter Estimates: HIV Prevalence
3.1. Introduction
In this chapter we looks at the role of statistical studies in providing 
parameter estimates We also review the available literature on HIV 
transmission to determine plausible ranges for the parameters which we use in 
the deterministic model described in chapter 6, which is used to provide future 
projections
Sources of parameter estimates of the sexual and drug using behaviour of 
intravenous drug users, are drawn primarily from studies conducted in Western 
Europe, in particular from studies conducted in Scotland and Italy wher.e 
patterns may be expected to be similar to those in Ireland Previous Irish 
sources include retrospective studies of persons attending needle exchange 
centres, persons being maintained on Methadone, and HIV-infected prisoners
We have also obtained refined estimates, particularly for example, of
«
intervention parameters, through our own retrospective studies carried out in 
conjunction with the AIDS Resource Centre, the Drug Treatment Centre and 
the Ana Liffey Drug Project (Dunne et a l , 1993, Dunne et a l , 1995)
The collection of statistics is not only an end in itself It is a means of 
providing information on which the development of plans and strategies are 
based The aim of our studies is to provide the basis (i e the parameters or a 
reasonable range of estimates of these) to refine the models which seek to 
determine the development of the epidemic
The key parameters in determining the rate of growth of the AIDS 
epidemic are (1) rate of contact between individuals in different sub populations 
and different populations, (2) risk of transmission per contact, (3) risk of 
developing AIDS given infection with HIV, and (4) risk of infectivity (i e , 
capability of transmitting HIV) over time, given infection has occurred These 
can be categorised under three headings demographic, behavioural and 
biological
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3.2. Demographic data
3.2.1 Size of the IVDU population
Current estimates of the size of the IVDU population in Dublin are 
generally informed guesses rather than estimates Several attempts to
estimate the size of IVDU populations in discrete locations have been 
attempted Frischer et al_ (1993) point out that ecological techniques used to 
estimate animal populations can be applied to IVDU populations In particular, 
the capture-recapture method (CRM) has been applied to drug-user 
populations Frischer (1992), applied this method to estimate the number of 
drug injectors in Glasgow (see also Frischer & Leyland, 1992 and Brancato et 
a l , 1992)
Prior to 1990, the most reliable indicator of general trends in the incidence 
of drug use in Dublin was the number of new cases seen in the Drug Treatment 
Centre (DTC) Ireland's major treatment centre for drug users, (later to be 
named the National Drug Advisory and Treatment Centre and, later still the 
DTC), was established in Jervis Street Hospital in Dublin in 1969 The Centre 
treats drug users from all parts of Ireland although 90% of their cases are from 
the Eastern Health Board Area and the vast majonty of these in turn are from 
the Greater Dublin Area
There was a dramatic increase in the number of new cases seen by the 
DTC from 1979 on, with a peak number of new cases (892) in 1982 Most of 
this increase was attributable to opiate users, particularly heroin addicts 
Indeed it was commonly thought that there was an opiate epidemic in Dublin 
during the years 1980-1985 (Butler, 1991) With the advent of heroin, 
intravenous drug use became the norm A prevalence study, commissioned by 
the Minister for Health, which investigated a north inner-city community during 
the period 1982-1983, revealed that 10 per cent of those in the 15-24 age 
group had used heroin in the year prior to the study Since 1982 the number of 
new cases has fallen, and the situation stabilised during the years 1983-1990 
In 1991 the DTC saw 424 new cases However, this fall off in the number of 
new clients seen by the DTC does not necessarily reflect a fall off in the 
incidence of drug use but rather reflects the situation in Dublin where the DTC 
is no longer the only drug addiction and treatment centre (for example, 652 
individuals with a history drug use attended the Ana Liffey Drug Project during 
1993, which was a 10% increase over the previous year) Indeed it has been 
suggested that there are indications of an upsurge of drug activity m Dublin 
(Department of Health, 1991, Irish Times editorial, 30th Sept 1994)
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Estimates of the number of IVDUs in Dublin varies from 3,000 to 15,000 
(Bury, 1989) (see page 11) The Catholic Social Service Conference (1988) 
estimated that there were 4,000 heroin users in Dublin in 1988, while another 
estimate placed the number of intravenous drug users in the Greater Dublin 
Area in 1990 at 7,000 (O'Kelly et a l , 1990)
In 1989 a comprehensive Dublin Drug Misuse Reporting System was set 
up in the Health Research Board to collate information on drug users in 22 
different treatment centres throughout the Greater Dublin Area Anonymous 
information on clients in treatment centres is returned to the Health Research 
Board on a regular basis The figures published for 1991 do not however 
include drug users treated in Mountjoy Prison, or those treated by general 
practitioners In addition there was some under-reporting in two of the 
participating centres (O'Hare and O'Brien, 1993)
In response to an AIDS in the World survey in 1992, the Irish national 
AIDS program estimated the number of IVDUs to be 4000 (Mann et a l , 1992) 
According to O'Hare and O'Brien (1993), an estimated 2006 persons received 
treatment for drug misuse in 1991, which is 29% of the 7000 estimated by 
O’Kelly et al (1990) This is a very high percentage of IVDUs in treatment if it 
is compared with the 14% estimated by Frischer (1992)
Such information as is available on the nature and extent of drug use in 
Dublin refers mainly to those drug users who are in treatment This is not the 
same as the total population using drugs, however, since it is likely that a 
significant proportion of persons using drugs are not receiving any form of 
treatment (Klee et a l , 1991b, Frischer, 1992, Des Jarlais and Friedman, 1987) 
Des Jarlais and Friedman (1987) state that the great majonty of IV drug users 
are not in treatment at any point in time Research has shown that many Irish 
drug users are using drugs for an average of four years before they present for 
treatment (Woods, 1992) The drug using population is also difficult to quantify 
because given the illegality of the activity drug users are difficult to contact
The female male ratio for treated Dublin IVDUs is estimated to be 1 3 3, 
based on the findings from the Dublin Drug Treatment Reporting System for 
1991 (O'Hare and O'Brien, 1993) However the proportion of females is 
probably greater than that estimated, since it is the belief of many drug workers 
that women tend to present for treatment later, if at all Due to the 
predominance of males in the IVDU community, the majonty of sex partners of 
male IVDUs will be non-IVDU females, and so, the potential for heterosexual 
transmission from male IVDUs to female non-IVDUs may be considerably 
greater than from female IVDUs to male non-IVDUs Differences in hetero-
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sexual transmission will also be affected by gender differences in sexual 
behaviour (male IVDUs tend to have higher numbers of sexual partners than 
their female counterparts) and also by asymmetry in the heterosexual 
transmission efficiency of HIV the transmission efficiency is estimated to be 
significantly greater from male to female than from female to male (Johnson & 
Laga 1988)
Other demographicjdetails necessary include the rates at which people 
begin and cease injecting drugs intravenously, the rates at which people begin 
and cease sexual activity, and the extent of recruitment into the drug using and 
sexually active populations Richardson et al (1993) in their retrospective 
study of IVDUs, found that the mean age of first injection for 150 Irish 
respondents was 19 7 years (sd of 4 3 years) and the mean duration of 
injecting was 6.3 years (sd of 4 6 years) McKeown et al (1993) found the 
mean age of first injection to be similar for 120 Irish subjects, with a mean of 
19 4 years for women but 18 years for men, a finding consistent with previous 
research indicating that women start taking drugs later than men (O'Hare & 
O'Brien, 1992) A more recent study by Smyth et al (1994) found a mean 
duration of injecting of 4 9 years for 152 males, and 3 6 years for 61 females, 
attending the Drug Treatment Centre
Transmission models require estimates of the size of the IVDU and the 
bridge community (which consists of those non-IVDUs who are the sexual 
partners of IVDUs), but these are rarely known and may be difficult to obtain 
precise estimates of, for a number of reasons, not least the sensitivity of the 
problem Klee et al (1991a), studied 169 injecting drug users in the North 
West of England from a variety of settings (both in and out of treatment) to 
determine HIV risk behaviour They found that 54% of their sample preferred 
sexual partners who were non-drug users, 41% felt that drug status was 
irrelevant and 5% preferred drug users The study found that in general, 
respondents were moderately successful in acquiring partners of the preferred 
drug status
3.2.2 HIV infection amongst the IVDU population
Estimating the prevalence of HIV infection among IVDUs is 
methodologically difficult because true random samples of the general 
population of drug injectors are not obtainable (see page 13) Donoghoe et al 
(1993), found that London drug injectors with no experience of treatment had 
significantly lower rates of HIV-antibody testing, and significantly higher levels 
of HIV prevalence and of unreported HIV positivity than those previously or
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currently in treatment The study reported by Rhodes et al (1993b), had 
similar findings Rhodes et al found that of 104 confirmed HIV-1 antibody 
positive drug injectors in London, 41 3% had never received treatment or help 
for their drug use, and that 52% had never received a named test for HIV 
antibodies In addition they found that the majonty of confirmed HIV positive 
respondents (70 1%) were unaware of their HIV positive status Rhodes et al 
(1993a), in a cross-national study of HIV prevalence and HIV risk behaviour 
among 1,037 IVDUs also found a higher rate of prevalence in those with no 
experience of drug treatment Contact with services increases the 
opportunities for AIDS education and the promotion of harm reducing injecting 
procedures McKeown et al (1993), in a survey of 120 clients of the 
Merchants' Quay drugs service in Dublin, found that since the drug users had 
come into contact with the service 38% had increased the use of clean needles 
and 14% had increased their use of condoms
Our study of IVDUs in a treatment setting (Dunne et a l , 1995), described 
in detail in the Appendix shows that most IVDUs {77%) had been tested for HIV 
antibodies Overall 26 (29%) were seropositive, 54 (60%) were seronegative 
and HIV status was unknown in 10 (11%) However, almost a third (31 6%) of 
IVDUs in our study were unaware of their antibody status, either because they 
had not sought testing at time of interview, or because they had not looked for 
the result once tested This strongly indicates that only part of the problem is 
being assessed
It was pointed out by Robertson et al (1986), in a letter to the Lancet, that 
young drug users are particularly at risk of AIDS because they rarely have their 
own equipment and have little contact with the medical services or access to 
health education
These studies suggest that previous investigations of HIV prevalence 
among drug users may be biased by drawing on samples primarily from 
treatment settings
3.3. Behavioural data
3.3.1 Introduction
The rate of transmission of AIDS in a given population depends on a large 
number of behavioural variables the most important of these are the duration 
of partnerships (needle sharing and sexual), the gender-specific rate of 
acquisition of new partners, the type of sexual practice, and the patterns of
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sexual 'mixing' such as mixing within and between populations with different 
disease prevalence like IVDUs and non IVDUs (Anderson and May 1988) In 
general, high degrees of within-group mixing tend to reduce the overall 
magnitude of the epidemic
3.3.1.1 Source of parameters for the IVDU population
The parameters forjhe IVDU population were obtained from groups of 
IVDUs from two different Irish treatment centres, (n=117), (Dunne et a l , 1995) 
Double-site sampling helps to reduce some of the inherent bias in single-site 
recruitment and enables us to determine a range of plausible values for 
parameters in the model described in Chapter 6 These parameters include 
age of first heterosexual activity, rate of needle sharing, whom sharing with 
(strangers or always the same people), injecting behaviour of sex partners, 
number of new sex partners per unit time, use of condoms and type of sexual 
activity, and HIV status We also use the results of a survey of 62 HIV positive 
women attending an HIV clinic between 1989 and 1991 to assess special 
groups within the parameter ranges and to complement our work (Comiskey et 
a l , 1993)
Studies in drug users are fraught with difficulties and, as mentioned 
earlier, recruitment of users into studies may be biased by selecting drug users 
from treatment programmes (Kozel and Adams 1986, Fnscher et a l , 1992)
3.3.1.2 Source of parameters for the non-IVDU population
Since research on sexual behaviour carried out in other countries cannot 
be applied with confidence to the Irish situation (Johnson et a l , 1989a), the 
parameters for the general non-IVDU population were obtained from two 
studies dealing with sexual habits in Ireland, which were conducted in the 
recent past The first, by Lansdowne Market Research (1992), assessed the 
attitudes, opinions and beliefs of 604 adults, aged 18-64 who returned self­
completed questionnaires in August 1992 These respondents were initially 
contacted through a survey amongst a nationally representative sample of 
1,400 adults aged 15 and older This two stage process resulted in an 
imbalance by age group, (too high a proportion aged 18-34 and too few aged 
50-64), and region, (too high a proportion living in Dublin), and so the findings 
are likely to reflect more liberal and less conservative attitudes and behaviours 
than if the sample had more exactly replicated the adult population aged 18-64 
Nevertheless, the authors contend that the sample size (604) is large enough 
and its composition sufficiently widespread demographically and
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geographically to give credibility to the survey findings as representative of a 
substantial part of the adult population of this country
The second survey was carried out by Irish Marketing Surveys on behalf 
of LRC Products (1993), which manufactures Durex This survey measured 
sexual behaviour and attitudes to condoms and AIDS, of a statistically 
representative sample of 766 persons aged 17-49 living in the Republic of 
Ireland The questionnaire in this instance was administered in two parts, the 
core questions were asked via face-to-face interviews whilst a self-completion 
booklet covering the most sensitive behavioural topics was used to give 
respondents complete privacy and confidentiality
3.3.2 Needle sharing partnerships
3.3.2.1 Rate of needle sharing
Clearly, the level of sharing is an important determinant of HIV spread 
(Schoenbaum et a l , 1989) A study conducted by Richardson & 
Papaevangelou (1994 a) for the E U Study Group, in two phases (1990-91 & 
1992-93), of the high risk drug use practices in European IVDUs (half of whom 
were recruited out of treatment settings) found that injecting practices carrying 
a high risk of HIV transmission remain common in European IVDUs Only the 
self reported efficiency of cleaning showed improvement 42% of respondents 
in the second phase had injected with another IVDU's used needle (45% on 
phase 1), and 46% said they never gave used equipment to others 40% (24% 
on phase 1) of those who used another's needle had used an effective method 
of cleaning
A study conducted by Kelaher & Ross (1994) found that high risk 
behaviour in Australia was most likely in situations where needle availability 
was low, craving was high and others present were well known and had 
previously shared together The results suggest that HIV risk behaviour is 
strongly linked to the environmental context rather than high risk individuals 
The authors suggest that easy access to needles may have contributed to the 
relatively low probability of HIV risk associated with predominant patterns of 
injecting drug use in Australia
However, Italy provides a strong counter example The legal availability 
of sterile needles and syringes without prescnption has not prevented the rapid 
spread of HIV among IVDUs in the northern part of the country (Des Jarlais &
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Friedman, 1987) This is perhaps indicative that availability does not 
necessarily imply usage
Robert et al (1990) studied behavioural changes in intravenous drug 
users in Geneva and found that the incidence of new HIV infection peaked 
before 1984 (seroprevalence increased from 6% in 1981 to 38% in 1983) and 
has since declined (IVDU s starting methadone maintenance in 1987-1989 in 
this city had a seroprevalence rate of 22%) The authors suggest that this 
decline is mainly due to decreased needle shanng
Coming nearer to home, by 1984, Edinburgh had a HIV infection epidemic 
among IVDUs Indeed seroprevalence rose to approximately 50% within 2 
years of the first seropositive sample By the end of 1988, 1578 people —55% 
of them IVDUs mainly concentrated in Edinburgh—were HIV positive in 
Scotland (Delamothe, 1989) It was also noted by Robertson et a l , (1986) that 
the level of sharing among IVDUs in Edinburgh (where there was a policy of 
restricting injecting equipment from 1982 to 1985) was significantly far higher 
than in Glasgow This finding was interpreted by the authors as being the key 
factor in explaining the differential patterns of HIV infection among IVDUs in the 
two cities and consequently they proposed that needles and syringes be made 
freely available to IVDUs This policy has since been implemented in Glasgow 
Frischer et al (1993), believe that this policy has been instrumental in 
maintaining low HIV prevalence among IVDUs in Glasgow and so lends 
support to the hypothesis that availability of clean injecting equipment may be 
an important factor in preventing the rapid increase in HIV infection Not 
withstanding this policy however, Frischer et al (1992), used a multi-site 
sampling strategy and found that a third of IVDUs in Glasgow continued to 
inject with used equipment
Klee et al (1991b) found that age and length of drug use (which 
predictably increased with increasing age) were important factors in sharing in 
the North-West of England Sharing was least prevalent among older 
respondents and long-term users maintained on methadone in long-term 
treatment More non-agency respondents in this study were currently sharing 
than those in contact with treatment services However, although no 
differences were found between agency and non-agency respondents in the 
younger age groups, regarding how recently sharing had occurred, significant 
associations were found for those over 25 years with non-agency respondents 
sharing on a more recent basis The authors suggest that the positive 
influences of treatment upon nsk behaviour may be heavily dependent upon 
age and that a reduction of risk observed in an 'agency' group could therefore
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be a reflection of the entry into treatment of a group already pre-disposed to 
share less They also point out however, that a predisposition becomes reality 
more surely if it receives environmental support These findings are backed up 
by Schoenbaum, (1989) who found that longer time in methadone treatment 
was associated with substantial lower HIV seroprevalence rates
A number of Irish studies have addressed this question Williams et al 
(1990) looked specifically at Irish IVDUs receiving methadone maintenance 
and known to be seropositive (N = 48), and investigated whether they had 
altered their behaviour as a result of being infected They found that since 
diagnosis the cohort had made significant alterations in their at risk behaviour 
for HIV transmission The number of IVDUs sharing injecting equipment 
reduced from 47 (98%) to 30 (63%, p < 0 001, McNemar test for matched pairs 
data) Of those who continued to share after diagnosis, only 6 (20%) did so 
regularly (P < 0 001) Forty-one (87%) had shared regularly prior to diagnosis 
However, despite this positive change, there remained a high level of at risk 
behaviour for further HIV transmission Despite being seropositive 30 
individuals (63%) had continued to share injecting equipment (even if at a 
reduced risk level)
Pomeroy et al (1991) assessed the needle shanng behaviour amongst 60 
patients attending a methadone programme in Dublin They found that with the 
advent of HIV there is some evidence of a change in needle using habits 
amongst IVDU in Dublin Although 97% admitted to previous needle sharing, 
only 22% shared needles in the previous 6 months despite continued 
intravenous drug use.
O'Mahony and Barry (1992), in a study of HIV risk behaviour amongst 
HIV-infected prisoners in the Irish prison system, found that 38% had shared 
needles while free, with others whom they did not know to be HIV positive, 
despite knowing that they themselves were HIV positive
A study of 120 clients of the Merchants' Quay drug service (McKeown et 
a l , 1993) found that 53% of those who inject also share needles and that there 
was no difference in sharing between women and men In addition 41% of 
those who share do not always clean their needles Of those who share and 
do not always clean 64% are HIV seropositive
In the study of 62 HIV positive women attending an HIV clinic between 
1989 and 1991, conducted by Comiskey et al (1993), all 51 (82 3%) Irish 
female IVDUs admitted to having shared needles There appear to be gender 
differences in needle sharing behaviour patterns (Barnard, 1993)
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Our two site study of 117 IVDUs (Dunne et a l , 1995, see Appendix), 
found that 67% of those who injected in the previous three months (n=79) had 
shared equipment There were no significant differences found in needle 
sharing risk behaviour by sex The vast majonty, 93 (80 2%) of the total group 
reported that they always cleaned needles 21 (18 1%) said they sometimes 
cleaned and 2 reported that they never cleaned injecting equipment However 
when questioned about the methods they employed in cleaning the equipment, 
only 60 (52 6%) subjects effectively cleaned the equipment
Several studies have reported evidence for behavioural change towards 
injecting risk reduction among IVDUs (Hart et a l , 1989, Williams et a l , 1990, 
Robert et a l , 1990, Klee et a l , 1991a, Pomeroy et a l , 1991, O'Mahony & 
Barry, 1992, Comiskey et a l , 1993, Desenclos et a l , 1993, Rhodes et a l , 
1993a, b) Increasingly those in treatment are using sterile injecting equipment 
and reducing the number of people with whom they share (Richardson & 
Papaevangelou, 1994 a, Pomeroy et a l , 1991, Robert et a l , 1990, Williams et 
a l , 1990)
3.3.2.2 Numbers of needle sharing partners
Little data are available on which to base estimates of rates of change of 
needle sharing partners by IVDUs (Kaplan, 1989, Blower and Medley, 1992) 
Williams et al (1990) in a study of Irish IVDUs receiving methadone 
maintenance and known to be seropositive (N = 48) found a significant 
reduction in the number of IVDUs sharing with two or more others, 42 (89%) to 
19 (63%) (P < 0 001), after diagnosis of seropositivity
O'Mahony and Barry (1992), in a study of HIV risk behaviour amongst 38 
HIV-infected prisoners in the Irish prison system, found that subjects who 
shared injection equipment reported an average number of 9 5 different needle 
sharing partners in the total t/me since they were diagnosed HIV positive A 
majonty, (68 4%), of the subjects had been diagnosed seropositive for at least 
5 years, (mean 4 7 years)
Comiskey et al. (1993) in a study which included Irish female IVDUs, 
found that the number of people shared with in one week ranged from 1 to 40 
with a mean of 6 94 and standard deviation of 9 43
Finally, in our study of HIV transmission (Dunne et a l , 19S5, see 
Appendix), it was found that the average number of people shared with in a 
week when subjects were injecting, ranged from 0 to 48 with a mean of 2 9 and 
a standard deviation of 7.1. For females the mean was found to be 2 24 (Std 
Dev =2 65) and the corresponding figure for males was 3 14 (Std Dev = 811)
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In addition despite being seropositive, 17 subjects (65 4%) admitted to having 
continued to share injecting equipment m the previous 6 months Of these, 
only one person said they limited sharing to one other person while 11 of the 
17 (64 7%) had shared with more than one other person (data were missing for 
5 subjects)
*
3.3.3 Sexual partnerships
3.3.3.1 Age of first heterosexual activity/sexual intercourse
Johnson et al (1989a), found that men and women in younger cohorts had 
experienced first sexual intercourse earlier than people in older cohorts This 
supports the findings of the two surveys conducted on sexual behaviour in 
Ireland
Lansdowne Market Research (1992), found the average age of first 
sexual intercourse to be 21 for the group as a whole and for the female and 
male respondents The corresponding average age for Dublin respondents 
was 20 Table 3 1 outlines the findings of the survey with regard to age of first 
sexual intercourse
In their study, Comiskey et al (1993), found that female IVDUs became 
sexually active at a younger age than other women The mean age of first 
sexual activity for female IVDUs was found to be 16 04 (95% C l of 15 33 to 
16 75) years and 17 55 (95% C l of 16 41 to 18 69) years for other women
Dunne et a l , (1995) found the mean age of first sexual intercourse for the 
total group to be 15 7 years (S D 2 4, range 9-29 years, median 15) 70% of 
the total group had initiated sexual intercourse by age 16, §ind over half of the 
subjects in all agency/sex groups reported initiating sexual intercourse by age 
15 51 7% of women (15 out of 29) and 52 3% of men (46 out of 88) had
experienced intercourse by the time they were 15 years old There were no 
significant differences between the sexes, or between the different age groups 
regarding age of first sexual intercourse
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Table 3.1 Findings of survey conducted by Lansdowne Market 
Research regarding age of first sexual intercourse
%of % of % aged % in Overall
Females Males 18-24 Dublin %
Under 15 2 2 6 2 2
15 years 2 _ 4 6 4 3
16 years 5 7 12 10 5
17 years 6 7 10 8 6
18 years 7 16 14 12 11
19 years 8 9 7 10 8
20 years 9 7 3 10 8
21 years 8 5 3 7 7
22 years 6 3 3 4 5
23 years 9 3 1 7 6
24 or older 23 21 1 11 21
Not yet 10 9 28 7 9
No information 6 8 6 8 9
Mean age 21 21 17 20 21
3.3.3.2 Rate of acquiring new sexual partners
The risk of acquiring HIV infection depends heavily on the number of 
sexual partnerships formed per unit of time, (Schoenbaum et a l , 1989, Wiley et 
a l , 1989, May and Anderson, 1987) Schoenbaum et al (1989) found that the 
odds of being infected with HIV increased by 24 percent with each additional 
sex partner who used intravenous drugs (from one to five or more), this 
association was independent of drug-use practices Data on rates of sexual 
partner change are limited at present, particularly for heterosexual populations, 
but the data that does exist suggests that the mean number of partners per 
year is related to the age and the sex of the individual, as might be expected 
Younger age groups tend to have a higher rate of sexual partner change than 
older age groups (Anderson, 1988, Johnson et al, 1989a, Lansdowne Market 
Research, 1992, LRC, 1993) The quantities that influence the dynamics of 
transmission are not simply the mean numbers of new sexual partners per unit 
time, but rather the mean number of partners per unit time plus the variance to
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mean ratio, s for females acquiring male partners and s for males acquiring 
female partners Although the mean rate at which females acquire new male 
sexual partners must obviously be identical with the mean rate at which males 
acquire new female partners, s and s will not be identical if the variability in 
levels of sexual activity among females differs significantly from that among 
males Measurement of s and s therefore requires information, which is not 
always available, on the full distribution of partner-change rates
Lansdowne Market Research, (1992), found the majonty of respondents 
(51%) to have had one sexual partner only in their life to date (However 16% of 
18-24 age group reported having had two partners by the time of the survey) 
The majonty, 58%, of female respondents had one sexual partner only and the 
corresponding proportion for male respondents was 44% (see Table 3 2)
Table 3.2 Findings of survey conducted by Lansdowne Market Research 
regarding number of sexual partners
%of %of % in Overall
No. of partners Females Males Dublin %
1 only 58 44 46 51
2 only 13 10 13 11
3 only 5 7 7 6
4 + 10 25 23 17
None 10 10 7 10
The Durex Report (1993), found the average number of sexual partners in 
the past 12 months of those aged 17-49 to be 1 38 The corresponding 
average for those who were married was 1 03 for female and 1 05 for male 
respondents The averages for single female and male respondents were 1 25 
and 2 72 respectively 21% of single men claim to have had at least three 
sexual partners within the past twelve months The 21-24 age group (single or 
married) was the one with the highest average number of sexual partners 
(2 17) in the past 12 months
When questioned about whether concern about HIV had resulted in 
changing their sexual behaviour 21% of all respondents acknowledged that 
they had adapted their lifestyles 5% of the cohort reported having fewer 
sexual partners, and 10% reported taking more care about the type of partner 
because of their concern about HIV (see also Mann et a l , 1992)
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Comiskey et al (1993) found that 45 (66 7%) of the women surveyed had 
at least one or more different heterosexual partners in the preceding year, half 
of whom were HIV negative or of unknown serostatus They also found that 
female IVDUs had fewer partners in the preceding year than the non IVDU 
women The range in the number of partners in the year before the study for 
female IVDUs was 0 to 1 partner, the mode was 1 and the mean was < 1 The 
range in the number of different heterosexual partners of non IVDU women was
1 to 36 partners, the mode was also 1 partner and the mean approximately 4 
partners, so evidently the distribution was highly skewed
McKeown et al (1993), in a survey of 120 clients of the Merchants' Quay 
drugs service found that the vast majonty (82%) of sexually active respondents 
had only one partner in the 6 months prior to the survey 18% had more than 
one partner, with an overall average number of sexual partners of 1 7 in the 6 
month period However O'Mahony and Barry (1992), in a study of HIV risk 
behaviour amongst HIV-infected prisoners in the Irish prison system, found that
the subjects reported an average number of 7 different sexual partners in the
)
total time since they were diagnosed HIV positive A majonty, (68 4%), of the 
subjects had been diagnosed seropositive for at least 5 years (mean 4 7 
years)
In our study of HIV transmission (see Appendix), 46 (43 8%) of the 
respondents claimed to have had more than one sexual partner during the 
preceeding 12 months The mean number of sexual partners in the total group 
was 2 35 (S D 2 7, range 0-14) The median number of sexual partners was 1 
There were no significant differences between the sexes or the age groups 
regarding whether subjects had had more than one sexual partner in the 
previous year The mean number of sexual partners for women was 1 9 (S D
2 1, range 0-8), the corresponding figure for women was 2 5 (S D 2 8, range 0- 
14) The median number of sexual partners for women and men was 1 The 
prevalence of sex with a non-IVDU was high in the group as a whole with 67% 
of subjects reporting at least one partner who was a non-IVDU However, this 
differed widely between the sexes Men were far more likely than women to 
have had a non-IVDU sexual partner in the previous year 77 9% of men 
compared to only 34 5% of women had a sexual partner who was a non-IVDU 
(X2=18 5, df =1, p < 0 0001) On the other hand women tended to have more
drug using sexual partners than men 75% of women had at least one IVDU 
sexual partner in the previous year compared to 41% of men (p = 0 014, 
Fisher's exact test)
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3.3.3.3 Condom use
There is less evidence for sexual risk-reduction among IVDUs than for 
injecting risk-reduction Many diverse studies of sexual behaviour report low 
levels of condom use among drug users and few signs of an increase in their 
popularity (Robert et a l , 1990, Pomeroy et a l , 1991, Klee et a l , 1991a, 
O'Mahony and Barry, 1992, Murphy et a l , 1993, Rhodes et a l , 1993a, 
Richardson & Papaevangelou, 1994 b) Condom use reduces the spread of 
HIV infection and other sexually transmitted diseases The European Study 
Group (1992), in a study of the risk factors for heterosexual transmission of HIV 
found that none of the 24 partners of HIV infected persons in their study who 
had used condoms systematically since the first sexual contact was infected 
A study of, discordant couples in the U S conducted by Fischl et al (1987) 
found that only one partner out of ten couples who had used condoms 
seroconverted, whereas 12 partners out of 14 couples who had not used 
condoms seroconverted
In Ireland, Lansdowne Market Research, 1992, questioned subjects on 
the types of birth control which they personally used in the past year 50% of 
men and 30% of women reported using a condom The overall percentage was 
38% for Ireland, but was 46% for Dublin respondents The highest percentage 
of condom users were in the 25-34 year age group (55%), with 65% of men 
under 35 years reporting their use
The Durex Report (LRC, 1993) found that 28% of the population surveyed 
regarded use of condoms as their main method of contraception The condom 
was found to be particularly popular amongst those aged 25-29 and those who 
lived in urban areas 39% of those who reported using condoms did so 
pnmarily as protection from AIDS/STD
When questioned about whether concern about HIV had resulted in 
changing their sexual behaviour 21% of all respondents acknowledged that 
they had adapted their lifestyles However, the majonty of these people still 
appear to be putting themselves at risk of contracting HIV by failing to use a 
condom with new sexual partners Only 5% of the cohort reported initialising 
use of condoms because of their concern Single men have more sexual 
partners on average than other groups but among them only 10% reported use 
of a condom because of their concern about HIV Although these single males 
recognise the threat of AIDS, they continue to put themselves at risk 20% of 
them had sex with a new partner in the year before the survey and did not use 
a condom
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The Durex Report (LRC, 1993) forecasted a 12% growth in the condom 
sales market following the changes in Irish legislation in July 1992, which 
legalised condom sales through retail outlets other then pharmacies The Irish 
condom market has grown by 66% in the years 1985-1992 The year of 
greatest growth was 1992 when condom sales increased by 16% over those in 
1991
Intravenous drug users have been a particular focus of public-health 
efforts to encourage the use of condoms because they are at risk of infection 
through sexual behaviour In a study of the seroprevalence of HIV antibody in 
452 persons enrolled in a methadone-treatment programme in the Bronx, New 
York, Schoenbaum et al (1989), found that heterosexual activity was an 
independent risk factor for drug users
In a study of risk behaviour among 104 HIV positive drug injectors in 
London, Rhodes et al (1993b), found that respondents who were unaware of 
their HIV positive status were less likely to use condoms with primary sexual 
partners than respondents aware of their HIV status
Studies have suggested that use of condoms is higher with casual rather 
than steady partners (Hart et a l , 1989, Klee et al, 1991a, Rhodes et a l , 
1993a, Watkins et a l , 1993, Richardson & Papaevangelou, 1994b) In a study 
of HIV prevalence and HIV risk behaviour among 1,037 injecting drug users in 
London and Glasgow conducted by Rhodes et al (1993a), it was found that 
70% of London respondents and 75% of Glasgow respondents never used 
condoms with primary partners, and 34% of London and 52% of Glasgow 
respondents never used condoms with casual partners Half (48%) of London 
respondents and 42% of Glasgow respondents reported sexual intercourse 
with non-injecting private sexual partners
Similarly, Watkins et al (1993), in a study of the factors associated with 
condom use in a cohort of 158 sexually active heterosexual in- or out-of­
treatment IVDUs in Philadelphia, found that being HIV-positive and having a 
casual partner was associated with increased probability of using a condom 
They found that HIV positive subjects were 10 6 times more likely to use a 
condom than HIV negative subjects This suggests that knowing that one is 
HIV-positive is an important determinant of condom use and that HIV testing 
and counselling may therefore increase the use of condoms They also found 
that drug use and risky drug behaviours, were not associated with condom use, 
and neither were partner use of IV drugs Condom use by HIV positive 
subjects was not significantly influenced by the likelihood of the partner being 
infected However there was an interaction between serostatus and the
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likelihood of the partner being HIV-infected Subjects who were HIV-negative 
and who perceived their partner as potentially infected were 2 5 times more 
likely to use a condom than subjects who thought their partner was unlikely to 
be infected Subjects with a casual partner were 4 4 times more likely to use a 
condom than subjects whose partner was a spouse or steady partner The 
authors found no significant differences between female and male behaviour in 
this regard
A study conducted by Richardson & Papaevangelou (1994 b) for the E U 
Study Group, in two phases (1990-91 & 1992-93), of the use of condoms by 
European IVDUs (half of whom were recruited out of treatment settings) found 
that the level of condom use in the total sample was similar in the two phases 
The study found that in the second phase 72% of the female and 68% of the 
male respondents never used condoms with their regular partners, while 56% 
of the female and 46% of the male respondents never used condoms with their 
casual partners Indeed only 30% of female and 28% of the male respondents 
always used condoms with their casual partners Their findings suggest that 
high-risk sexual behaviour continues at high prevalence among European 
IVDUs
In Ireland a study on changes in risk behaviour of IVDUs receiving 
methadone maintenance and known to be seropositive conducted by Williams 
et al (1990), found that since diagnosis of HIV seropositivity the number of 
subjects using condoms had increased significantly Results are summarized 
in Table 3 3
Table 3.3 Behavioural change following diagnosis of HIV infection.
Before
Sexually active 98%
Using condoms 13%
Always use condoms 2%
N = 48
After McNemar test for
matched pairs data 
88% (64% with one partner)
64% p < 0 001
38%
However, despite this positive change, there remained a high level of at 
risk behaviour for further HIV transmission Despite being seropositive more 
than one third (36%) (down from 87%) who remained sexually active, did not 
use condoms
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Pomeroy et al (1991) found that 40% of their cohort of IVDUs attending a 
Methadone Programme in Dublin, used condoms on a regular basis
O'Mahony and Barry (1992), found that 51% of HIV infected prisoners in 
Dublin had unprotected sexual intercourse, while free, with others whom they 
did not know to be HIV positive Only 14% reported always using a condom 
This group reported an average number of 7 different sexual partners since 
they were diagnosed HIV positive The authors also found that there was 
considerable independence between risk-taking behaviour in the sexual and in 
the drug-taking domains, in that risk-taking in one area was not highly 
predictive of risk-taking in the other More HIV positive IVDU prisoners report 
risk behaviours in the sexual domain rather than in the drug domain 
O'Mahony and Barry point out that these findings highlight the potential of this 
group as a bridgehead for spread of HIV into the heterosexual population (see 
also Moss, 1987 and McKeown et a l, 1993)
Many of these findings are also confirmed anecdotally by Irish medical 
and social-workers, who report that HIV risk behaviour is more common in the 
sexual domain than in the drug domain and that condom use is more likely to 
occur with a casual partner than with a steady partner Sexual relationships 
between steady partners are based on trust, and the introduction of condoms 
into an ongoing relationship may be perceived as a violation of that trust 
Indeed France et al (1988) in a study of heterosexual spread of HIV in 
Edinburgh found that few regular partnerships always practised safe sexual 
techniques, even after a partner was known to be positive for HIV Therefore 
large proportions of those most at risk (non-IVDU steady partners) do not use 
the only known safe prophylactic against HIV infection For heterosexual 
transmission to decrease, interventions must also focus on changing 
behaviours within ongoing steady relationships
A study conducted by McKeown et al (1993), for the Merchants' Quay 
drug/HIV service, found that 63% of respondents do not always use a condom 
Further analysis revealed that 21% of sexually active respondents were 
involved in some kind of risky sexual behaviour (i e unprotected sex between 
partners one of whom is either HIV positive or has unknown HIV status)
Of the 45 women attending an Irish HIV clinic surveyed by Comiskey et al 
(1993) who had at least one or more different partners (half of whom were HIV 
negative or of unknown serostatus), only a little over a quarter (12) always 
used condoms Many of the male sexual partners were not intravenous drug 
users Only 7 (20 6%) of the 34 sexually active IVDU women and 5 (45.45%) 
of the 11 other women always used condoms, not withstanding the fact that all
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the women were regularly attended a HIV clinic and received regular 
counselling on HIV transmission
Another study of Contraceptive practices in HIV seropositive females in 
Ireland attending the G U M Department of St James's Hospital found that 
only 22% used condoms (Murphy et a l , 1993) Those who were currently 
injecting drugs were less likely to use reliable contraception than the 
heterosexual group Thejneterosexual group were more likely to use condoms 
consistently in comparison to the current IVDU group In fact only 7 (35%) of 
the heterosexual group and only 1 (4%) of the current IVDUs used condoms 
consistently All of these women had been fully counselled on safe sexual 
practices The vast majority (88%) of the sexually active women stated that 
they had one regular partner
Similarly, our study of HIV transmission (see Appendix) found that of the 
total group only 28 (23 9%) subjects reported that they always use condoms 
53 (45 3%) reported sometimes using them and 36 (30 8%) never use them 
Men were less likely than women to always use condoms (22% of men 
compared to 31% of women, %2= 7 1, df =2, p = 0 029) In the total group there 
were no significant differences between the age groups, or the HIV status of 
subjects, regarding condom use
Our study also analysed the use of condoms by stratifying by the number 
of sexual partners in the previous year, and by sexual contact with intravenous 
drug users There was no significant difference between those subjects who 
had had more than one partner in the previous year and others regarding 
condom use In the total group no difference in condom use was seen between 
subjects who reported sexual contact with intravenous drug users and subjects 
who did not, nor between subjects who reported sexual contact with non-IVDUs 
and subjects who did not. This also held true when the group was stratified by 
sex A high proportion of men reported sexual contact with a non-IVDU 
woman, indicating the potential for widespread heterosexual transmission of 
HIV to non-IVDU women from infected male drug users
There was a significant difference in condom use when measured against 
those who had been tested for HIV and those who had not been tested 26 7% 
of those who had been tested always use condoms compared to only 14 8% of 
those who had not been tested (%2= 6 47, df =2, p = 0 039)
It seems reasonable to infer that, if a significant proportion of drug users 
who are in contact with services and have been tested for HIV, are engaging in 
behaviours which effectively spread HIV then an even higher proportion of 
IVDUs who are not in contact with these services and have not been tested for
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HIV are probably involved in similarly risky behaviour We note that risky 
behaviour is not confined to drug users however, and appears to be quite 
prevalent among non-drug using Irish persons who are heterosexuals (Condon 
et a l , 1993, LRC, 1993)
Currently, estimation of the appropriate values for many of the sexual and 
IVDU behavioural parameters for transmission models is limited by the 
availability of the data These types of behaviour patterns are extremely 
heterogeneous and significant gender differences are found for both, 
(Schoenbaum, 1989) Our model (Chapter 6) therefore includes gender- 
specific behavioural heterogeneity In our work we have endeavoured to 
estimate such parameters from studies conducted among the Irish populations 
with which we are concerned. More quantitative information is, however, 
required on sexual activity patterns both in the general heterosexual population 
and in the IVDU population
3.4 Biological data
It is necessary to estimate the values of several biological parameters for 
transmission models, for example, the incubation period, the survival times, the 
heterosexual transmission probabilities per sexual partnership (i e the 
probability that a person will acquire the virus from their seropositive sex 
partner during a sexual partnership), and the probability of HIV transmission by 
sharing one infected needle
3.4.1. Incubation period
The incubation period of AIDS is defined as the time between first 
infection with HIV and the development of AIDS Variations exist in the timing 
of the diagnosis of disease because of differing interpretations of the definition 
of AIDS (Centers For Disease Control (CDC)) and because of different 
experiences of investigators
Much work has focused on the estimation of the distribution of the 
incubation period in homosexual and transfusion-associated cases, using a 
variety of models, and different averages such as the mean and median, 
(Medley et a l , 1987, 1988a, b, Blythe & Anderson, 1988b, Anderson, 1988, 
Biggar, 1990) The median here measures the time by which 50% of the 
infected population develop AIDS These studies are presently such that there 
is often relatively direct information on the distribution of incubation times up to
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4-7 years, but beyond that one is extrapolating on the basis of the assumed 
mathematical form of the distribution The most reliable estimates are obtained 
when considering the probability or hazard of developing AIDS in the first years 
after seroconversion This implies that the mean, which depends critically on 
the upper tail of the distribution for a distribution with a positive skew, is not a 
good indication of the information in the data (Medley et a l , 1987, Mariotto et 
a l , 1992) The rate at which individuals develop AIDS is a function of time- 
since-infection (the hazard function), the age of the patient, probably the risk 
group to which the infected person belongs, and possibly the patient's sex, 
(Anderson et a l , 1986, Medley et a l , 1987, 1988a, b, Goedert et a l , 1987 and 
1988, Longini et a l , 1991, Manotto et a l , 1992, The Italian Seroconversion 
Study, 1992)
Lagakos and De Gruttola (1989) found no significant differences in the 
conditional distributions of the incubation time of females and males in 
nonparametric analyses of data from 1,206 persons who developed AIDS as a 
result of contaminated blood transfusions However, Medley et al (1987), in a 
study of transfusion infected patients, found that the incubation times for 
females were longer than those for males Notional means (and medians) for 
the females and males are 8 8 years (8 4 years) and 5 6 years (5 5 years), 
respectively, on the basis of a model that assumes exponential growth in 
incidence of infected transfusions and a Weibull distribution for the incubation 
period The Weibull distribution is a generalisation of the exponential and has 
the advantage of considering a non-constant hazard over time (Kalbfleisch & 
Prentice, 1980) The Weibull distribution is equivalent to supposing that the 
risk of converting to AIDS increases as the time from HIV infection increases 
(Cox and Oakes 1984) It should be borne in mind that as more data become 
available the estimate of the average incubation period is likely to increase
Unfortunately, there is a relative dearth of studies of the incubation period 
of HIV in women, IVDU groups or in heterosexual groups Disease
progression among IVDUs may differ from that of seropositive subjects 
belonging to other transmission groups because of different age and sex 
distributions (Mariotto et a l , 1992, Fernandez-Cruz et a l , 1990) It has also 
been suggested that progression rates for IVDUs are higher than in the 
homosexual/bisexual population, because of an already weakened immune 
system, suggesting that IVDUs have a poorer prognosis However, there is 
little evidence to support this hypothesis Most studies indicate that HIV 
progression does not differ significantly between IVDUs and other risk groups 
(Biggar, 1990, Mariotto et a l , 1992, Selwyn et a l , 1992)
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Currently there is no evidence to suggest that progression rates differ 
between female and male IVDUs (The Italian Seroconversion Group, 1992, 
Selwyn et a l , 1992, Mientjes et a l , 1993) However, age has been found to be 
significantly associated with progression younger IVDUs having less rapid 
disease progression than those who were older at the time of infection (The 
Italian Seroconversion Group, 1992, Manotto et a l , 1992, Selwyn et al., 1992, 
Mientjes et a l , 1993)
As indicated in Table 3 4, current estimates of the mean and median 
periods, for sexually active adults tend to lie in the range of 6-15 years, 
irrespective of risk group (Longini et a l , 1989, De Gruttola et a l , 1988, Medley 
et a l , 1987, Medley et a l, 1988 a, b, Mariotto et a l , 1992) However as well as 
being limited in their value, most of these estimates have very wide confidence 
intervals The incubation period is expected to increase with time because of 
increasing opportunities for treatment at an earlier point in the disease process 
(Schechter et al 1989) This increase with time has to some extent been seen 
by the Italian Seroconversion Group (1992), which found that the risk of 
developing AIDS was 21% within 7 years following seroconversion, which 
suggests that the lower bound of the estimate of median incubation period 
suggested above (6 years) may be an underestimate for more recent years
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Table 3.4 Estimates of the median incubation period of AIDS (sexually
active adults)
Risk/Data Sample Reference Median time
arouo_____________ size_________________________ (years)
Homo/Bisexual 155 De Gruttola et al 8 8
men 1988
The U S Army 1796 Longini et al 
1991
9 6*
IVDUs 343 Alcabes P et al 
1992
100
Mixed
(278 were IVDU) 
aged 16-24 years 
aged 25-34 years 
aged > 35 years
420 Mariotto et al 
1992
152 
82 
6 1
* Refers to the time from seroconversion to opportunistic infection
diagnosis
3.4.2. Survival time
The inability of the person with AIDS to withstand infection means that 
survival times are relatively short Most studies which have estimated the 
survival time of persons with AIDS have concentrated on homosexual and 
transfusion-associated cases There are few published studies of survival time 
of AIDS in IVDUs (Lundgren J et a l , 1994, Seage et a l , 1993, d'Armmio 
Monforte et a l , 1992, Rasch et a l , 1992, Batella et a l , 1989) Once an 
individual develops AIDS, the average survival time appears to be between one 
and three years (WHO 1993) This will be dealt with in more detail in Chapter 
4
3.4.3. Transmission
In studying the transmission dynamics of HIV infection it is important to 
ascertain the relationship between the incubation period of the disease AIDS,
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and the duration and intensity of infectiousness over the incubation period 
Individuals infected with HIV pass through a series of progressive irreversible 
stages (at least 4), from infected but antibody negative to acquired immune 
deficiency syndrome diagnosis (Redfield et a l , 1986) Studies suggest that 
infectiousness varies with disease stage, reaching a maximum shortly before 
the onset of AIDS, but this has been difficult to measure (Pedersen et a l , 
1987, De Vincenzi, 1988^Goedert et a l , 1987 and 1988, Johnson et al , 1989b, 
Laga et a l , 1988 and 1989, European Study Group, 1989 and 1992, Padian et 
a l , 1991,) These studies suggest that infectiousness is at a low level 
(possibly even zero) throughout most of the incubation period, but then rises 
sharply during a period of perhaps one to three years before the onset of AIDS 
Infectiousness may also be heightened for a short period (a few months to a 
year or more) immediately after infection, but this is not well established 
(Bongaarts, 1989)
Variable infectiousness as suggested by the studies named above 
contradicts the assumption of a constant value for the transmission parameter (3 
but such an assumption has been judged not too unreasonable for 'population 
based' studies (Anderson & May, 1991)
Other complicating factors such as susceptibility of the contact, condom 
use, and co-factors such as the presence of other sexually transmitted 
diseases, and the type of sexual contact also affect the risk of transmission 
The European Study Group (1992) found that older age of the female partner 
increased the nsk of male to female sexual transmission
3.4.3.1 Heterosexual transmission
Sexual partnership studies have been conducted to estimate the value of 
the heterosexual ( female to male and male to female) transmission 
efficiencies (Tables 3 5 and 3 6) (Goedert et a l , 1988, De Vincenzi, 1988, Laga 
et a l , 1988, Peterman et a l , 1988, Johnson & Laga, 1988, Padian et al , 1987 
and 1991, European Study Group, 1989 and 1992) These studies involve 
momtonng monogamous couples in which one partner is HIV-infected and the 
other is uninfected Although these studies have limitations due to their small 
sample sizes and selection biases, they are the only means by which the 
heterosexual transmission efficiencies of the virus may be evaluated 
Strikingly, the majority of recent studies have found no relationship between the 
risk of transmission and length of relationship or number of acts of sexual 
intercourse (Table 3 5) These studies seem to indicate that there is marked 
heterogeneity in infectivity and possibly susceptibility between individuals, and
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that infectivity may vary over the long incubation period from HIV infection to 
AIDS
Table 3.5 European and American studies of sexual transmission of HIV
from men to women
Reference
Major risk 
factors in 
index case
No of
partners
studied
% of partners 
with antibodies 
to HIV
Padian et al 
1987
Bisexual/injecting
drug user 97 24%
Goedert et al 
1988 Haemophiliacs 124 14%
Peterman et al 
1988 Blood transfusion 55 18%
De Vincenzi 
1988 Mixed 104 28%
Laga et al 
1988
African connections/ 
heterosexuals 62 53%
European Study 
Group 1989 Mixed 155 27%
Padian et al 
1991 Mixed 307 20%
European Study 
Group 1992 Mixed 404 20%
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Table 3.6 European and American studies of sexual transmission of HIV
from women to men
Reference
Major risk 
factors in 
index case
No of
partners
studied
% of partners 
with antibodies 
to HIV
Padian et al 
1987 Injecting drug users 20 0%
Peterman et al 
1988
Transfusion
associated 25 8%
De Vincenzi 
1988 Mixed 27 4%
Laga et al 
1988
50% African 
heterosexuals 16 13%
Padian et al 
1991 Mixed 72 1%
European Study 
Group 1992 Mixed 159 12%
These studies have reported that transmission from infected men to 
women is more likely than from infected women to men Indeed Johnson and 
Laga (1988), suggest that there may be a two-to threefold difference in the 
probabilities The European Study Group (1992) found that male to female 
transmission is 1 9 times more effective than female to male transmission
Peterman et al (1988), has documented transmission from male to female 
and female to male following one or two acts of penile-vaginal contact It has 
however also been found that many women and men remain seronegative 
despite hundreds of episodes of unprotected intercourse, which suggests that 
factors other than numbers of exposures play an important role in determining 
susceptibility to infection
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Estimates of heterosexual efficiencies are subject to much uncertainty, 
and are extremely heterogeneous ranging from 0 to 71 (Anderson & May, 
1988, European Study Group, 1989, 1992, Johnson & Laga, 1988, Padian et 
a l , 1987, 1991) The variability in the results of these studies may be due to 
the differences in the study methodology, how the cases were ascertained, the 
risk group studied, the clinical status of the index case, the definition of the 
contact cases (some examined only long-term partners), the small sample 
sizes, the heterogeneity in sexual practices, the behavioural-biological 
cofactors, the partnership duration and the differences in condom use The 
results of the studies imply that the value of the heterosexual transmission 
efficiency (P) is almost always below 0 5 Anderson et al (1992) considered a 
range of transmission risks whose means for female-male and male-female 
range from 0 09 to 0 2 per partnership Studies of non-IVDUs suggest that the 
value of p is skewed towards the low end of the probability scale, but studies of 
heterosexual transmission in IVDUs suggest that the value of p may be much 
higher than in non-IVDUs (this may be another factor contributing to the 
atypical nature of HIV transmission in Ireland)
3.4.3.2. Transmission through needle sharing
It is known that the probability of transmission during needle sharing is at 
least as great as that due to sexual contact
In the case of intravenous drug users the likelihood of transmission 
appears to correlate with the number of injections involving the sharing of 
unsterilized needles (Friedland & Klein, 1987, Schoenbaum et a l , 1989)
The transmission risk per partner given by Blower et al (1991) was 0 5 
In our model a more conservative estimate of 0 25 per partner is used as a 
base estimate (see Williams and Anderson, 1994), but it seems likely that a 
wide range of values is possible as found for other parameters
3.5. Conclusions
There is a clear need for the collection of much more detailed data on all 
the parameters discussed above, although the social, ethical, and practical 
problems surrounding such research are formidable
Detailed quantitative information is needed on patterns of sexual 
behaviour in different areas of Ireland in order to properly model the epidemic
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in all its detail (Kingman et a l , 1988) This will require the conduct of extensive 
sociological and behavioural surveys
It is difficult to evaluate behaviour in any human group and perhaps most 
difficult of all in a population of IVDUs One such difficulty is that such data are 
subject to recall error The findings of studies of interpartner reliability of 
reporting, have been reasonably favourable however, with both partners 
providing reliable information on recent sexual behaviours (Upchurch et a l , 
1991, Padian et a l , 1990). A second factor is the sensitive nature of the 
information sought, and the possible tendency of IVDUs to give socially 
desirable answers to such questions A third factor is that these behaviours, 
especially sexual behaviour, involve aspects that are difficult to investigate fully 
within limited time spans and attention spans Finally there is the difficulty that 
much of the available information relates to groups that are in some sense self 
selected, for example, consisting of individuals attending drug treatment 
centres
Despite these problems of accurate parameter estimation, the extent of 
the potential benefits arising from prediction of infection levels, even with wide 
bounds, makes it worthwhile proceeding with a mathematical model
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Chapter 4
Survival with AIDS
4.1 Introduction
Survival studies of patients with AIDS are an important aspect of 
monitoring the AIDS pandemic They provide information on the response of 
different subgroups to the syndrome, and enable mathematical modellers and 
health care professionals to estimate future needs
Statistics on AIDS cases and deaths in Ireland are compiled by the 
Department of Health Up to the end of June 1994, the cumulative total number 
of recorded AIDS cases in Ireland was 408 This represents 27 3% of all 
known HIV seropositive individuals
A total of 209 deaths due to AIDS have occurred up to the end of June 
1994 41% of these are related to IV drug use and 10% relates to those who 
acquired the infection through heterosexual contact
4.1.2 Life expectancy of AIDS patients
Once AIDS is diagnosed, the life expectancy of patients is relatively short, 
although it depends on factors such as age, risk group, and the nature of the 
opportunistic infection or cancer that triggered the diagnosis of the disease 
Most studies to date, of the survival times of AIDS patients have concentrated 
on homosexual men We analysed the pattern of survival for patients 
diagnosed with AIDS in Ireland, the majonty of whom are intravenous drug 
users Our cohort of 193 patients represents 61% of all those who were 
diagnosed with AIDS in Ireland up to March 1993 We also assessed the 
relative influence of sex, age-group, risk-group, manifestation of disease at 
diagnosis, and treatment with anti-viral therapy on survival
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4.2 Methods
4.2.1 Patients
The study cohort was made up of 193 patients of St James' Hospital, 
Dublin, who were diagnosed as having AIDS, between 1986 and the 15th 
March 1993 There were 4 other patients whose death was attributed to AIDS, 
but since there was no date of diagnosis available for them (except perhaps 
date of death), they were omitted from the cohort In addition to these 
omissions one other patient who was still alive in September 1994, claimed to 
have been diagnosed with PCP in 1982, in London This patient first visited St 
James's Hospital in 1992 and was not diagnosed with an AIDS defining illness 
by this hospital up to March, 1993 Since there was no official confirmation of 
the PCP diagnosis, and, since such a long survival with AIDS (12 years) is 
unlikely, this patient too was omitted from our analysis
Reporting of AIDS in Ireland began in 1982 and was based on the clinical 
case definition established by the Centres for Disease Control, which included 
pathological confirmation of the presence of opportunistic disease The AIDS 
case definition was revised in 1985 and in 1987 and further revised in 1993
4.2.2 Missing values
Midpoint intervals were assumed in year and month of diagnosis of AIDS 
and of death if data were missing This was the case for three subjects where 
only year of death was recorded, for sixteen subjects where only year and 
month of death were available, and for ten cases where only year of diagnosis 
was recorded
4.2.3 Censoring
In addition to missing values two of the patients who had died had not 
died of AIDS related illnesses, (both of whom were male, under 30 years of age 
and intravenous drug users, and one had committed suicide), and for two other 
patients it was unknown whether or not their death was due to an AIDS related 
cause, and so it was decided to censor the data for these cases Patients who 
were alive at the end of the study (30th September 1994) and who had visited 
the hospital since the 30th of September 1993 were assumed to be alive and 
were censored at the study end date Patients who were not known to be dead 
but who had not visited the hospital since before the 30th of September 1993 
were censored at the mid point between the date of their last visit and the 30th 
of September 1994 There were 19 patients in the latter group
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4.2.4 Covariates
The following major variables were evaluated sex, age at diagnosis (< 
30, 30 to 34, 35 to 39, or > 40 years), risk group (indicating probable route of 
acquisition intravenous drug use, homo/bisexual activity only, intravenous 
drug use and homo/bisexual activity or other risk factor), treatment, year of 
diagnosis and manifestations of AIDS at diagnosis
Manifestation of disease at diagnosis was categorised in two different 
ways Using the criteria which are defined in the protocol of AIDS diseases 
developed by the CDC (see section 4 3 14), and labeled by us as GRP+, we 
categonse the cohort into six groups (A, B, C1, C1+D, D, and E)
In order to better compare our results with other studies, we also 
categorised the manifestation of disease at diagnosis according to criteria 
used in previous studies, and labelled by us as PCP+ This criteria divides the 
cohort into seven groups, (Kaposi's sarcoma alone, Kaposi's sarcoma and P 
carinn pneumonia (PCP), Kaposi's sarcoma with other infections or conditions, 
PCP alone, PCP with other infections or conditions, one other infection alone 
— i e , only one condition was recorded as manifestation of disease at 
diagnosis, and two other infections — i e , two or more manifestations were 
recorded)
Both categorisations of manifestation of disease were based on any 
manifestations which were recorded within one month of AIDS diagnosis
4.2.5 Data analysis
Data were analysed using the statistical package SAS (SAS Institute Inc,
1988) and the LIFETEST procedure in particular Survival curves were 
investigated using non-parametric methods specifically obtaining life-table 
estimates of survival LIFETEST was also used to test (using the Wilcoxon 
test) the variables of interest for their association with each other and pooled 
over the defined strata Cox proportional hazards regression analysis (P2L 
procedure [BMDP]) was used to construct a proportional hazards model for 
predicting length of survival and to identify the independent predictors of 
survival among the covariates (Hopkins, 1985) The model was constructed 
using a stepwise procedure (maximum partial likelihood ratio method) with a p 
value of 10 as the entry criterion and 15 as the removal criterion at each step 
Differences in survival were summarised by calculating relative hazard 
estimates for the different levels of each variable
Survival was examined in the total group and in each of the subgroups of 
interest Since 365 day intervals were used to calculate the survival curves,
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the numbers of patients surviving per year are approximations For 
convenience of presentation, the cumulative probability of survival and its 
standard error are expressed as percentages The median conditional 
survival - the time at which the cumulative probability of survival is 50 percent - 
is the expected median survival if all subjects in the cohort were followed until 
death and no new cases of AIDS were diagnosed It must be distinguished 
from the median observed survival, which is the median value in the 
distribution of the lengths of survival Due to the rapid increase in cases, the 
median observed length of survival in the cohort (full group) was shorter than 
the expected value (observed vs expected, 491 vs 576 days [Table 4 1])
All percentages quoted refer to the group as a whole unless otherwise 
stated
4.3 Results
4.3.1 Patient details
4.3.1.1 Sex
The cohort was 80 8% male and 19 2% female (Table 4 1) This provided 
a male/female ratio of approximately 4 2/1 54% of women were less than 30 
years of age while only 35% of men belonged to this age group ( x 2 = 4 4, p < 
0 04) The mean age for men was 33 years and that for women was 30 years
4.3.1.2 Age
All patients were between 21 and 55 years of age at the time of diagnosis 
The mean age was 32 and the median age was 31 The largest age group 
comprised subjects less than 30 years of age (see comparison with other 
studies in the discussion), accounting for 38 9% of the cases followed by 
subjects 30-34 years of age, accounting for 28% of the cases, and those in the 
35-39 years of age category with 21 2% The smallest grouping comprised 23 
subjects who were 40 years of age and older (11 9%), 22 of whom were male, 
21 of whom were Homo/bisexual, and 18 of whom died within the study period 
69 3% of all those under 30 years of age were I V drug users 91 3% of 
subjects over 40 were homosexual or bisexual men The mean age of those in 
the 40+ age group was 46 years
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Table 4.1. Distribution of Patients with AIDS (St. James' Hospital, Dublin, 
1986-1993), According to Study Variables and Length of Survival.
VARIABLE NO OF 
SUBJECTS
193Entire cohort 
Sex
Men 156
Women 37
Risk group 
Intravenous drug use 98 
Homo/Bisexual activity 72 
H/Bisexual & IVDU 7
Other risk factor 16
Age
<30 75
30-34 54
35-39 41
40+ 23
Manifestation of disease (PCP+) 
Kaposi's sarcoma alone 14 
Kaposi's sarcoma and PCP 4 
K S and another disease 1 
P cannn pneumonia alone 61 
PCP and another disease 10 
One other disease alone 94 
Two other diseases alone 9
LENGTH OF SURVIVAL 
MEDIAN*** 
days 
576
576
590
574
548
561
643
590
397
715
331
395
328
548
696
574
500
441
Median cumulative survival, derived from product-limit curves
4.3.1.3 Risk group
The percentage of intravenous drug users was 50 8%, that of 
homo/bisexual men 37 3%, that of subjects who were both intravenous drug 
users and homo/bisexual men 3 6% and that of subjects whose risk group was 
neither of the above 8 3%, (16 subjects, 10 of whom were female)
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83 7% of IVDUs were less than 35 years of age, whilst only 43% of 
homo/bisexual men were aged less than 35 years Indeed 29 2% of 
homo/bisexual men were over 40 years of age (the comparable proportion for 
IVDUs was only 2%) The mean age for those whose risk was homo/bisexual 
activity was 36 years whilst that of IVDUs was 30 years Homo/bisexual men 
therefore tended to be older than IVDUs When risk-groups other than IVDU 
alone and homo/bisexual activity alone were omitted from the analysis 
homo/bisexual men were significantly older than IVDUs (n = 170, %2 =37 2, 
df=3, p<0 0001)
4.3.1.4 Manifestation of disease at diagnosis
PCP was the manifestation with the highest frequency (37%), followed by 
Oesophageal Candida in 13% of cases A detailed protocol definition of AIDS 
diseases divides patients into 5 subgroups A, B, C1, D and E Subgroup A 
includes patients with constitutional disease such as wasting syndrome due to 
HIV Subgroup B includes patients with neurological disease such as HIV 
encephalopathy Subgroup C1 includes patients with symptomatic or invasive 
disease due to one or more secondary infectious diseases such as 
oesophageal candidiasis, PCP or cryptococcosis Subgroup D includes 
patients with secondary cancers such as Kaposi’s sarcoma and subgroup E 
includes patients with other clinical findings or diseases, such as Cervical 
cancer Table 4 2 shows a frequency table of all diseases recorded within one 
month of diagnosis, grouped according to the above definition, and table 4 1A 
shows the distribution of patients with AIDS according to Disease Group and 
length of survival
However in order to better compare results with other studies the 
manifestations of disease at diagnosis were classified into groups as described 
in the section on methods One other disease alone was the predominant 
manifestation of AIDS at diagnosis (48 7%), followed by PCP alone in 31 6%, 
Kaposi's sarcoma alone in 7 3%, PCP and another disease in 5 2%, two or 
more other diseases in 4 7%, Kaposi's sarcoma with PCP in 2 1% and Kaposi’s 
sarcoma with another disease which only accounted for 0 5% The mean age 
of those whose manifestation of disease at diagnosis was Kaposi's sarcoma 
either alone or with PCP (18 subjects) was 39 years This contrasts with those, 
whose manifestation was other than the above, whose mean age was 32 (see 
table 4 1 for details of relative sizes of groups)
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4.3.1.5 Year of diagnosis
Although diagnosis of AIDS in the cohort began in 1986 only 4 7% of 
cases were diagnosed before 1988 76 2% of the cohort were diagnosed
between 1989 and 1992
Table 4.1 A. Distribution^ Patients with AIDS (St. James' Hospital, Dublin, 
1986-1993), According to Disease Group and Length of Survival.
VARIABLE NO OF 
SUBJECTS
LENGTH OF SURVIVAL 
MEDIAN*** 
days
Entire cohort 193 576
Disease Group (GRP+)
A 3 —
B 13 216
C1 146 672
C1 + D 6 416
D 24 216
E 1 229
TABLE 4.2 Frequency Table of Disease Group (GRP+) at Diagnosis
Disease
GrouD
Frequency Percent Cumulative
Freauencv
Cumulative
Percent
A 3 1 6 3 1 6
B 13 6 7 16 83
C1 146 75 6 162 83 9
C1+D 6 3 1 168 87 0
D 24 124 192 99 5
E 1 05 193 100 0
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4.4 Survival
The crude mortality ratio in the cohort (the total number of deaths divided 
by the total number of cases) was 79 3% The proportion surviving by this 
crude measure was therefore 20 7% 68% of those who were aged 35-39 had 
died compared to more than 78% of those in each of the other age groups 30 
subjects (15 5%) survived for more than three years 26 of these were male 
giving a male female ratio^of 6 5 1 as compared to 4 2 1 for the full group, and 
15 (50 %) were aged less than 30 years as compared to 38 9% of the full 
group Only 4 (13 3%) of those who survived for more than three years were 
aged 30 - 34 as compared to 28% of the full group 13 subjects (6 7% of the 
total group) -10 of whom were male and 6 of whom were under 30 years of age- 
survived for more than four years Only one patient survived long enough to be 
censored at the study end point (7 3 years after AIDS diagnosis)
The life-table method estimates long-term survival more appropriately 
The survival graph for the cohort is shown in Figure 4 1 The cumulative 
probability of survival (mean ± SE) at five years (1825 days) was 6 5 ± 2 5 
percent (Table 4 3) The median conditional probability of survival from the 
date of diagnosis was 576 days as noted above in Table 4 1 The graph 
suggests three main phases with the end of the second year and the end of the 
fourth year marking the turning points The phases suggest no dramatic 
changes over time, but failure rate was slightly more rapid in the early years 
than in the later years The final phase is based on survival in 13 subjects and 
is truncated in Figure 4 1 at 2661 days
4.4.1 Survival in major subgroups
The values for survival in each of the major subgroups are shown in 
Tables 4 1, 4 1 A, 4 3 and 4 3A
72
CO 
3
Overall Survival of 193 patients with AIDS
SURVIVAL
Figure 4 1 Overall Survival of 193 patients with AIDS
Table 4 3. Cumulative Probability of Survival, According to Study Variables and
Length of Survival.
VARIABLE CUMULATIVE PROBABILITY OF SURVIVAL
1 YR 2 YRS 3 YRS 4 YRS 5 YRS 
percentages (mean ± SE)
Entire cohort 69 0± 3 3 36 8± 3 6 27 4± 3 6 14 7±3  2 6 512  5
Sex
Men 70 3±3 7 37 1 ± 4 0 28 6± 4 0 13 413  4 7 812  9
Women 63 4± 8 1 36 0± 8 6 21 6± 8 3 21 618  3
Risk group
IVDU 67 9±4  7 35 7± 5 1 25 5± 4 9 13 614  2 5 213 0
Homo/Bisexual 67 6± 5 5 38 4± 5 9 32 5± 5 9 17 515  5 8 714  5
IVDU and H/B 85 7±13 2 39 Q± 19 2
Other risk factor 75 0±10 8 35 5±13 2
Age
<30
30-34
35-39
40+
79 7±4  7 37 7 ± 5 8 26 0±5  4 13 0±4  4 8 3 ± 3  9
55 1 ± 6 8 28 7± 6 5 17 9±6  4 17 9±6  4
80 2± 6 3 49 3± 8 3 41 1 ± 8 7  1 9 2 ± 8 5  6 4 ± 5 9
46 7±10 5 31 9±10 1 319±101 1 0 6 ± 9 3  1 0 6 ± 9 3
Manifestation of disease (PCP+)
KS alone 571±13 2 26 7±121 26 7±121 26 7±12 1 13 3±11 2
KS and PCP 25 0±21 6 
KS+another dis 100 0+ 0 0
PCP alone 85 0±4  6 48 4±6  7 28 2±6  5 4 2 ± 3 2
PCP+otherdis 60 0±15 5 27 3±14 6 27 3114 6 13 6±12 1 13 6±12 1
Another dis alone 63 2± 5 0 34 4±5  2 28 8±5  3 23 8±5  4 6 0 ± 3 9
2 other diseases 66 7+15 7 33 3±15 7 33 3±15 7 16 7±142 167±142
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6YRS
2 2± 1 7
2 6 + 2 0
5 2±3  0
5 0± 3 4
16 7±14 2
Table 4.3A Cumulative Probability of Survival, According to Disease Group (GRP+)
and Length of Survival.
VARIABLE CUMULATIVE PROBABILITY OF SURVIVAL
1 YR 2 YRS 3 YRS 4 YRS 5 YRS 6YRS
percentages (mean ± SE)
Entire cohort 69 0 1 3  3 3 6 8 1 3 6 27 4 1 3 6 1 4 7 1 3 2 6 5 1 2 5 2 211 7
Disease Group (GRP+)
A 66 7127 2
B 46 1 113 8
C1 77 7 1 3  5 43 7 1 4  3 31 8 1 4  3 1 5 9 1 3 8 6 8 1 2 9 2 9 1 2 2
C1+D 50 0120 4 1 6 7 1 15 2
D 37 5 1 9  9 1 8 7 1 8 3 1 8 7 1 8 3 1 8 7 1 8 3 9 4 1 7 8
E 0 0
4.4.1.1 Age
The subgroup with those who were aged 35-39 years had a more 
favourable survival pattern, with a median survival of 715 days and a 
cumulative probability of survival of 80 25 ± 6 3 percent at one year (p < 0 04 
when compared to all other patients, Wilcoxon test of equality over strata) On 
the other hand, subjects aged 30-34 or those aged over 40 years had the least 
favourable prognosis particularly in the early stages, ( median 395 days, 
cumulative probability of survival at one year 52 6 ± 5 7 percent, p < 0 002 
when compared to all other patients, Wilcoxon test) Figure 4 2 shows survival 
stratified by age
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Survival of patients with AIDS grouped by age
SURVIVAL
TIME
TIME(DAYS) -1—1—1- 1 — 3— *  3
1 Under 30 2 30-34 3 35-39 4 40+
4 2 Survival of patients with AIDS grouped by age
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4.4.1.2 Sex
Sex differences are apparent primarily at larger survival times, i e no 
women survived after the fifth year However the difference is not significant 
Figure 4 3 shows survival stratified by sex
Survival of patients with AIDS grouped by sex
S U R V IV A L
TIME
TIME(DAYS) -1— 1— t- 1 2
1 Male 2 Female
Figure 4.3 Survival of patients with AIDS grouped by sex
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4.4.1.3 Risk group
There were no significant differences in survival when patients were 
stratified by risk group (Figure 4 4)
Survival of patients with AIDS by risk-group
SURVIVAL
TIME
T lM E {O A Y S )  -1— 1— t* 1 2 *3— 3— 3- 3 *  *  *  4
1 IVDU 2 Homo/bisexuai activity 3 IVDU + H/B activity 4 Other risk factors
Figure 4 4 Survival of patients with AIDS by nsk-group
78
4.4.1.4 Manifestation of disease at diagnosis
In order to better compare results with other studies the manifestations of 
disease at diagnosis were classified into groups as described in the section on 
methods PCP alone (61 subjects) was the manifestation of disease with the 
most favourable survival pattern, with a median survival time of 696 days and a 
cumulative probability of survival of 85 ±4 6 percent at one year On the other 
hand, subjects whose disease at diagnosis was Kaposi's sarcoma either alone 
or with PCP had the least favourable prognosis (18 subjects, median 363 days, 
cumulative probability of survival at one year 50 ± 11 8%) However the above 
results were not statistically significant, and, as pointed out earlier (section 
4 3 14), the mean age of those whose manifestation of disease at diagnosis 
was Kaposi’s sarcoma either alone or with PCP was 39 years contrasting with 
that of ‘other’ manifestations (mean age was 32)
The difference in survival time between subjects with Kaposi's sarcoma 
and those with other diagnostic features were contrary to those found in other 
studies In this study K S is the manifestation with the second shortest 
survival time The Reeves and Overton study (1988) and the Rothenberg and 
Woelfe et al study (1987) both agree that K S is the manifestation with the 
longest survival time between diagnosis and death The discrepancies 
between this study and the aforementioned may be explained by the tendency 
of homosexuals with AIDS to get K S and the older age of homosexual 
subjects in this study (see patient details) Patients with Kaposi's sarcoma in 
this case were generally older than those with other manifestations of disease 
The discrepancy may also be partly explained by the fact that only 19 subjects 
(9 8%) had Kaposi's sarcoma recorded as a manifestation of disease, a smaller 
proportion than in other studies (see discussion). Figure 4 5 shows survival 
stratified by manifestation of disease (PCP+) and Figure 4 6 shows survival 
stratified by disease group (GRP+)
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Survival of patients with AIDS by manifestation of disease (PCP+)
S U R V IV A L
TIME
TIME(DAYS) H— 1— V 1 2 *3— 3— *  3  4 «5— 5— 5- 5 > «  6  — ? — ?■ 7
1 Kaposi's sarcoma alone 2• KS and PCP 3 KS and another disease 4 PCP alone 
5- PCP and another disease 6' One other disease alone 7 At least two other diseases
Figure 4 5 Survival of patients with AIDS by manifestation of disease (PCP+)
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4.4.2 Patients with the most favourable survival
Figure 4 7 shows survival time in the subgroup with the "more favourable" 
survival (patients aged 35-39 years who were initially diagnosed with an 
opportunistic disease) compared to all others The graphs are different with 
respect to the likelihood of early death but coincide more closely after about 3 
years, although clearly, numbers are smaller as the tails are approached The 
cumulative probability of survival at one year among patients aged 35-39 years 
who were initially diagnosed with an opportunistic disease was significantly 
better at 84 1 ± 6 5  percent (p < 0 03, Wilcoxon test of equality over strata ), 
with a median conditional survival of 956 days, the corresponding value at one 
year among the remainder of the cohort was 66 0 ± 3 8 percent, with a median 
conditional survival of 547 days The survival curve for the comparison group 
crossed that of the 'more favourable' subgroup after the third year
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Survival in the subgroup which showed a ‘more favourable’ survival 
time compared to all others
SURVIVAL
TMC(CMYS) « t- » 1 2
1 Patients aged 35-39 years initially diagnosed with an opportunistic disease (n = 32)
2- All Others (n = 161)
Figure 4 7 Survival in the subgroup which showed a ‘more favourable’
survival time compared to all others
4.4.3 Short - term survival
Overall, 14 persons (7 3% of the full cohort) died within one month of 
diagnosis of AIDS with the percentage of women dying within this short period 
higher than that of men (5(13 5%) of all women vs 9(5 8%) of all men) 7 of
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the 14 were aged between 30 and 34 years, and only 28 6% were under 30 
years Interestingly none were aged 35-39 and only three were on anti-viral 
therapy 4 of the 14 were patients with a manifestation of disease from group 
D, which gives a higher proportion than that in the full cohort Severity of 
disease at diagnosis was not available in the data set Numbers in this group 
are clearly very small
Within the first sixjnonths of diagnosis 37 persons (19 2% of the full 
cohort) had died, of whom 17 (45 9%) were aged between 30 and 34 years, 9 
(24 3%) were 40 years of age and older, 21 (56 8%) were IVDUs, nearly a 
quarter (24 3%) had been diagnosed with a disease from group D, and 
21 (56 8%) were on anti-viral therapy
4.5 Treatment with anti-viral therapy
Zidovudine treatment of AIDS patients was licensed in 1987 Survival for 
167 subjects who were treated with zidovudine or 2', 3'-dideoxyinosine (ddl) or 
DDC (only one subject) at some point during their illness was compared with 
survival for 26 subjects who were not receiving any anti viral therapy (11 of 
whom it is important to note died within one month of diagnosis of AIDS, and 
one of whom was treated with a prophylactic drug (septrin)) In addition 2 of 
the subjects who were included with those on treatment were involved in a drug 
trial and it is therefore unknown whether they were, in fact, on treatment or on a 
placebo
Since we have no evidence of the selection procedures used nor of the 
state of health of individuals at either the time of diagnosis or the time of first 
treatment we cannot be sure that the two groups (i e those on treatment and 
others) are comparable
Survival is calculated without regard to actual duration of therapy 
Therapy with either zidovudine ddl or DDC was significantly associated with 
increased survival in the group as a whole, and, when stratified by the 
covariates age-group, sex, and risk-group (p <0 0002, Wilcoxon test for the 
association of survival with covariates) There was no significant difference in 
survival between the sexes for those who were on therapy But of those who 
were not on therapy, women had a longer median survival time (300 days) than 
did men (40 days) However this difference was not significant The mean age 
for those on treatment was 32 and that for those who were not on treatment 
was 34
The influence of each of the six covariates (sex, risk-group, age-group, 
treatment, year of diagnosis and manifestation of disease at diagnosis in the 
presence of each of the others was assessed in a single proportional hazards 
model to predict length of survival (see Table 4 4 for significant results) In this 
model a relative risk of 1_and positive coefficients imply an increased risk and 
therefore indicates a negative relationship with survival Anti-viral drug 
treatment was the best independent predictor of survival followed by year of 
diagnosis and disease group (GRP+) Sex, manifestation of disease at 
diagnosis (PCP+), age-group and risk-group were not significant predictors and 
were excluded by the model
The proportional hazards model also suggests that improved survival was 
associated with being on anti-viral therapy and having a disease from the C1 
group (GRP+) Being aged 35-39 years was also associated with improved 
survival but did not fall within a 95% confidence interval Survival was shortest 
for those patients aged 30-34 and those aged over 40 years, those who were 
not receiving anti-viral treatment, those whose manifestation of disease at 
diagnosis included Kaposi's sarcoma or other cancer, or those whose disease 
was neurological Referent groups were those determined to have the best 
survival curves by the categories given below (see figures 4 2-4 6)
Tabfe 4.4 Effect of significant covariates on relative hazards for persons
with AIDS
Patient Characteristics Coefficient ± SE* Relative hazard ** o value 
Not on Therapy -0 185 ± 0 236 0 31 <0 0001
Year of Diagnosis $ 0 203 ± 0 055 1 22 <0 0001
Disease Group (GRP+) 0 206 ± 0 107 1 23 <0 061
** Proportionate increase or decrease in hazard compared with baseline of 
1 0, with effects of all other covanates held constant
$ The time dependent covariate Year of diagnosis was used to test the 
proportionality assumption, the result of which suggested that the 
proportional hazards model is valid
4.6 Proportional-Hazards-Model coefficients for covariates.
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Table 4.5 Proportional-Hazards-Model Coefficients for Covariates with
Referent Group
Co van ate Referent Coefficient* ±  SE Relative risk of death ** p value
Sex Men
Wo m e n not significant
Age-group 35-39 p=0.0764
<30 ~0 170 ±0  229 1 19
30-34 0 567 ± 0 246 1 76
40+ 0 449 ±0  303 1 57
Risk-group IVDU
Homo/bisexual not significant
IVDU & H/Bisex
Other
Treatment
Not on therapy On therapy 1 249 ± 0 233 3 49
Disease grp (GRP+) C1
A -0 369 ± 1 007 0 69
B 1 164 ±0314 3 20
C1+D 0 592 ±0  461 1 81
D 0 634 ±0  243 1 92
E 1 542 ±1 012 4 67
p=0 0001
p=0 0003
Manifestation PCP alone
KS in any form not significant
PCP with another disease
One other disease alone
2 or more other diseases
*A coefficient is the logarithm of the relative risk of death at any time, as 
compared with the value in the referent group A value of zero implies 
an identical risk of death, whereas a positive (or negative) coefficient 
implies an increased (or decreased) risk
** exp (Coeff )
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4.7 Significant findings
In the overall analysis the influence of each of the major variables in the 
presence of the others was tested Treatment with anti-viral therapy, year of 
diagnosis, and disease group to which the patient belonged at diagnosis, had a 
significant influence on the survival of the cohort (p<0 0002, p<0 0006 and 
p<0 02 respectively, Wilcoxon test for the association of survival with 
covanates) They also remained significant when the cohort was stratified over 
sex, risk, age, and manifestation of disease groups
Age-group, disease-group, treatment-group (i e either on anti-viral 
treatment or not on treatment), and year of diagnosis showed significant 
differences between strata (p < 0 01, p < 0 002, p < 0 0002 and p < 0 04 
respectively, Wilcoxon test of equality over strata) Patients aged 35-39 
showed longer median survival times (715 days) than all other age groups 
(median survivals 547 days), (p < 0 04, Wilcoxon test) Patients whose 
disease group was opportunistic disease/s alone (CDC IV group C1) had a 
significantly longer median survival (672 days) than did all others (i e those 
whose disease was Kaposi’s sarcoma (K S ) or other cancers, those with 
neurological disease, or, those with other diseases), (median survivals 281 
days), (p < 0 0002, Wilcoxon test)
Survival did not differ significantly by sex or risk group alone, nor did it 
differ significantly by manifestation of disease when grouped according to 
criteria used in previous studies, and labeled by us as PCP+
Five (2 6%) patients survived more than 5 years after AIDS was 
diagnosed, all of whom were male
4.8 Discussion
In our cohort of 193 subjects, the cumulative probability of survival at one- 
year was estimated to be 69 ± 3 3 percent and the five-year cumulative 
probability of survival was estimated to be 6 5 ± 2 5 percent As currently 
estimated the spectrum of survival is bounded by 14 persons who died within 
one month of diagnosis and by one person who survived past the truncation 
time Within these bounds there is considerable heterogeneity
The probability of survival is most strongly influenced by treatment with 
anti-viral therapy It is strongly influenced too by year of diagnosis and 
disease-group at diagnosis
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Among groups defined by a single factor, subjects aged 30-34 and those 
aged over 40 years, those who did not receive anti-viral therapy, those whose 
manifestation of disease at diagnosis included Kaposi's sarcoma or other 
cancer, or those whose disease was neurological appeared to have the poorest 
prognosis
4.8.1 Comparison with other studies
To date a number of studies have estimated survival among AIDS 
patients Median survival ranged from 280 days to 760 days The survival time 
found by this study is therefore comparable to previous first world studies of the 
survival of persons with AIDS However only 13 of these 19 studies were 
conducted on subjects who were diagnosed since 1987, the date of the 
introduction of anti-viral therapy For all cases, the median survival was 576 
days in this study, 581 days in Cologne (Faetkenheuer et a l , 1991), and 608 
and 633 days respectively for those patients diagnosed in 1987 in the U K 
(Peters et a l , 1991) and in Washington State (Lafferty et a l , 1991) The 
cumulative probability of survival for 12 months, after a diagnosis of AIDS was 
69 0 ± 3 3 percent in this study compared with 54 ± 1 percent in Massachusetts 
(Seage et a l , 1993) and 48 8 ± 0 7 percent in New York City (Rothenberg et 
a l , 1987), (see table 4 6) The cumulative probability of survival for 3 years 
after diagnosis, was 27 4 ± 3 6 percent in this study compared to 13 1 percent 
in San Francisco (Lemp et a l , 1992) and 22 ± 0 8 percent in New York City 
(Rothenberg et a l , 1987)
The natural history of AIDS in this study as indicated by the survival time 
is therefore similar to that in other Western countries The main discrepancies 
between median survival times for this study and the others reside in the times 
for certain age groups and the times for those patients with Kaposi's sarcoma 
Many studies however indicate that of all the age groups those over 40 years 
have the worst prognosis (eg Seage et al , 1993, Lemp et al , 1992, 
Whitmore-Overton et a l , 1993, Altes et al., 1992, d’Arminio Monforte et a l , 
1992, and Morlat et a l , 1991) and this is in agreement with our findings
In this study the survival curves varied significantly with age at the time of 
diagnosis of AIDS, with the median survival time ranging from 715 days in 
those who were aged 35-39 years to 331 days in those who were 40 years of 
age or older at the time of diagnosis
The median survival time for patients who were infected by way of 
homosexual practices was 548 days this study and 578 days for those 
diagnosed between 1988 and 1990 in San Francisco (Osmond et a l , 1991)
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There was no significant difference, in this study, in survival times between 
those infected in this way and those infected because of their use of 
intravenous drugs Batalla et al (1989) studied the survival time of AIDS in 
289 IVDUs and found the survival time of IVDU-related AIDS to be slightly 
longer than the estimated survival times calculated for other risk groups 
Seage et al (1993) found the contrary to be the case
There were marked„differences in the median survival of patients whose 
manifestation of disease at diagnosis was Kaposi's sarcoma alone and those 
patients in other studies who were initially diagnosed solely with this disease 
This study showed a median survival time of 395 days compared with one of 
645 days in the U K. (Marasca & McEvoy, 1986) and 750 days In New York City 
(Rothenberg et a l , 1987) However there were only 14 (7 3%) such patients in 
this study However an Australian study showed similar survival times to this 
one with a median survival time of 377 days for patients with K S (Whyte et a l , 
1989), (see table 4 6) ‘
Therefore, when considering the data which concern the mode of 
transmission, and the survival time, it is apparent that survival with AIDS in 
Ireland is similar to that in other developed countries even though Ireland has 
one of the highest percentages of drug related AIDS cases among those 
countries who report to AIDS Surveillance in Europe (WHO-EC Collaborating 
Centre on AIDS, 1993)
A comparison of recent studies forms the basis of the final table in his 
chapter The survival times found in this study are more in line with more 
recent studies (i e those conducted since 1990) than with earlier ones 
However the significant differences (in this study) between Kaposi's sarcoma 
and other diagnostic features were if anything contrary to those found in other 
studies In this study K S is the manifestation with the second shortest 
survival time The Reeves and Overton study (1988) and the Rothenberg and 
Woelfe et al study (1987), (see table 4 6), have overall agreement between 
them The two sets of results are very close They both agree that K S is the 
manifestation with the longest survival time between diagnosis and death and 
that of all the age groups, those over 40 have the worst prognosis Our study 
would agree with both studies mentioned only with respect to the latter finding 
The discrepancies between this study and the aforementioned may be 
explained by the time difference (in so far as this study includes diagnoses up 
to 1993 and survival may have improved with knowledge gained over the years, 
in particular with regard to treatment of PCP) and by the fact that only 13 (18%) 
subjects out of the 72 homo/bisexual men and only 7 3% of the total Dublin
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cohort, had Kaposi's sarcoma recorded as the manifestation of disease at 
diagnosis Thirteen of the 14 of those whose manifestation of disease at 
diagnosis was recorded as Kaposi's sarcoma alone in this study were 
homo/bisexual men and one was an IVDU Nine subjects out of the 14 were 35 
years of age and older
The epidemiology of AIDS in Ireland has been described previously 
(Comiskey, 1991) and has been shown to be unlike that in other developed 
countries in terms of the distribution of cases by sex, the age-groups that are 
affected and the risk activities that lead to infection with HIV Of all the cases 
of AIDS in this study, 66 8% of cases were found in patients who were 34 years 
of age and younger, 90 2% who were aged 40 or younger and 97.4% in 
patients who were aged 50 or younger
The age group of those patients 30 years of age and younger (the largest 
age group in this study), comprised 38 9% of the entire cohort compared to 
only 18% of the New York City cohort (and the smallest age-group) described 
by Rothenberg et a l , (1987) On the other hand one third of the New York City 
cohort were aged 40 and older compared to only 11 9% of this study's cohort 
In all the New York City cohort comprised 43% of subjects 34 years and 
younger and 57% of subjects over 34, while the corresponding figures for this 
study were 66 9% and 33 1 % respectively
The mean age (32 years) for cases of AIDS found in the present study 
was lower than that which has previously been reported in other studies from 
the United Kingdom (38 yrs) (Marasca & McEvoy, 1986), in New York City 
(Rothenberg et a l , 1987) and for adult men (37 years) and women (35 years) 
in the United States (Centers for Disease Control, 1986)
This difference in the ages of patients with AIDS in Ireland compared with 
the U K and the United States is understandable when the method of infection 
of these patients is considered The high proportion of patients whose risk 
activity included intravenous drug use and the generally young age of 
intravenous drug users clearly influences the younger mean age of persons 
with AIDS in Ireland and in this study Supportive evidence of the relatively 
young age of intravenous drug users with AIDS is found in Glasgow (mean 
age, 21 years) (Robertson et a l , 1986), and Dublin (mean age, 25 for those 
IVDUs in treatment), (O’Hare & O’Brien) The Dublin report states that 
preliminary information from the Pompidou Group (Hartnoll, 1993, E C project) 
shows Dublin with the lowest mean age for census clients (December 1990) at
25.7 years Of the other cities in the study the mean age for clients was almost 
six years older in Copenhagen and eight in Amsterdam It points out that while
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census data are not in all cases representative for cities they do indicate a 
trend of older long term users in those cities like Amsterdam, Copenhagen and 
Stockholm with a longer history of problem drug use. The report further states 
that available data for all treated drug users (as distinct from census clients 
only) show current Dublin users to be younger than most of their European 
counterparts, with the exception of Lisbon, Glasgow and Edinburgh
The crude mortalityjatio in this study was 79 3% while that in New York 
City (Rothenberg et a l , 1987) was 66 8%
Among those in this study who received anti-viral therapy, survival did not 
differ by gender This is consistent with the findings of Lemp et al (1992)
Our study observed a higher rate of parenteral drug use but a smaller 
percentage of homosexual or bisexual men compared with the same risk 
factors seen in the other studies mentioned Our cohort enumerated 91 
(47 2%) active drug users and 7 (3 6%) who were former drug users contrasted 
with only 72 (37 3%) who described themselves as homo-or bisexual Drug 
users (active and former) outnumbered homo-or bisexual men by 1 36 to one 
This finding reflects the higher prevalence of HIV infection among IVDUs in 
Ireland
Table 4 6 compares the current study to some of the more comprehensive 
previous reports on survival, published between 1987 and 1993 The differing 
results may be attributed in part to differing features, including a wide variation 
in sample size, differences in the starting date (i e , date of diagnosis) used for 
survival curves, variation in the type, timing, and analysis of diagnostic 
categories, and differing approaches to criteria for diagnosing AIDS, including 
adherence to the case definition of the Centres for Disease Control and the use 
of serologic evaluation
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Table 4.6. Median Cumulative Survival and Characteristics of Previous
Studies as Compared with the Current Study
New York 
Citv 1987
U.K.
1988
Australia
1989
Median cumulative survival (days) 347 377 316
Sex
Men 357(90 5%) 383(97%) 347(96 2%)
Women 263( 9 5%) 106( 3%) 116( 3 9%)
Risk group
Intravenous drug use 282(28.5%) 328( 0 5%)
Homo/Bisexual activity 392(58 3%) 383(89%) 347(87 0%)
Other risk factor 255( 7 5%)
Age
<30 371(18 4%) 435(19%) 347(11 4%)
30-34 387(24 6%) 468(19%) 347
35-39 357(23 6%) 398(23%) 347
40+ 300(33 3%) 301 (39%)
Manifestations
Kaposi's sarcoma alone 750(17 0%) 456(23%) 377(19 3%)
K S and another disease 325( 3 3%) 246( 3 2%)
K S and PCP 381 ( 5 8%) 322( 6%)
P cannn pneumonia alone 318(43 6%) 389(46%) 347
P C P  and another disease 301(12 3%)
One other disease alone 209(13 9%) i 152-298(25% )
Two other diseases alone 235( 3 7%) I
No of cases 5833 663 554
Mean age 37 37
Diagnoses included Two major diseases At presentation At presentatici
Period studied 1981-1985 1982-1987 1982-1987
Starting date Date of diagnosis Date of diag Date of diag
Censoring date Sept 1986 March 1987 July 1987
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Table 4.6. Median Cumulative Survival and Characteristics of Previous
Studies as Compared with the Current Study
Massachusetts
1993
Current Study
1994
Median cumulative survival (days) 406 576
Sex
Men 411 (90%) 576(80 8%)
Women 347(10%) 590(19 2%)
Risk group
Intravenous drug use 342(18%) 574(50 8%)
Homo/Bisexual activity 444(62%) 548(37 3%)
Other risk factor 341 (16%) 643(8 3%)
Age
<30 416(22%) 590(38 9%)
30-34 447(27%) 397(28 0%)
35-39 443(22%) 715(21 2%)
40+ 345(29%) 331 (11 9%)
Mamfestations
Kaposi's sarcoma alone 505(10%) 395( 7 2%)
K S and another disease 328( 2%) 548( 0 5%)
K S and PCP 391 ( 5%) 328(2 1%)
P carimi pneumonia alone 458(41%) 696(31 6%)
P C P  and another disease 405(14%) 574( 5 2%)
One other disease alone Ì313(27%) 500(48 7%)
Two other diseases alone I 441 (4  7%)
No of cases 1931 193
Mean age 36 32
Diagnoses included At presentation At presentation
Period studied 1979-1989 1986-1993
Starting date Date of diag Date of diag
Censoring date Dec 1989 March 1993
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4.9 Recommendations
From a public policy point of view, mortality information is particularly 
important to both health care planners and disease modellers, who need the 
information to accurately project the needs of the future AIDS population As 
prophylaxis and treatment for opportunistic diseases improve, and as ever 
larger numbers of patients receive antiretroviral therapy with zidovudine and 
other drugs still under development, it can be expected that the number of 
persons living with severe HIV-related immunosuppression and /or AIDS will 
increase
The impact of prolonged survival of people living with AIDS on the health 
care system needs evaluation In particular, the observed increases in survival 
with AIDS, noted in most recent studies (Faetkenheuer et a l , 1991, Peters et 
a l , 1991, Merrick et a l , 1992, Rasch et a l , 1992, and Lafferty et a l , 1991) 
mean that it is important to begin to view AIDS not as an acute condition but as 
a chronic condition Thus the development of appropriate home and chronic 
care services, and long-term HIV prevention programs will need to be 
addressed
4.10 Conclusions
The St James' Hospital cohort differed from the other studies 
documented in this report which classified risk category, in that it had higher 
proportions of intravenous drug users (50 8% were IVDUs and 37 3% were 
homo/bisexual men ) and younger subjects (mean age was 32) These 
differences do not seem to have affected overall survival Other demographic 
details which may have had a bearing on survival patterns included a male 
female ratio which was approximately 4 2 1, (80 8% male and 19 2% female) 
This study therefore included a larger proportion of female subjects than did 
any of the other studies (Faetkenheuer et al., 1991, Seage et a l , 1993, 
Rothenberg et a l , 1987, Reeves & Overton, 1988, Whyte et a l , 1989, and 
Rasch et a l , 1992) to which this report referred, with male female ratios 
ranging from 9 1 to 32 1
The cumulative probability of survival was 69% at one year and 6 5% at 
five years, with median conditional probability of survival of 576 days, in 
comparison to 581 days in Cologne (Faetkenheuer et a l , 1991), 608 days in 
the United Kingdom (Peters et a l , 1991), 633 days in Washington State for
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cases diagnosed during 1987 (Lafferty et a l , 1991), and, 578 days in San 
Francisco for those diagnosed between December 1988 and August 1990 
(Osmond et a l , 1991)
Short-term and long-term survival patterns were distinctive with 'late' 
presentation a feature (see also Murphy et a l , 1991, on the Irish situation) 
Fourteen patients died within one month of diagnosis of AIDS and 5 (all male) 
survived more than 5 years after AIDS was diagnosed
Significantly longer survival times were apparent for those who were on 
treatment with anti-viral therapy, and patients who were aged 35-39 years at 
diagnosis had a significantly longer median survival (715 days) than did all 
others (547 days) In addition patients whose disease group was opportunistic 
disease/s alone (CDC IV group C1) had a significantly longer median survival 
(672 days) than did all others (median survival = 281 days) Survival did not 
differ significantly by sex or risk group
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Chapter 5
A Perturbation Model for HIV Transmission
5.1. Introduction
An analytic solution to the system of equations (2 11)-(2 16) described in 
Chapter 2 is of course the preferred and most advantageous outcome 
However there are a number of difficulties m attempting this, some of which 
were pointed out in Chapter 2 and others which will become apparent as we 
describe the particular alternative approach dealt with here
Perturbation methods seek to approximate the exact solution by 
constructing an approximate solution as a series in e Therefore, before turning 
to numerical methods and as there appeared to be a reasonably small 
parameter involved in equations (2 11 )-(2 14) we decided to investigate the 
possibility of using perturbation methods to construct an approximate solution 
as a series in e
There are some problems in which the function sought is not an 
elementary function of its arguments, as for example an equation describing a 
harmonic oscillation with a small amount of friction When those arguments 
include a small parameter, or perturbation term, e, it is sometimes 
advantageous to seek a representation of the function f ( x , e) in the form
/ ( * ; £ )  =  ¿ /„ (;t )E "  (5 20)
n=0
for suitable functions f n that depend only on and not on e In other words 
the solution of some non-linear problems can be made to depend on the 
solutions of a sequence of linear problems (Carrier, 1990) In general it is 
desirable for e to be quite small, le  0 < e  « 1 , since the infinite series will only 
be a good approximation to the real solution when e «  1, and the closer e is 
to 1 the more terms in the series one must use in order to get a reasonable
approximation It is better therefore that e is such, that for small e, the quantity 
fo + efi + e2f2 differs very little from / 0 + e/i
In studying scientific phenomena or technological questions, the important 
requirement is that a very few terms of a series of the above form (5 20), 
provide an approximate description of the function which has all of the 
accuracy which the investigation requires Procedures which provide useful 
series having the form of equation (5 20) are called perturbation methods 
because it is assumed that the difference between the given operator and the 
simpler operator is only a small perturbation of the latter A singular 
perturbation problem is a problem that depends on a parameter (or parameters) 
in such a way that solutions behave nonumformly as the parameter tends 
toward some limiting value of interest The nature of the nonuniformity can 
vary from problem to problem In practice, one seeks a uniformly valid, easily 
interpretable approximation to the non-umformly behaving solution (Smith, 
1985)
5.2 Perturbation methods for HIV models
In Chapter 2 we looked at various deterministic models of the 
transmission dynamics of HIV and its progression to AIDS We defined a very 
simple model for the spread of AIDS based on the three states susceptible, 
infected with HIV but not yet diagnosed as having (full) AIDS and diagnosed 
with AIDS We also defined an infection rate which is the product ps of the rate 
s of partner change and the probability p of transmission of infection The set 
of differential equations (2 11) - (2 16) described in Chapter 2, is reproduced 
here and is given by
= k -  (212)
d X , ( t )
=  b  - P » S f X A ‘)Ym( t ) / N m ( O - H / V O  (2 11)
^  = P f smXn (t)Yf  (t ) /N ,  ( 0 - ( a  +  H „ X .  (0  (2 14)
dYAt)
- ¿ p  = |3 ms,X t (t)Ym (t)/Nm (t) -  (a  + n ,  )YS (/) (2 13)
^  = (2.16)
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= <xYf  (r) -  ( | i /  +  v ) ^  (0
where X m, X f ,Ym,Yf , Am, Af X ^ f ^ m^ f ^ n ,sf , N m, N f ,\i.m, \ i f , a , and v are
as defined in chapter 2
Suppose we let £ = ps This would appear to be reasonable since P7 (the
probability of sexual transmission from a female to a male) is in the region of 
0 0054 and sn , the rate of partner change for males is in the region of 1 93 
The product pf sm is therefore 0 0104 The corresponding figures for pm and s f 
are 0 0783 and 1 13, and the product pmsf  is 0 0885 If e is taken to be 0 0104 
then 8e approximates 0 0885 Both e and 8e are smaller than 1 (If we take e to 
be 0 0104, then e2 will be 0 00011 and e3 will be 0 000001), and the 
contributions to successive terms in the series of equation (5 20) tend rapidly to 
zero The solution of (2 12), X m = X m( t , e ) of the problem depends analytically 
on the parameter e, hence X M can now be represented in the form
X„(i,e) = £ x “ (r)E- (521a)n
for suitable functions X that depend only on t and not on e
The next step is to try an expression like (5 21a) as a solution for the non­
linear system rather than just a single equation, so that we have
^ ^ e )  = ^i0)W +^i1)W+e2^ i2)W+e3^ i3)W+ •• (5 21b)
and similar expressions for X f ,Ym,Yf ,Am,and,Af .
Using this perturbation method the functions are determined by 
substituting (5 21) into the non-linear system (2 11) - (2 16) and equating 
coefficients of like powers of e in the resulting equations so as to obtain an 
infinite sequence of problems (or linear differential equations) that can be 
solved recursively for the unknown functions
The series so obtained should converge if e is small enough and if the 
functions X {® ,x f ],Y^],Y^ 0), A{®and, a |0) are all bounded The solutions of our
system of equations are bounded since the total population is bounded over a
maximum of a 30 year period In many applications all that is needed for an
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adequate approximation is the term in the first power of e, and this can usually 
be found quite easily
Allowing e to equal 0, in equations (2 11) - (2 16), clearly produces a 
linear system with constant coefficients which we can solve exactly to obtain 
the analytical expressions for X ^  ,X (p  ,Y^ ^  ,A^)and,A(f  which are given
below
^ ( t ; 0 ) = (5 22)
—K  f +  A, f e ^ f +  Ci jj. f
x f  W >)=— - — L <5 23> 
\^/e
y” (i;0) = ^ b r  <524>
( 5 2 5 )
. c4a  c4a  + c6a  -  c6v
(tf>) = ------------  r  + —-------—(— r - (5 26)
( - a  + v )e (a+R")i ( a - v > (^ +v)i
. . _. c,a  c3a  + c^a -  c/v
Af (t$)  = --------- ^  r  + -^-------5—-----5—  (5 27)
( - a  +v)e^cx+^ i (a -v )e^ v+ /^ i^
Substituting (5 21) into the non-linear equation (2 12) as described above 
and multiplying across by Nf (t) gives
(xi°)(f)+exi1)(r)+ ){N{/0)(t)+eN{f )(t)+ } = \,{iV;o)(i)+e^;i)(r)+
e{xi«(f)+ex2)(f)+. }{3f (f)+tf®(r)+
^ ( ^ i 0)(i)+e^l1)(i)+ • .Xa^ M + eA ^M -k ..} (5 28)
and similar substitutions can be made for the other equations in the system 
(2 11) - (2 16)
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Equating coefficients of like powers of e in this last equation and 
simplifying, we find
1
e nN f
(
-I
k=0
- e n£ [ x i n-;)(r)ivy)] +
J = 0  J ;= 1
\ , £ [ e  -  n „ £ re *
*=0
e S
k=0 J=0
(5 29)
We similarly equate coefficients of equal powers of e in each of the other 
revised equations in the system (2 11) to (2 16) to obtain expressions for the 
equivalent functions of i  only i e
The first order expansion, X „ ( t ) ,  of equation (5 29) is then
dX (i)
dt = + X Ï V +  M W ” ) /
(Z (0)+ yW + A (°))) {530)
Solving for the first order solution X „ ( t )  gives us an integral equation
X“ «  = e ^ ] - c tlx , { \ a e -1" “'-“-1 -  Vxe^“*"1 -
0 '
ci (imvg“ a^+tl/ ^  + cla\ime~u^a+^  -
V-l~c + Xfa +c2a [ife~uil/ +
Xfve uiLf - c 2jif ve Bfl/ -Xf v +c6ajif e
c4 \ifve + c4ajif e “^ /+v) -  Xfae uiLf 1 \iu
We similarly expand in each of the other equations to obtain integral equations 
for X ? K t ) J i H t ) j } % ) , A ^ t ) a n d , A ? ( t )
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X(;Kt) = <f ^  J-8c3m.l \u e~ u[a~'lj+'lm) -Xfae-u{a+^  + “(a+t°  -
0 '
c2 ^ v e - u(a+^  + c2a\ife-u{a+^  -  ) /
( M-/(-cs ^ mve'“(ti”+v) + \,a + cfl +
\ye~ uv'm -  q 1xnye~vv'm -  \ y  +c5oqime“u^ ”,+v'> -
c3 M-mve_^ a+^ "^  + c3a|ime_“^ M+v^ -  T^ae'^Jjdu
F“>(f) = e-(” “J ,Ic4n; (-c,n.vi -'*' +c1on„e- "  - \J 0B--' +
0
( 1¿fve"^+*' ^  + fyx + + X f i e ^ ’ -
c2v\ife'uilf -  XfV +  c6a|i/<f“^v+^  -c4v|i/e“^ a+^  ^+
c4ajj./ e"^ v+ti/^  -  A, y a e_u>1/ Jjdu
Yf )(t) = e~^ l+v' ,^ \%c-i \im{-c1\Lf \e~uv'm +c2a\ife~uiLm -  A^ae-“4*" +
0
A^ve-141" + A-y-oce- “^ 1""^ -  A^ve- “^ 1”-^ ^
( V-i (-c5 |imve“u(v+^ ) + \ a +  cxa\ime~^ + A.mve- “^" -  
c , \ \ i me ~ ^  -  A mV +  c5a | i me ' “( v + 0 - c 3v ^ me ' “(a+tlJ +
W ^ ‘“(v+^ ) -  A, moce- “^  J^ jdu
A jp (t) = e ' ^ j a  Y ^ (u )e u^ d u
0
4 ‘>(0 = <f <v+l‘'> Jalf(«)/<v+>l'W
0
However, except for the latter two, these integrals are not easily solved 
analytically and so we proceeded to obtain numerical estimates of the 
coefficients X%Kt),X®At)Y®{t)j}%),A™(t), and, A®it) of 8 by substituting
the exact expressions for the zero order solutions and,
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A|0) in equation (5 30) We thus make use of asymptotically assisted numerics
by using the information obtained analytically to reduce the amount of 
computation required in the numerical method
The parameter set discussed in Chapter 3 and described for our specific 
problem in Chapter 6, with the exception of the initial conditions, is used to 
obtain the first order numerical solutions A starting year of 1990 is used, as 
the heterosexual epidemic had started in Dublin by this time Initially, 2 males 
and 59 females are assumed to be infected, and 0 males and 5 females are 
assumed to be AIDS cases These figures are obtained from the results of a 
full numerical solution to a system of equations describing the transmission of 
HIV from IVDUs to non-IVDUs (for details see Chapter 6)
When the zero order analytical solutions plus the first order numerical 
solutions are plotted against time, the results approximate the full numerical 
solutions to the system (which are obtained using the Mathematica computer 
system, see Appendix II), very well, (i e error between 0 8% and 10%),
The second and third order combined perturbation and numerical 
solutions may then be obtained recursively in order to improve the accuracy 
The second order expansion, X {^ ( t) ,  of equation (5 29) is then
XÏ’M = (-[n„Xi2)(A}”’)2 ) - 2^.XiaX “ A f  -  V i . x ^ x f f  +
A)X°Jf° -  A ° X ' j ; - 2 -  X W  -  
2tl „ X t»X (; ,Y}°, + X:X'f Y!° -
X'-i??)1 -  ’{r}°’F -  A°X°J) -  x : x °,y; ) /
( X f ] +7/(0) + Aj0))2 (5 31)
with corresponding expressions for
We again adopted the same procedure of substituting the zero order solutions
and the numencal estimates of the first order solutions
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into equation (5 31) to obtain numerical estimates of the coefficients
These increased the accuracy of the perturbation estimate when 
compared to the full numerical solutions (i e error between 0 2% and 4%, see 
Figures 5 1 - 5 4) The female estimates are more accurate than those 
describing the transmission for males
Plot of combined perturbed and numerical system of Ym up to the 
second order compared with the full numerical solution.
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30
T ime (years)
Figure 5 1 Plot of combined perturbed and numerical system of Ym up to the 
second order compared with the full numerical solution
z
0
25
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Plot of combined perturbed and numerical system of Yf  up to the
second order compared with the full numerical solution.
Time (years)
Figure 5 2 Plot of combined perturbed and numerical system of Yf  up to the 
second order compared with the full numerical solution
Plot of combined perturbed and numerical system of Am up to the 
second order compared with the full numerical solution.
Time (years)
Figure 5 3 Plot of combined perturbed and numerical system of Am up to the 
second order compared with the full numerical solution
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Plot of combined perturbed and numerical system of Af  up to the
second order compared with the full numerical solution.
Time (years)
, Figure 5 4 Plot of combined perturbed and numerical system of A f up to the 
second order compared with the full numerical solution
5.3 Sensitivity analysis varying e
We now look at the situation where the value of e is larger than the
0 0104 which is initially attributed to it Putting e equal to 0 05 results in the
approximate solutions diverging quite rapidly from the full numerical solutions 
to the system, for periods of over 5 years for Ym,Yf ,Am,and,Af
However when e was set to 0 03 the two solutions approximated each 
other reasonably well
5.4 Another approximate analytic approach
In this approach we take Nm and Nf  to be straight lines An examination
of census data shows that the increase in the sexually active population in 
Dublin over a 20 year period is linear Thus Nm and Nf , the populations of
sexually active males and females, are linear functions of time and may be 
expressed as lines such that
Nm =  tym + mmt and
Nf = §f +mf t 
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where <j>/ and <j>/ are the initial number of sexually active females and males in 
the population and mmt and mf t are the respective rates of growth of sexually
active males and females
Taking Nm and Nf  as linear functions means that we are now dividing by
a linear function of t as opposed to a constant in (5 29)
Using the perturbation method described above, and expressing Nm and 
Nf in terms of lines givesljs the following equation in place of (5 30) above
X ™ !'» )/ ( ♦ ,  +m,t) (532)
We similarly expand in each of the other equations to obtain equations for
)and,Af{t)  Taking Nm and Nf  as linear functions
enables us to expand and obtain numerical solutions more easily for higher 
orders
5.5 Conclusions
With perturbation methods one always hopes that a very few terms of the 
expansion will be needed to describe the solution of a given problem with all 
necessary accuracy In the situation described here this was certainly the case 
when the senes was expanded to the 2rd order
There is overall agreement between the full numerical method of solving 
the system and the perturbation method once e is smaller than 0 03 However 
if the model were to include IVDUs then e would be in the region of 1 19, 
because of the higher probability of transmission through needle sharing and 
because of the greater number of needle sharing partners In this case e is 
larger than 1 and so perturbation methods are out of the question
To conclude perturbation methods may be a useful way to model the 
transmission of HIV but only for a heterosexual population which does not mix 
sexually with IVDUs or homo/bisexuals, having on average less than 5 and 3 
(for males and females respectively) sexual partners per year, and a fairly high 
rate of condom usage
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Chapter 6
Data Based Mathematical Models to Assess 
the Epidemiological Consequences of 
Heterosexual and IVDU HIV Transmission.
6.1 Introduction
This chapter presents a simple two-population epidemic model for the 
spread of HIV, makes allowances for the special problem of heterosexual 
transmission in which female-to-male transmission may be less efficient than 
male-to-female transmission, and models the interaction of two populations, 
one of which becomes infected much more rapidly than the other The model is 
used to provide qualitative insights into HIV epidemiology in Dublin and to 
clarify the relationship between heterosexual and IVDU transmission
We have developed a model for the transmission and spread of HIV that 
incorporates many of the factors described in chapter 2 Our model allows two 
modes by which susceptibles may become infected through heterosexual 
contact or by the sharing of needles by IVDUs Pennatal transmission and 
transmission via blood products are not represented in the model, nor is 
homosexual transmission
In general, sets of non-linear differential equations such as those used in 
our model do not admit of explicit analytical solutions But for practical 
purposes we can use computerised forms of numerical integration to make the 
required time-projections into the medium-term future, (i e up to the year 
2010)
6.1.1 Simplifying assumptions adopted:
It is assumed that the population mixes homogeneously within groups, 
that all infected individuals are equally infectious and that there is a constant 
level of infectiousness The model does not allow for variation in the rate of 
progression from HIV seropositive to AIDS (i e all infected individuals move out 
of the infectious class at the same rate) The assumption that, on average,
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there is a roughly constant level of infectiousness over the entire duration of 
the average incubation period of AIDS is not too unreasonable for population 
based studies (Anderson & May, 1991) We assume too that approximately all 
infected individuals eventually develop AIDS This latter assumption is 
suggested by an increasing amount of evidence (Anderson & May, 1991) We 
further assume that those in the AIDS class do not contribute to the spread of 
the disease, that death from AIDS only occurs after an individual has passed 
into the AIDS (removed) class, and that deaths from causes other than AIDS 
can be neglected in the age-groups, and on the time-scales, of interest for the 
epidemic
In order to obtain a working model we have chosen to ignore several 
factors that we know are important, especially age structure, and geographic 
location (see Chapter 1) Initially we also ignore changes in behaviour, but 
introduce them to the model at a specific point in time No explicit allowance is 
made for heterogeneity of sexual/drug activity within each population subgroup 
considered, with the exception of the parameter for sexual partnership with 
IVDUs and non-IVDUs No specific allowance is made for prostitution, in 
particular among the IV drug using population
No allowance is made for the possible lengthening over time of the 
survival times of AIDS patients due to improvements in medical care This can 
be justified to a large extent since the survival parameter is taken from a study 
of patients who were only diagnosed with AIDS after 1986
Hence, we wish to stress that the qualitative insights which the sensitivity 
analysis produces are of much greater significance than any of the specific 
numerical values that are predicted for the future number of AIDS cases
6.1.2 The basic model
Consider a constant population of heterosexuals divided into 4 subgroups 
on the basis of gender and use or non-use of IV drugs The proportion of new 
recruits allocated to each subgroup is held constant over time and deaths can 
only occur from AIDS related diseases Each subgroup is divided into three 
types of classes that reflect the disease status of the persons in the group 
These classes are susceptibles, those who are at risk of acquiring the disease, 
infectives, those who are able to transmit the disease to a susceptible person, 
and AIDS or removed, those who do not take part in the transmission of the 
disease
Transmission of the disease may occur whenever a susceptible person
engages in sexual or needle sharing activity with an infective individual, who
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may be a member of any of the sub-groups It is therefore necessary to include
a mechanism which allows for contact between individuals from different
subgroups We have modelled the inter-group sexual mixing by means of a
contact matnx S with elements sv which give the probability that an individual
from subgroup / comes into contact with an individual from subgroup j (see
Table 6 4 The IVDU group has a distinct set of parameters relating to sexual
contact but is further distinguished by being subject to HIV through the sharing
of needles used for drug injections The mter-group needle sharing activity is 
modelled by means of a contact matnx N with elements r|y which give the
probability that an individual from subgroup / comes into needle sharing contact 
with an individual from subgroup j  (see Table 6 6)
The numbers of susceptibles, mfectives and AIDS cases at time t are 
denoted by X,(t),Yt(t), and At(t) The subscnpt / (/ = 1, 2, 3, and 4) denotes the 
four different subgroups within the population male and female drug users and 
male and female non-drug users respectively The model consists of a set of 
coupled ordinary differential equations, based on the model of Comiskey 
(1992), (see equations (2 17) - (2 19) in chapter 2) Our model however 
includes the effect of migration (due mainly to emigration), and is further 
distinguished in that it does not subtract migration due to cessation of 
sexual/needle sharing activities from the third equation This is because we 
want the total number of AIDS cases each year, including those who have 
ceased to use drugs or to be sexually active The model has the following 
structure
where X,(r) + ^ (r) + A,(r) = Pi(i), A,, are the recruitment parameters to the 
female and male IVDU and non-IVDU population, the mean incubation period is 
1/a, and the rate of deaths due to AIDS is 1/d Both 1/a and 1/u are assumed 
to be the same for all individuals The average annual rate of estimated net 
migration (due mainly to emigration) from the population, Wy, is assumed to be
(6 1)
(6 3)
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the same for all subgroups The rates of migration from population / due to 
cessation of sexual activities, l/m  and 1/jj.4 , are assumed to be the same for 
female and male non-IVDUs, and the rates due to cessation of drug using 
activities and \ / \ i2, are also assumed to be the same for IVDU females
and males The model does not take account of those IVDUs who cease using 
intravenous drugs but who do not cease to be sexually active, since the 
proportion of susceptibles that they contribute to the non-IVDU population is 
negligible (in the region of 0 0029) The sexual transmission coefficients j5iy for
spread of infection from female to male and from male to female are also 
assumed to be different May and Anderson, (1987), suggest that 
(3/ < Pm < P,, where p is the corresponding coefficient for homosexual males
Similarly, the rates for sexual partner change sy of females and males are
probably not the same, and are likely to be substantially smaller than the male 
homosexual rate py, the probability of transmission during a single needle
sharing act from an infectious in group j  to a susceptible in group / is assumed 
to be the same for females and males
6.2 Initial choice of parameter values
Initial values are allocated to each of the parameters as detailed below in 
Tables 6 1 - 6 5  Plausible ranges for parameter values are fully explored in 
Chapter 3 The parameter value relating to the incubation period, in the 
projection, is that recommended by the UN/WHO modelling workshop (United 
Nations and World Health Organisation, 1989) and was used in the model 
developed by Bulatao (1991) for the World Bank
A starting year of 1982 gave the best match to the official Department of 
Health data The epidemic is assumed to have been seeded by a single 
infective male IVDU with all other individuals uninfected
6.2.1 Initial population
The transmission of the AIDS virus from IVDUs to non-IVDU 
heterosexuals, is modelled within the Dublin population of those aged 15 to 45 
years, since the vast majonty of IVDU are within this age range Census data 
for 1981 give the population for Dublin in the age range 15-45 years as 
460,243 We use this figure as the base figure for the number of sexually 
active individuals in Dublin, in the population under consideration, (including 
IVDUs who share needles) This is based on the findings of Lansdowne
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Market Research (1992), who found that the average age of first sexual 
intercourse for all those aged 18-24 was 17 years (see Table 3 1) Also, in our 
HIV Transmission Survey (1994), we found the average age of sexual 
intercourse for IVDUs to be 15 years (see Appendix) However, this figure 
includes persons who are exclusively homosexual, and those who are celibate, 
or in closed partnerships over the course of the epidemic The overall 
population figure here is reduced by an arbitrary 7% to 428,026, to account in 
part for these factors in line with the model described by Williams and 
Anderson, (1994), where an arbitrary 2% was subtracted to account for the 
above factors excluding male homosexuals, whom they incorporated into their 
model. The balance of 5% is based on a conservative estimate of homosexual 
prevalence in a typical Western European capital city (see Johnson AM et a l , 
1992,‘ BajosN et a l , 1991, Rogers S M & Turner C F , 1991, and Sundet J M 
et a l , 1988)
The estimate of the number of IVDUs (4,000), is based on the estimate of 
the Irish national AIDS program (Mann et a l , 1992) According to O'Hare and 
O'Brien (1993), an estimated 2006 persons received treatment for drug misuse 
in 1991 Our figure of 4000 suggests that one in two (50%) IVDUs are in 
treatment, which is a very high proportion of IVDUs in treatment if it is 
compared with the 14% estimated by Frischer (1992), (see Chapter 3 section 
32  1)
We assume initially that 95% of IVDUs share injecting equipment based 
on the findings of numerous studies such as that of Pomeroy et a l , (1991), 
where 97% of the study group had shared needles prior to the advent of HIV 
(see Chapter 3, section 3 3 2 1) In addition a study by McKeown et a l , (1993) 
found that there was no difference in sharing between females and males The 
female male ratio (1 3) of IVDUs, is estimated on the basis of the findings 
from the Dublin Drug Treatment Reporting System for 1991 (O'Hare and 
O'Brien, 1993), (see chapter 3 section 3 2 1)
The figure for female non-lVDUs, 218,663, is the residue after deducting 
the estimates for female IVDUs The figure for male non-IVDUs is similarly 
obtained Table 6 1 provides details and Chapter 3 considers parameter 
estimation in more detail
The parameter value 1/y given for migration from the population (due 
mainly to emigration), is taken from the Census data for 1991
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6.2.2 Rates of joining and leaving the non-IVDU population
Numbers of females and males becoming sexually active each year were 
estimated to be the same as the number of females and males of 15 years of 
age in the Dublin population (1981 census), minus the numbers entering the 
IVDU population The rate of leaving the non-IVDU heterosexual population 
1/30 is set to correspond to the 15-45 years age range (see Table 6 1)
6.2.3 Rates of joining and leaving IVDU population
The rates of recruitment are estimated on the basis of the findings of the
1990 and 1991 Health Research Board (HRB) reports on treated drug misuse 
in the Dublin area (O'Hare and O'Brien, 1992, 1993) The reports detail 
information on first treatment contact and estimate treated incidence relating to 
those clients who received treatment for the first ever time during 1990 and
1991 We conservatively assume that the number joining the IVDU population 
is comparable to twice (see section 6 2 1) the number seeking treatment for the 
first time in any year, although obviously the subjects joining the population of 
IVDUs are unlikely to be the same subjects as those seeking treatment for the 
first time, i e a simple multiple of a constant rate throughput
The HRB found that 574 drug users entered treatment for the first time in 
1990, of whom 59% had been IVDU at some time In 1991 the corresponding 
figures were 450 drug users of whom 42% had injected at some time We 
combine the’ figures to get an average number of IVDUs seeking treatment for 
the first time over the two year period
New recruits are then split between groups in the same proportions as in 
the original population throughout the simulations The resulting estimated 
figures for female and male recruits each year are 132 and 396 respectively
The rate of leaving the IVDU population is based on our survey of HIV 
transmission (see Appendix Table A 2) and is similar for females and males 
The mean number of years injecting for IVDUs was found to be 6 5 years This 
is similar to that (6 3 years) found by Richardson et al , (1993), (see section 
3 2 1) The reciprocal of the mean is used as an estimate of the migration rate 
out of the female and male IVDU populations (see Table 6 1)
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Table 6.1 Demographic parameters employed in the numerical
simulations
Dublin Recruitment Migration from
Group____________Poo Split  population ( a, )
1 Male IVDU 3000 396 0 15
2 Female IVDU 1000 132 0 15
3 Male non-IVDU 205363 9577 0 033
4 Female non-IVDU 218663 9568___________ 0 033
Initial population 428026
Migration (due mainly to emigration) 0 007 (1/y)
6.2.4 Incubation period of Acquired Immune Deficiency Syndrome
Variation in the incubation period of AIDS which is measured as the time 
from infection to diagnosis of AIDS is discussed in Chapter 2 Here an overall 
median of 10 years is used as recommended by the UN/WHO modelling 
workshop (United Nations and World Health Organisation, 1989, and Bulatao, 
1991) The corresponding incubation rate is therefore 0 1 per year (see Table 
6 2 )
6.2.5 AIDS-related mortality
AIDS-related mortality (which measures the time from diagnosis of AIDS 
to death) has been set to give a median life expectancy of 1 58 years in line 
with the Survival Analysis described in Chapter 3 Individuals who have 
developed AIDS are assumed to be no longer IVDU or sexually active, so the 
AIDS mortality used in the model does not directly affect the effective size of 
the infectious population
6.2.6 Sexual and needle sharing transmission probabilities
Sexual transmission risk
The estimation of transmission risks is subject to much uncertainty A 
wide range of estimates have been quoted (see Chapter 3) The mean 
probability of sexual transmission per partnership suggested by Anderson et 
a l , (1992) ranged from 0 09 to 0 2 The mid-point of this range is 0 145
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However the Durex survey (LRC, 1993) found that 28% of their 
respondents (see Chapter 3) used condoms as their main method of 
contraception They further found that 46% of Dublin respondents used 
condoms as a birth control method in the previous year The midpoint figure of 
0 145 is therefore reduced by 46% and the resultant figure of 0 0783 is used as 
the probability of sexual transmission from male non-IVDUs to female non- 
IVDUs Studies involvingJVDUs report the average use of condoms to be 30% 
(see Chapter 3) The midpoint figure of 0 145 therefore, is reduced by 30% to 
get the probability of sexual transmission from males to females for 
partnerships involving IVDUs (see Table 6 2)
The figure for the probability of sexual transmission from females to males 
is based on the 1% found by Padian et a l , (1991) Padian’s figure is also 
reduced by 46% and 30% to allow for condom use by non-IVDUs and IVDUs 
respectively
Needle-sharing transmission risk
The parameter for the probability of transmission through needle sharing 
per partner is set at 0 2, a more conservative figure than the 0 25 given by 
Williams and Anderson (1994), but in line with that used by Comiskey, (1991), 
in her model for the transmission of HIV in Ireland A 5% reduction in this 
parameter allows for those IVDUs who do not share needles Table 6 2 
provides details
Table 6.2 Epidemiological parameters used in the numerical simulations
Mortality due to AIDS per year (v) 1/1 58
HIV incubation rates per year (a) 1/10
Transmission probability for type of contact per new partnership 
Heterosexual
median IVDU-female to male ((312, (3 14, (3 32) 0 007
median non-IVDU-female to non-IVDU-male(P34) 0 0054
median IVDU-male to female ( p 21, p 23 > P «) 01015
median non-IVDU-male to non-IVDU-female(P43) 0 0783
Needle sharing
A
P
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0 19
6.2.7 Rate of sexual partner change
Rates of changes of sexual partners of non IVDUs were calculated on the 
basis of the findings of the Durex Report (1993), (see section 3 3 3 2) The 
report found that the average number of sexual partners in the previous 12 
months for those who were married, was 1 03 for female and 1 05 for male 
respondents The averages for single female and male respondents were 1 25 
and 2 72 respectively The figures in Table 6 3 were calculated by applying 
these figures to the 199T census data on the number of married and single 
females and males in the population
Rates for the IVDU population were found from the HIV Transmission 
Survey described in the Appendix (Dunne et a l , 1995) The mean number of 
sexual partners for female and male IVDUs was 1 9 and 2 5 respectively (see 
Table 6 3)
Table 6.3 Initial parameters relating to rates of change of sexual partners
Group Rates (average number of
________________________________________ new partners per veah
Rate of sexual partner change (s)
Male IVDU 2 48
Female IVDU 1 88
Male non-IVDU 1 93
Female non-IVDU 1 13
6.2.7.1 Between-group mixing
The size of the bridge group, i e , that group of non-IVDUs who are in 
sexual partnerships with IVDUs, has only been crudely estimated This crude 
estimate is based on the results of the HIV transmission survey described in 
the appendix, which suggests that the size of the bridge group is approximately 
67 per cent of the size of the IVDU community The sex ratio in the bridge 
community is female-biased because the sex ratio in the IVDU community is 
male-biased and hence male IVDUs are more likely than female IVDUs to have 
non-IVDU sex partners This likelihood is confirmed by our HIV transmission 
survey, (see Appendix, Dunne et a l , 1995)
According to the results of the survey, the prevalence of sex with a non-
IVDU was high in the group as a whole with 67% of subjects (n = 77; 2 missing
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values), reporting at least one partner who was a non-IVDU However, this
differed widely between the sexes Men were far more likely than women to
have had a non-IVDU sexual partner in the previous year 77 9% of men (n =
67) compared to only 34 5% of women (n = 10) had a sexual partner who was a
non-IVDU (x2=18 5, df =1, p < 0 0001)
On the other hand women tended to have more drug using sexual
partners than men 75% of women had at least one IVDU sexual partner in the
previous year compared to 41% of men (p = 0 014, Fisher’s exact test)
In our transmission model we denote the rate of sexual partner change 
that an individual in group i has per unit time with a member of group j , by sy
For example su is the average number of female IVDU partners a male IVDU
has in unit time Dunne et a l , (1995, see Appendix), found that female IVDU
respondents had a mean of 0 59 non-IVDU sexual partners in the previous
year Similarly the rate of sexual partner change for female IVDUs with male
IVDUs is 1 29 The corresponding rates for male IVDUs were 1 76 for non-
IVDU female sexual partnerships and 0 for partnerships with IVDU females
(see Table 6 4)
However estimating the parameter for the rate of sexual partner change of 
non-IVDU females and males with IVDU males and females proved to be more 
difficult We had no information on the extent to which non-IVDUs mixed 
sexually with IVDUs To estimate this parameter for non-IVDU females we 
calculate
gh 
gh+ ko
f = mean number sexual partners of a non-IVDU female, 
g = mean number of non-IVDU female partners which an IVDU male has, 
h = proportion of the male population which is IVDU, 
k = mean number of sexual partners of a non-IVDU male, 
o = proportion of the male population which is non-IVDU
The corresponding parameter for non-IVDU males is similarly estimated 
The results are as follows
s41 = /  , where
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Male Female Male Female
______________ IVDU IVDU______ non-IVDU non-IVDU
Table 6.4 Matrix of mean number of sexual partners per year st]
Male IVDU 0 00 0 72 00 1 76
Female IVDU 1 29 0 00 0 59 0 00
Male non-IVDU 0 00 0 0046 0 00 1 9254
Female non-IVDU 0 0148 0 00 1 1152 0 00
6.2.8 Needle sharing partnership rates
As with the rates of change of sexual partners little data are available on 
which to base estimates of rates of change of needle sharing partners by 
IVDUs Comiskey et a l , (1993) used a value of 6 94 as the yearly needle 
sharing parameter Needle sharing partnership rates used in this model are 
based on the HIV Transmission Survey described in the Append'x The mean 
number of needle sharing partners per week was found to be 2 24 (Std Dev
=2 65) for females, and 3 14 (Std Dev = 8 11) for males The distribution was
therefore very skewed and highly variable
The mean number of needle sharing partners of females and males (per 
week) is multiplied by a conservative factor of 2 to obtain the parameter for the 
average number of needle sharing partners per year (see Table 6 5)
Table 6.5 Initial parameters relating to rates of change of needle sharing
partners
Group____________________________ Rates (new partners per veah
Needle sharing partnerships (n)
Male IVDU 6 28
Female IVDU 4 48
6.3 The result of taking the chosen parameter values
Taking due note of the serious limitations in assigning fixed or exact 
parameter values based on variant populations, as described in section 6 2, we 
now consider what insights emerge from the numerical study of the model 
behaviour
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6.3.1 AIDS cases
Ten years after the introduction of one infectious person (1992), and no 
change in sexual or needle sharing behaviour, 209 cases of AIDS are 
predicted, as shown in Figure 6 1 Table 6 6 provides details of the number of 
AIDS cases in each risk group
Table 6.6 Predicted numbers with AIDS
Heterosexual
Year Male Female Male Female
' IVDU IVDU non-IVDU non-IVDU
1982 0 0 0 0
1984 0 0 0 0
1986 2 0 0 0
1988 10 3 0 1
1990 49 14 0 7
1992 141 41 1 26
1994 219 67 2 64
1996 241 77 4 106
1998 236 76 7 144
2000 225 73 9 174
2002 217 70 11 197
2004 211 68 14 214
2006 207 67 15 227
The number of IVDUs with AIDS increases rapidly until 1996 and then 
begins to slowly decrease because of the fall in the size of the susceptible 
IVDU population This is due to the fact that 70% are already infected with HIV 
by 1996 The IVDU population is therefore quickly saturated with the infection 
However the number of non-IVDUs, particularly females, with AIDS continues 
to increase, although from the early 1990s the doubling time is reduced and the 
percentage increase in the number of AIDS cases falls each year (see Figure 
61)
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Predicted Numbers with AIDS: 1982-2006
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•Female non-IVDU
'02 '04 '06
Fig. 6 1 Predicted Numbers with AIDS in the IVDU and non-IVDU 
subgroups (y= AIDS prevalence)
6.3.2 HIV infection
Six years after the introduction of one infectious person (1988), and no 
change in sexual or needle sharing behaviour, already (approximately) 5 
percent (42) of female and 6 percent (151) of male IVDUs are infected by the 
virus, as shown in Figure 6 2 After 10 years 50 per cent (423) of IVDU women 
and 56 percent (1408) of IVDU men are infected, whereas for the same period 
only 0 14 per cent (315) of the non-IVDU women and only 0 0045 percent (10) 
of the non-IVDU men are infected (see Table 6 7)
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Table 6.7. Predicted numbers infected with HIV
Heterosexual
Year Male
IVDU
Female
IVDU
Male
non-IVDU
Female
non-IVDU
1982 1 0 0 0
1984 5_ 1 0 0
1986 27 7 0 3
1988 151 42 0 18
1990 646 183 3 94
1992 1408 423 10 315
1994 1637 519 23 620
1996 1560 505 39 888
1998 1461 474 55 1092
2000 1392 451 71 1244
2002 1350 436 85 1359
2004 1325 427 97 1446
2006 1310 422 108 1513
The number of IVDUs who are infected increases rapidly until 1994 and 
then begins to slowly decrease because of the decline in the size of the 
susceptible IVDU population The number of non-IVDUs who are infected 
increases at a slower pace, but continues to increase into the long-term future 
However from 1994 onwards the increase in the number of non-IVDUs who are 
infected becomes less and less rapid The female non-IVDU population is 
much more seriously affected than the corresponding male population (see 
Figure 6 2)
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Predicted Numbers with HIV Infection
year
Fig 6 2 Numbers infected with HIV in the IVDU and non-IVDU 
subgroups, (y = HIV prevalence)
6.3.3 Comparison with actual data
To ensure that the parameter values for our model are reasonable, we 
compare the predictions they produce with surveillance data on the number of 
AIDS cases attributed to IVDU use or heterosexual activity The true number of 
cases of AIDS acquired through heterosexual contact is only crudely estimated 
by surveillance data, because of difficulties in documenting such transmission 
All AIDS patients who use IV drugs are considered to have acquired the 
disease parenterally (through the skin or intravenously), even though some of 
them may have had HIV-infected sexual partners Because of this the 
percentage of AIDS patients ascribed to heterosexual contact is most probably 
an underestimate
Two hundred and forty six cumulative adult AIDS cases (that are 
attributable to either IVDU or heterosexual transmission) were reported to the 
Department of Health by the end of December 1994 of whom 124 had died (see 
Tables 6 8 and 6 9) These actual numbers of reported cases minus those who 
had died, can be compared with the number of AIDS cases that are predicted 
by the model (see Table 6 6) When comparing the two sets of figures, it
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should be remembered that the reported AIDS cases may reflect only a fraction 
of the true HIV morbidity and mortality in IVDUs, due to reporting delays and 
under-reporting errors The AIDS case definition was originally devised based 
upon AIDS cases in homosexual men It became apparent that IVDUs appear 
to present with a larger spectrum of HIV-related infections than other risk 
groups, and that therefore AIDS cases were being under-reported This was a 
major factor in the expansion of the AIDS case definition in 1987 It is evident, 
therefore, that the reported AIDS cases may be expected to be far fewer than 
the predicted cases due to under-reporting, especially in the years before 
1988
The predicted figures can be compared with the official Department of 
Health data on both AIDS cases and HIV infection Tables 6 8, 6 9, and 6 10 
provide details
Table 6.8 Actual Department of Health AIDS cases
Heterosexual
Year IVDU Cumulative non-IVDU Cumulative
1982 0 0 0 0
1984 2 2 0 0
1986 3 5 0 0
1988 21 26 2 2
1990 50 76 10 12
1992 58 134 18 30
1994 64 198 18 48
Year
Table 6.9 
IVDU
Actual Department of Health AIDS deaths
Heterosexual 
Cumulative non-IVDU Cumulative
1982 0 0 0 0
1984 2 2 0 0
1986 2 4 0 0
1988 7 11 1 1
1990 14 25 4 5
1992 30 55 10 15
1994 48 103 6 21
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Table 6.10 Actual Department of Health cumulative HIV seropositive
The figures in Tables 6 8-6 9 are national figures and not just figures for
Dublin They possibly include non-IVDUs who may have been infected via
homosexual or bisexual contact
—
individuals
Heterosexual
Year Male Female Male & Female
IVDU IVDU non-IVDU
1986 258 78 0
1988 351 112 2
1990 430 140 91
1992 517 169 166
1994 573 185 209
The figures in Table 6 10 are the total number of individuals who tested 
seropositive to the virus (see Chapter 1) They therefore include results for the 
whole country and for those who may have developed AIDS or died since 
testing seropositive In addition these figures may include heterosexuals who 
may have been infected via homosexual or bisexual contact
Although the initial set of parameter values produce AIDS prevalence 
curves that are close to the observed data for 1982-1990, they differ widely in 
the number of cases projected for the year 1994 (compare Table 6 6 with 
Tables 6 8 and 6 9) The actual figures shown in Tables 6 8 and 6 9, are much 
less than the figures predicted by the model (see Table 6 6) The difference is 
too large to be explained by under-reporting It may be that the model may be 
too stringent in some areas, or alternatively, this difference may be due to 
intervention policies by Drug Treatment agencies The following section 
examines the scenario in which some intervention takes place
6.4 Behaviour change due to intervention policies
The number of IVDUs which the model predicts to be infected with the
AIDS virus, by the end of 1989, is 422 The number of AIDS cases predicted
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for that year is 29 These figures are similar to the actual number of 
seropositive individuals and cases recorded by the Department of Health for 
1989 If, as the predicted figures and the actual figures suggest, the number of 
lVDUs who are infected is in the region of 420-520 in 1989, then the IVDU 
community must be aware, at this time, of the impact of AIDS.
The first needle exchange centre began operating in Baggot St in 
February 1989, and others have been established since then Needle 
exchange has been shown to reduce the level of sharing among IVDUs (see 
Chapter 3, section 3 3 2) If we therefore halve the probability of transmission 
through needle sharing from 1989 onwards, so that ff = 0 095, the results are 
as follows (see Tables 6 11-612)
Table 6.11 Predicted numbers with AIDS given intervention 
ff = 0.095 from 1989 onwards
Heterosexual
Year Male Female Male Female
IVDU IVDU non-IVDU non-IVDU
1982 0 0 0 0
1984 0 0 0 0
1986 2 0 0 0
1988 10 3 0 1
1990 27 8 0 5
1992 48 15 0 12
1994 76 24 1 23
1996 107 34 2 39
1998 135 43 3 60
2000 154 49 4 82
2002 164 53 5 104
2004 168 54 7 124
2006 168 54 9 141
2008 166 54 10 155
2010 163 53 11 166
When the probability of transmission through needle sharing is reduced in
this way, the peak in the number of AIDS cases occurs later than in the original
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model (see Figure 6 3) In the model with intervention the number of AIDS 
cases peaks 23 years after the introduction of the infection, whereas the 
original model peaks after 14 years This is because of the slower increase in 
the number of those infected in the former model The adjusted model predicts 
that by the year 2010, 48 percent of IVDU women and 50 percent of IVDU men 
will be infected with the virus, and that 0 48 percent of non-IVDU women (n= 
1108) and 0 035 percent of non-IVDU men (n = 80) will be infected
Figure 6 3 illustrates the predictions with respect to the model with 
intervention
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Fig 6 3 Predicted Numbers with AIDS in the IVDU and non-IVDU 
subgroups given intervention (y= AIDS prevalence)
The following table predicts the numbers of HIV infections up to the year
2010
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Table 6.12 Predicted numbers infected with HIV given intervention
Heterosexual
Year Male
IVDU
Female
IVDU
Male
non-IVDU
Female
non-IVDU
1982 1 0 0 0
1984 5_ 1 0 0
1986 27 7 0 3
1988 151 42 0 18
1990 262 79 2 59
1992 429 133 4 123
19^4 636 200 9 218
1996 836 265 15 345
1998 982 314 23 491
2000 1059 341 33 639
2002 1084 351 43 774
2004 1080 350 53 889
2006 1065 346 63 981
2008 1049 341 72 1053
2010 1035 336 80 1108
In the model with intervention the number of those infected with HIV also 
peaks later than in the original model (see Figure 6 4) The spread from the 
IVDU population to the non-IVDU population is first apparent four years after 
the introduction of the infection Non-IVDU females are infected four years 
before their male counterparts The number of non-IVDU females who are 
infected is consistently far greater than the number of non-IVDU males 
infected This asymmetry in the sex ratio of non-IVDU AIDS cases is due to the 
asymmetry in the heterosexual transmission efficiencies, the gender-specific 
differences in sexual behaviour and the asymmetnc sex ratio in the IVDU 
community, (the majority of IVDUs are males, consequently the majority of their 
sex partners are non-IVDU females)
A similar pattern is apparent in both the original and the intervention 
models regarding the lower percentage increase in the numbers of those 
infected and those with AIDS, from the early 1990s to the end of the projection 
period The adjusted model predicts 289 cases of AIDS, in the IVDU and
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heterosexual population of Dublin, in the year 2000 It further predicts 364 
cases in 2005 and 393 cases in 2010 Figure 6 4 illustrates the predictions
Predicted Numbers with HIV-lnfection given intervention: 1982-2010
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Fig. 6.4 Predicted Numbers with HIV-infection in the IVDU and non-IVDU 
subgroups given intervention (y= HIV prevalence)
6.4.1 Comparison of adjusted model with actual data
A good match to heterosexual and IVDU, AIDS prevalence data, was 
achieved ( compare Table 6 11 with 6 8 and 6 9) The figures which the 
adjusted model produce for the number of AIDS cases are similar to the actual 
number of AIDS cases published by the Department of Health In 1994 the 
model predicts 100 IVDU cases and 24 heterosexual cases of AIDS These 
figures compare favourably with those of the Department of Health which are 
95 and 27 respectively when allowances are made for those who died from 
AIDS The differences could possibly be explained by reporting delays and 
under-reporting However, it should be noted that the heterosexual figure 
published by the Department of Health includes heterosexual cases from 
outside Dublin and possibly heterosexuals infected via relationships with 
Homo/bisexuals
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6.5 Sensitivity of the model
Transmission models may be used to make quantitative predictions, for 
example, to estimate the future number of AIDS cases The precision of these 
predictions is often limited by the uncertainty in estimating both the sizes of the 
risk groups and the values of biological-behavioural transmission parameters 
(Blower et a l , 1991, Anderson & May, 1988) Where epidemiological data are 
scarce and the transmission process is complex, mathematical models can be 
used to perform simulation studies with different parameter values A variety of 
outcomes are possible, depending on particular choices of critical parameters 
Therefore, transmission models can be analysed to assess the variability in the 
prediction estimates and to determine which parameters or assumptions are 
the most important in contributing to the imprecision in predictions In order to 
have confidence in the results of model projections, it is necessary to explore 
the effects of variation in parameters on the spread of the disease
The model (see equations 6 1-6 3) is used to predict the future number of 
AIDS cases in certain risk groups The sensitivity analysis involves the 
repeated evaluation of the previously described deterministic model, with key 
variable values changed in each of several runs The probable number of 
cumulative AIDS cases produced by the sensitivity analysis reflects the likely 
range of possible outcomes, rather than the absolute upper and lower bounds 
of the system The initial exploratory approach is to determine which 
parameters are most influential
In this case, the prediction variability is due to the uncertainty in 
estimating the values of the model's 35 different variables/parameters (23 
biological-behavioural transmission parameters and the initial sizes of 4 
subgroups as well as the recruitment and migration rates )
6.5.1 Range of parameter values chosen for the sensitivity analysis
To analyse the sensitivity of the model to the plausible ranges of 
parameters, we evaluated it at extremes of the range given, in particular for 
those parameters which had the highest degree of uncertainty We assume 
that the initial values chosen (see Tables 6 1 to 6 5), are at the lower end of the 
range (with the exception of the between-group sexual mixing parameter), and 
in the following section we evaluate the model at the maximum of the range 
Table 6 13 gives details of these parameter values
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Table 6.13 Parameters used in the sensitivity analysis 
(maximum of range)
HIV incubation rates per year
a 1/8
Transmission probability for type of contact per new partnership 
Heterosexual
median IVDU-female to male ( p 12, p 14, p 32) 0 084
median non-IVDU-female to non-IVDU-male(P34) 0 0624
median IVDU-male to female (p 21, p p4l) 0 14
median non-IVDU-male to non-IVDU-female(P43) 0 104
Needle sharing
p~ 0 2375
Needle sharing partnerships per year
Male IVDU 9 42
Female IVDU 6 72
6.5.2 The results of the sensitivity analysis
This section examines the results of exploratory variations above and 
below our ‘best’ estimate values, as described above The adjusted parameter 
set is used as a basis for examining how sensitive the prediction curves 
produced by the model are, to modest changes in parameter values (Tables 
6 14-6 18, 6 20-6 21, 6 23-6 24) Only the figures for AIDS cases are
presented, since cases of AIDS are the only visible measurement of the
epidemic which has some accuracy
6.5.2.1 Varying the size of the initial population and the related
recruitment rate
The first question which is addressed by the sensitivity analysis is the 
effect of varying the size of the initial IVDU population and the related 
recruitment rates
The number of IVDUs may be much greater than 4000 O’Kelly et a l ,
(1990), estimated 7,000 IVDUs in Dublin, but for the sensitivity analysis we
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choose a slightly more conservative figure of 6000, as the maximum in the 
range (which suggests that the percentage in treatment is 33%, see section 
621) ,
The maximum number of IVDUs recruited each year is taken as three 
times the number entering treatment for the first time each year (see section 
6 2 3) This is consistent with the factor of three times the number of IVDUs in 
treatment, which is allowed for in the initial population above)
The number of IVDUs recruited each year is therefore changed to 792 
The female male ratio of 3 1 is maintained The resulting estimated figures 
for female and male IVDUs and IVDU recruits each year are 1500 and 4500, 
and 198 and 594 respectively The between-group mixing parameters are 
recalculated to allow for the larger size of the IVDU population The results are 
shown in Table 6 14
Table 6.14 Predicted numbers with AIDS given intervention 
and larger IVDU population
Year Male
IVDU
Female
IVDU
Male
non-IVDU
Female
non-IVDU
1982 0 0 0 0
1984 0 0 0 0
1986 2 0 0 0
1988 10 3 0 1
1990 28 8 0 5
1992 52 16 0 13
1994 86 27 1 25
1996 130 41 2 45
1998 176 56 3 71
2000 214 68 5 103
2002 237 76 7 137
2004 249 80 9 169
2006 252 81 11 197
2008 250 81 14 220
2010 247 80 16 239
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This scenario is similar to that described by Table 6 11 in that it also, 
generates considerably more AIDS cases in non-IVDU females than in non- 
IVDU males, which is to be expected given the gender ratio in the IVDU 
population and the differential in the probability of infection between females 
and males
However we can see that the numbers predicted by this simulation are 
greater than those predictions which are based on the smaller IVDU 
population, particularly from 1994 onwards (see Table 6 11) The overall 
number of AIDS cases produced here for the year 2010, is actually almost 49% 
greater than that presented in Table 6 11 The results (Table 6 14) confirm that 
the number AIDS cases is heavily dependent upon the size of the IVDU 
population
In this scenario, the total number of AIDS cases in 1994 is 139, a figure 
which is only 14% greater than the actual number of cases published by the 
Department of Health, for these risk groups (n=122) The difference of 17 
cases could possibly be explained by reporting delays or under-reporting 
However it should be remembered that the official figures do not just relate to 
Dublin, although the IVDU population is confined to Dublin
6.5.2.2 Varying the incubation period parameter
The sensitivity of the model to the length of the incubation period is 
analysed by taking a value of 0 125 for this parameter, which relates to an 
incubation period of 8 years This value is chosen to assess sensitivity based 
on results obtained in a recent study by Kelly, (1994) Table 6 15 is generated 
by the same set of values for the initial subgroup sizes and the biological- 
behavioural transmission parameters that were used to generate Table 6 11, 
with the exception of the parameter for the incubation period
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Table 6.15 Predicted numbers with AIDS given intervention
and a shorter incubation period
Year Male Female Male Female
IVDU IVDU non-IVDU non-IVDU
1982 0 0 0 0
1984 0 0 0 0
1986 2 0 0 0
1988 11 3 0 1
1990 29 8 0 5
1992 49 15 0 12
1994 77 24 1 23
1996 109 34 2 38
1998 140 44 2 58
2000 163 52 4 79
2002 177 57 5 101
2004 183 59 7 121
2006 184 60 8 138
2008 183 59 9 152
2010 180 58 10 162
In this particular scenario, at the end of the projection period, less than 
0 4% of non-IVDU women and 0 025% of non-IVDU men are infected
This set of parameter values produces AIDS projections that are close to 
the observed data for 1994 They are also very similar to those produced by 
the set of parameters described in section 6 4, in the number of cases 
projected for the period 1982 to 2010 (Table 6 11)
6.5.2.3 Varying the transmission probabilities
Needle sharing transmission
To analyse the sensitivity of the model to the parameter for the probability 
of transmission through needle sharing, the upper bound of this probability is 
set at 0 2375 until 1989 and then halved This figure is 5% less than the 0 25, 
suggested by Williams and Anderson (1994), to allow for those IVDUs who do 
not share Table 6 16 provides details of the results
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Table 6.16 Predicted numbers with AIDS given intervention and
needle sharing transmission probability = 0.2375
Year Male
IVDU
Female
IVDU
Male
non-IVDU
Female
non-IVDU
1982 0 0 0 0
1984 0 _ 0 0 0
1986 4 1 0 0
1988 39 10 0 4
1990 105 31 0 19
1992 158 48 1 45
1994 189 59 3 76
It is obvious when comparing this table with Table 6 11, that the model is 
very sensitive to the parameter for the needle sharing transmission risk These 
figures do not compare favourably with the actual official statistics in that they 
over-predict the number of AIDS cases each year The above results suggest 
that either, a value of 0 2375 is too high for this particular parameter ((3y), or, 
that the value for the number of needle sharing partners (ny) is too high (see
equations 6 1 to 6 3) However, considering the low number of needle sharing 
partners used it seems more likely that the transmission probability is too high
Sexual transmission
The sensitivity of the model to this parameter is measured by using the 
mean probability of sexual transmission per partnership (relating to an 
undifferentiated incubation period) found by the European Study Group, 
(1992) These figures, 0 12 and 0 2, for female-to-male and male-to-female 
transmission respectively, are reduced by 46% and 30% to allow for condom 
use, in the same way as in the original model (see Table 6 13) Table 6 17 
gives details of the results
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Table 6.17 Predicted numbers with AIDS given intervention and
changes in sexual transmission probabilities
Year Male Female Male Female
IVDU IVDU non-IVDU non-IVDU
1982 0 0 0 0
1984 0 _ 0 0 0
1986 2 1 0 0
1988 13 3 0 2
1990 36 11 3 9
1992 66 20 8 23
1994 103 32 17 47
The above results are similar to the official figures for the years up to
1990, but are higher than the official statistics for the number of AIDS cases
reported each year from 1990 to 1994 Again this indicates that either the 
greater values for this parameter (Py) are too high, or, that the parameter for
the number of sexual partners {sv) is too high (see equations 6 1 to 6 3)
However, considering the conservative number of sexual partners used by the 
model it seems that the former situation is more likely It should be noted that 
the model is less sensitive to the sexual transmission probability parameter 
than it is to the needle sharing transmission parameter (the needle sharing 
transmission parameter was only increased by a factor of 1 25, whereas the 
sexual transmission parameter was increased by a factor of 1 4 for male to 
female transmission and by a factor of 12 for female to male transmission
6.5.2.4 Varying the number of needle sharing and sexual partners
Needle sharing partners
To analyse the sensitivity of the model to the parameter which describes 
the number of needle sharing partners per year, a figure is used which is a 
conservative factor of 3 times the figure found by Dunne et a l , (1995), for the 
mean number of needle sharing partners per week The number of partners is 
only increased until 1989 and then resumes the original, lower, value (as given 
in Table 6 5) The results are shown in Table 6 18
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Table 6.18 Predicted numbers with AIDS given intervention and
needle sharing partnership rates = 6.7 and 9.4 (f and m)
Year Male Female Male Female
IVDU IVDU non-IVDU non-IVDU
1982 0 0 0 0
1984 1 0 0 0
1986 11 3 0 1
1988 107 30 0 11
1990 191 58 1 44
1992 202 64 3 80
1994 194 63 5 110
The model is very sensitive to changes in this parameter value
Increasing the number of needle sharing partners by a factor of 1 5 for just the 
first 6 years, results in a doubling of the predictions shown in Table 6 11 for 
1994 The figures shown above (Table 6 18) do not compare favourably with 
the official statistics for the number of AIDS cases for the years 1982 to 1994
Sexual partners
The sensitivity of the model to this parameter is examined by increasing 
the mean number of new partners per year (see Table 6 3) by 50% The same 
method as that used to produce Table 6 4 is used to estimate the between 
group mixing figures (see Table 6 19) Table 6 20 provides details of the 
results of such a scenario if the increase in the number of partners continues 
until 1994 Table 6 21 provides details of the results if the number of partners 
is only increased until 1989 and then resumes the original, lower, value (as 
given in Table 6 4)
Table 6.19 Matrix of upper bound of the mean number of sexual partners
per year st]
Male Female Male Female
_________________ IVDU______ IVDU______ non-IVDU non-IVDU
Male IVDU 0 00 1 08 00 2 64
Female IVDU 1 935 0 00 0 885 0 00
Male non-IVDU 0 00 0 007 0 00 2 888
Female non-IVDU 0 022 0 00 1 673 0 00
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Table 6.20 Predicted numbers with AIDS given intervention and
a greater number of sexual partners for the total period
Year Male Female Male Female
IVDU IVDU non-IVDU non-IVDU
1982 0 0 0 0
1984 0 0 0 0
1986 2 0 0 0
1988 11 3 0 2
1990 30 9 0 8
1992 53 18 1 20
1994 84 28 2 39
This set of parameter values produces AIDS projections that are close to 
the observed data and the predicted figures (see Table 6 11) for the IVDU 
population for 1994 However they overestimate the number of AIDS cases in 
the non-IVDU heterosexual population
Table 6.21 Predicted numbers with AIDS given intervention and 
a greater number of sexual partners until 1989
Year Male Female Male Female
IVDU IVDU non-IVDU non-IVDU
1984 0 0 0 0
1986 2 0 0 0
1988 11 3 0 2
1990 29 9 0 7
1992 52 16 0 14
1994 81 25 1 26
1996 112 35 2 43
1998 139 44 3 64
2000 157 50 4 86
2002 165 53 6 108
2004 168 54 7 128
2006 167 54 9 144
2008 165 54 10 157
2010 163 53 12 167
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This set of parameter values produces AIDS projections that are close to 
the observed data for 1994 They are also very similar to those produced by 
the set of parameters described in section 6 4, in the number of cases 
projected for the period 1982 to 2010 (see Table 6 11)
6.5.2.5 Varying the between-group sexual mixing parameter
Dunne et a l , (1995, see Appendix), found that female IVDU respondents 
had a mean of 0 59 non-IVDU sexual partners in the previous year and male 
IVDU respondents had a mean of 1 76 non-IVDU female sexual partnerships 
(see Table 6 4) To examine the sensitivity of the model to the between-group 
sexual mixing parameter the above means are halved for both females and 
males while retaining the mean rate of sexual partner change given in Table 
6 3 (1 88 for female IVDUs and 2 48 for male IVDUs) The same method as 
that used to produce Table 6 4 is used to estimate the revised between group 
mixing figures for non-IVDU females and males (see Table 6 22) Table 6 23 
shows the results of this change for the total period (1982-2010)
Table 6.22 Matrix of varied mean number of sexual partners per
year stJ
Male Female Male Female
_________________ IVDU IVDU non-IVDU non-IVDU
Male IVDU 0 00 1 60 00 0 88
Female IVDU 1 585 0 00 0 295 0 00
Male non-IVDU 0 00 0 0023 0 00 1 9277
Female non-IVDU 0 0075 0 00 1 1225 0 00
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Table 6.23 Predicted numbers with AIDS given intervention
and varied between-group sexual mixing
Year Male
IVDU
Female
IVDU
Male
non-IVDU
Female
non-IVDU
1982 0 0 0 0
1984 0 0 0 0
1986 2 0 0 0
1988 11 3 0 1
1990 29 9 0 3
1992 52 16 0 7
1994 81 26 0 13
1996 114 37 1 21
1998 141 46 1 32
2000 159 52 2 44
2002 168 55 3 56
2004 170 56 4 66
2006 169 56 5 74
2008 167 55 5 81
2010 164 54 6 86
This set of parameter values produces AIDS projections that are close to 
the observed data for 1994 The spread of the disease in the non-IVDU 
population is markedly affected by variation in the amount of contact among 
individuals from different sub populations According the these results, by the 
year 2010 only 95 non-IVDU heterosexuals have AIDS, a figure which is 
approximately half that found using the higher between-group sexual mixing 
parameter (see Table 6 11)
However such vanation in this parameter does not affect the spread in the 
IVDU population up to the year 2010 The results of this particular scenario 
demonstrate the significance of the dynamic interaction of heterosexual and 
IVDU transmission
6.5.2.6 Varying the initial number of infecteds
The epidemic may have been seeded by more than one infective and so 
the sensitivity of the model to the initial number of infecteds is analysed by
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looking at the situation where this parameter is increased to 2 infecteds Table 
6 24 gives the results of such a scenario
Table 6.24 Predicted numbers with AIDS given intervention 
and initial number of infecteds = 2
Year Male
IVDU
Female
IVDU
Male
non-IVDU
Female
non-IVDU
1982 0 0 0 0
1984 1 0 0 0
1986 4 1 0 0
1988 19 5 0 2
1990 48 14 0 9
1992 79 24 1 21
1994 111 35 1 38
This set of parameter values produces AIDS projections that are an 
overestimate of the observed data and the predicted figures (see Table 6 11), 
particularly after 1990
6.5.3 Discussion of results of sensitivity analysis
It is apparent from the sensitivity analysis that the variability between 
realisations of the same epidemic model is in general high, and this has 
implications for prediction The 10 sets of parameter values described above 
(see Tables 6 1-6 2, 6 4-6 5, 6 13, 6 19 and 6 22) produce AIDS incidence 
curves that vary in their closeness to the observed data for 1982-1994 Often, 
even when particular sets of parameter values produce figures that are close to 
the observed data for 1982-1994, they differ widely in the number of cases 
projected for the year 2010 (e g compare Table 6 11 with Table 6 14 and Table 
6 23) This is not altogether surprising since the longer the forecasting horizon, 
the more the errors are compounded
The model contains 35 variables, however only 14 (2 subgroup sizes, the 
initial number of infecteds and 11 biological-behavioural transmission 
parameters) were sampled For these 14 key parameters 2 alternative values 
were selected, for each of which the ratio of female : male non-IVDU cases is 
always at least 20 1 for the first 20 years However the relative efficiency of
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transmission is 14 5 1 (male-to-female to female-to-male transmission) This 
may be explained by the differential in the number of sexual partners of 
females and males
6.5.3.1 The qualitative relationship between the input and the
output variables
The qualitative relationship is the same for nearly all the key variables, 
apart from the average incubation period, which is inversely proportional to the 
predicted number of AIDS cases This is because even though individuals 
remain infectious for a longer period and consequently can infect more 
individuals, the rate of progression to disease decreases Usually, a longer 
incubation period i e 10 years as opposed to 8 years results in a more drawn- 
out epidemic (a slower decline in cases following the peak in incidence) For 
all other key variables an increase in the input value leads to an increase in the 
future number of AIDS cases
6.5.3.2 The few key parameters which are important in contributing
to the prediction imprecision
The more sensitive the outcome of the model is to a particular parameter 
value or assumption, the more important it is to measure precisely the 
parameter value or to confirm the validity of the assumption However the 
sensitivity analysis revealed that not every variable is significant in contributing 
to the AIDS case prediction variability or error
The size of the IVDU population and the average incubation period 
parameter, have the most significant effect on the number of AIDS cases in the 
IVDU population in the year 2010 When the size of the IVDU population is 
increased by 50% there is a resultant increase of 51% in the total number of 
IVDU infections and AIDS cases in 2010 When the incubation period 
parameter is increased by 25% the total number of AIDS cases in the year 
2010, in the IVDU population, increases by 10% However the figure for IVDUs 
who are infected in 2010 is decreased by 31%
The size of the IVDU population also affects the spread of AIDS in the 
non-IVDU population An increase of 50% in the IVDU population results in an 
increase of 44% in the number of non-IVDU AIDS cases in 2010
The increase of 25% in the incubation period parameter results in a 
decrease of 3% in the number of non-IVDU AIDS cases in 2010 and a 
decrease of 22% in the number of HIV infections in this group
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When the parameter for probability of infection by needle sharing is 
increased by 25% it has little effect on the IVDU population, but results in a 
27% increase in the number of AIDS cases in the non-IVDU population (HIV 
infections increased by 24%).
Similarly the increase in the parameter for the two heterosexual 
transmission efficiencies has little effect on the number of AIDS cases in the 
IVDU population. When this parameter is increased by 1100% for female-to- 
male transmission and by 40% for male-to-female transmission it produces a 
242% increase in the number of AIDS cases in the non-IVDU population in the 
year 2010.
Increasing the parameter for the number of needle sharing partners by 
50% results in a decrease of 3% in the number of IVDU HIV infections and 
AIDS cases. The result in the non-IVDU population is an increase of 16% in 
the number of AIDS cases, and an increase of 12% in the number of HIV 
infections.
The effect of increasing the parameter for the number of sexual partners 
by 50% for the first six years has little or no effect on either population. 
However if the increase is for the full projection period the non-IVDU population 
is affected to a far greater extent than is the IVDU population. In this case the 
number of AIDS cases in the non-IVDU population is increased by 61% in the 
year 2010, whereas the IVDU population figure is only increased by 2%.
When the between-group mixing parameter is decreased by 50% it has 
little or no effect on the number of IVDUs with AIDS in 2010, but it results in a 
decrease of 48% in the number of non-IVDUs with AIDS. Under conditions of 
highly assortative mixing the timing of the rise in heterosexual incidence 
depends on the level of seeding from the IVDU epidemic; as soon as the 
heterosexual epidemic begins to take off, especially in the female sub­
population, the effect of changes in other groups is swamped by that of 
numbers of female heterosexual infecteds. These results show clearly the 
sensitivity of model outcomes to variation in the patterns of contact among 
individuals and the need for better data on such interactions to aid in 
understanding and predicting the spread of HIV (see Table 6.23).
The increase in the initial number of infecteds from 1 to 2 makes little 
difference to the number of IVDUs or non-IVDUs who are infected or who have 
AIDS in 2010.
The simulations suggest that the uncertainties in estimating the values of 
the biological-behavioural transmission parameters and the size of the IVDU 
population are critical in affecting the prediction imprecision of the future
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number of non-IVDU heterosexual AIDS cases Five parameters in particular 
seem to be the most important in contributing to the prediction imprecision 
These are the size of the IVDU population, the two heterosexual transmission 
efficiencies, the rate of sexual partner change and the between-group mixing 
parameter The uncertainties in estimating the values of the remaining 
demographic, biological, and IVDU behavioural transmission parameters (see 
Tables 6 1-62 and 65) are of lesser importance in contributing to the 
prediction imprecision for the AIDS cases These remaining parameters are 
the average incubation period (or variation in the rate of progression from HIV 
seropositive to AIDS), the initial number of infecteds, the rate of sharing 
needles, and the HIV transmission efficacy of a needle sharing partnership with 
an infected person These results show that sexual and IVDU behavioural 
parameters, as well as biological parameters are important in prediction 
imprecision for non-IVDU AIDS cases
6.6 2010 and beyond
6.6.1 General discussion of model with intervention
(see section 6.4)
Extending the time limit of the model beyond 2010, reveals that the 
epidemic will become endemic after 80 years of its genesis However because 
of the nature of deterministic models it is likely to be unreasonable to expect 
the model to be accurate for more than 40 years into the future (as mentioned 
earlier, numerical errors accumulate over long periods of time, see 6 5 3) 
Indeed even within a 40 year period the parameters should be continuously 
reassessed as they are evidently changing overtime
This model predicts that 20 years after the introduction of the virus into 
the Irish population, the number of women and men who will have become 
infected but not yet developed AIDS will be 1127 and 1125 respectively (see 
Table 6 12)
The model can also be used to predict the date at which more non-IVDUs 
will have been infected than IV drug users For women this date is 1994, but 
for men even if the model is run for 100 years the number of non-IVDUs who 
are infected remains in the hundreds, whereas the number of IVDUs infected 
has already passed 1000 by the year 2000 (see note on asymmetry in the sex 
ratio of non-IVDU AIDS cases in section 6 4)
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In this model the increase in the number of new IVDU infections flattens 
out around 1998, whereas this does not happen in the non-IVDU population for 
another 30 years, long after the end of the projection period
For IVDUs saturation effects in prevalence cause a peak in the number of 
AIDS cases after about 22 years (2004) (Fig 6 3), whereas prevalence curves 
for heterosexuals continue to rise for the duration of the simulations (up to year 
2010) (Figs 6 3 and 6 4) Section 6 6 4  discusses the sensitivity of the 
transmission parameters Through increased condom usage
By 2010, the end of the projection period, 2559 persons are HIV-infected 
These forecasts present a sufficiently servere prospect, however, the impact 
could be more severe in that several assumptions concerning sexual behaviour 
and disease parameters in the model are based on incomplete knowledge and 
may therefore be too optimistic Finally, although the model has been shown to 
simulate the growth and the impact of the epidemic quite accurately up to the 
present, there is no guarantee that key assumptions will remain valid in the 
future It should also be emphasised that in reality, in the early stages of an 
epidemic with small numbers of infected individuals, stochastic effects come 
into play which can have a marked impact on when the epidemic curve is seen 
to rise
6.6.2 Intervention
One role of mathematical modelling is the theoretical evaluation of 
preventive measures, particularly in the context of their intensity and the timing 
of their introduction In this case models can become a tool for public health 
decision makers With theoretical experiments the behaviour of the system is 
understood by altering the assumptions and /or parameter values and 
measuring the effect on the outcome variable Models may therefore be used 
to make qualitative predictions by generating particular scenarios
6.6.3 Timing of reduction in needle sharing
As an example of such a qualitative prediction, we look at the situation 
where the parameter relating to the probability of infection through needle 
sharing is not halved until 1990 (Table 6 11 was generated by halving this 
parameter in 1989) The results are given in Table 6 25
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Heterosexual
Table 6.25 Predicted numbers with AIDS given intervention
3* = 0.095 from 1990 onwards
Year Male Female Male Female
IVDU IVDU non-IVDU non-IVDU
1982 0 0 0 0
1984 0 ~ 0 0 0
1986 2 0 0 0
1988 10 3 0 1
1990 40 11 0 6
1992 72 22 1 17
1994 105 33 1 34
1996 134 42 3 54
1998 154 49 4 77
2000 165 53 5 100
2002 169 55 7 121
2004 168 55 8 139
2006 166 54 10 153
2008 164 53 11 164
2010 162 53 12 173
When the probability of transmission through needle sharing is reduced 
one year later, the peak in the number of AIDS cases occurs later than in the 
model where intervention occurs earlier (see Table 6 11 and Figure 6 3) In 
this model the number of AIDS cases peaks 20 years after the introduction of 
the infection, whereas the previously mentioned model peaks after 23 years 
This is because of the faster increase in the number of those infected in the 
former model However this change in the timing of intervention does not seem 
to have any greater effect than to speed up the growth m the number of 
infecteds by one year
6.6.4 Greater use of condoms and needle exchange
Irish legislation contributed to limiting contraceptive availability Until 
1993, condoms could only be sold by registered pharmacists or Family 
Planning Clinics and only to individuals of 17 years or over. As mentioned 
earlier the first needle exchange clinic opened in 1989, the second centre
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opened in November 1991, and others have been established since then 
These clinics also distributed condoms and promoted condom use We shall 
therefore take 1992 as an estimated time point at which condom use increases 
and sharing of injecting equipment decreases in our next simulation To 
assess the impact of the timing of such changes we examine the situation if the 
changes do not occur until 1998 The risk through sexual intercourse, as 
described in section 6 2 6, is decreased by 60% for both IVDUs and non- 
IVDUs, and the risk through needle sharing is further decreased to one third of 
its original value (see Table 6 2) Tables 6 26 and 6 27 provide details of the 
results
Table 6.26 Predicted numbers with AIDS given greater use of 
condoms and needle exchange from 1992 onwards
Heterosexual
Year Male
IVDU
Female
IVDU
Male
non-IVDU
Female
non-IVDU
1982 0 0 0 0
1984 0 0 0 0
1986 2 0 0 0
1988 10 3 0 1
1990 27 8 0 5
1992 45 14 0 11
1994 57 17 1 16
1996 66 20 1 21
1998 74 23 1 26
2000 80 25 1 30
2002 86 26 2 35
2004 90 28 2 39
2006 94 29 2 44
2008 97 30 3 47
2010 99 31 3 51
The result of the behaviour changes described above being implemented 
in 1992, a time point 10 years after the introduction of the virus, is dramatic. 
The total number of persons with AIDS in the populations under discussion, in
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the year 2010, is 184, which is less than half the number of AIDS cases should 
there be no such changes in behaviour (see Table 6 11)
Table 6.27 Predicted numbers with AIDS given greater use of 
condoms and needle exchange from 1998 onwards
Heterosexual
Year Male
IVDU
Female
IVDU
Male
non-IVDU
Female
non-IVDU
1982 0 0 0 0
1984 0 0 0 0
1986 2 0 0 0
1988 10 3 0 1
1990 27 8 0 5
1992 48 15 0 12
1994 76 24 1 23
1996 107 34 2 39
1998 131 41 3 57
2000 133 42 3 66
2002 128 40 4 71
2004 122 38 4 73
2006 117 37 4 74
2008 113 36 5 74
2010 110 35 5 74
When behaviour changes are not implemented until 1998, a time point 16 
years after the introduction of the virus, it results in a 43% decrease in the 
number of AIDS cases in 2010 The simulations reveal that the timing of 
changes in behaviour for a given forecasting horizon, has a very substantial 
impact on the predicted impact of the disease, particularly amongst the female 
non-IVDU population If control is introduced at an early stage (t = 10 years), 
the simulations suggest that over a time-scale of 28 years 212 less people will 
be infected with HIV than if control is introduced at a later stage (t = 16 years) 
The epidemiological effects of behavioural change will be dependent 
upon both the magnitude, the type, and the timing of the behaviour change, 
and should ideally be investigated through a time-dependent analysis
146
V3
6.6.5 Experimentation results of no needle sharing among IVDUs
As an example of a theoretical intervention experiment in the IVDU group, 
simulations were performed to study the effect of blocking HIV transmission 
through the sharing of contaminated needles
To illustrate how the model may be used to study the effect of blocking 
the transmission through needle sharing, all transmission probabilities relating 
to this type of partner contact are set to zero, that is $  = 0  in the model, from 
1996 onwards All other parameters are the same as those used to provide the 
results outlined in Table 6 11 The effect on the number of AIDS cases is 
shown in Table 6 The effective contact rates within and between the risk 
groups are now due to only one mode of transmission, sexual intercourse 
Transmission via needle sharing is completely blocked The simulation results 
of this hypothetical intervention experiment are shown in Figure 6 5
Table 6.28 Predicted numbers with AIDS given no needle sharing
from 1996 onwards
Heterosexual
Year Male
IVDU
Female
IVDU
Male
non-IVDU
Female
non-IVDU
1982 0 0 0 0
1984 0 0 0 0
1986 2 0 0 0
1988 10 3 0 1
1990 27 8 0 5
1992 48 15 0 12
1994 76 24 1 23
1996 96 31 2 39
1998 75 27 2 51
2000 50 20 3 54
2002 32 15 4 51
2004 19 10 4 45
2006 12 7 4 39
2008 7 5 3 32
2010 4 3 3 26
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Predicted Numbers with AIDS given No Needle-Sharing from 1996
'82 '84 '86 '88 '90 '92 '94 '96 '98 '00 '02 '04 '06 '08 '10
year
Fig 6.5 Predicted Numbers with AIDS in the IVDU and non-IVDU subgroups 
given no needle sharing from 1996 on (y= AIDS prevalence)
There is clearly a very dramatic decrease in the number of AIDS cases in 
the year 2010 In fact by the year 2020 there are no IVDU AIDS cases and 
only 4 IVDUs are infected with the virus The decrease in the non-IVDU 
population is slower, but no less dramatic By the year 2020 there are only 10 
cases of AIDS in the non-IVDU population and 52 persons are infected with 
HIV
It is interesting to compare these results with model studies by Kaplan 
(1989), which demonstrate that policies such as the distribution of cleansing 
solutions and /or injection equipment among drug addicts could slow or stop 
the intravenous transmission of HIV (see also Hart et a l , 1989)
An overall decrease in sharing injection equipment has been reported in 
countries that have instituted any kind of increased access to syringes Since 
the late 1970s the Netherlands has a national policy of harm reduction for drug 
users, and the first needle-exchange program was established in Amsterdam in 
1984 Buning et al (1986), found that the use of needle exchanges in 
Amsterdam was associated with less sharing among injectors, that the 
frequency of injecting did not increase, and that there was no evidence of an 
increase in the total number of IVDUs as a consequence Hart et al (1989), 
evaluated a needle exchange in central London and found that the rate of 
sharing fell, both compared to rates prior to entry to the scheme and during the 
period of study Hart also found that the frequency of injecting did not increase,
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that there was a reduction in the proportion of clients with multiple partners, 
and that needle exchanges probably played a large part m preventing 
acquisition of HIV in that there were stable HIV prevalence rates overtime
Guydish et al (1993), in a study of all drug-treatment admissions in San 
Francisco County over a 4-year period, found that no negative consequences 
of needle exchange were detected Specifically, the presence of the exchange 
program was not associated with (1) increases in injection drug use, (2) 
increases in needle-sharing behaviour, or (3) changing drug-use behaviour 
from non-injection to injection They also found that neighbourhoods without 
needle-exchange sites showed a greater increase in proportion of admissions 
for injection drug use, and in frequency of injection, overtime
A similar program has been implemented in Dublin since 1989 mainly 
because of the appeal of needle exchange as an HIV prevention strategy An 
evaluation of the needle-exchange program in Dublin (Dunne et a l , 1993), 
suggests that the program contributes to decreased needle sharing among 
IVDUs participating in such programs Dunne et a l , (1993) found that 50% of 
clients reported the sharing of injecting equipment in the period before the 
needle exchange scheme, while only 5 6% reported sharing in the period 
before their last visit, and only 1 3% of those who visited in the final quarter of 
the period under study reported sharing
Mann et al (1992) point out that the efficiency of syringe exchange in 
decreasing HIV behaviour depends on how much of the IVDU community can 
be covered If the program is not large enough to increase the proportion of 
sterile syringes in the IVDU community as a whole, it may have no broad 
impact on risk behaviour or transmission of injection-related disease, although 
individual participants may benefit Coverage here includes the number of 
IVDUs who use the service, and is also related to hours of operation and 
convenient access to sites
The question for the epidemiologist is whether changes in sexual and 
drug using behaviour are adequate to reduce the rate of virus transmission, 
particularly since behaviour change only commenced when a large proportion 
of IVDUs were already infected The risk of infection increases as the 
prevalence of infection in the population rises Therefore behavioural risk 
reduction will only reduce the incidence of infection if it is of a magnitude 
sufficient to outweigh the increased risk inherent in the rising prevalence, or if it 
occurs at an earlier stage of the epidemic when infection rates are low Here 
the problem may be primarily political, namely, obtaining and maintaining 
support for prevention prior to the emergence of a visible problem, and
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maintaining it over the long term in the absence of an epidemic to generate 
public support
6.7 A final modification to the model
Comiskey assumed that those who are infected and have developed AIDS 
[of whom there are A(t)] will not transmit infection to any partners although they 
will still form new partnerships But it could be more realistic to assume that 
these individuals play no further part in the epidemic, that is, that they cease to 
form new partnerships (Isham, 1993) In this case the appropriate infection 
rate is J3sX(r)y(r)/[X(r) + y(r)] (see equations 6 1 and 6 2)
In Table 6 25 we see the effect of this modification for the case already 
illustrated in Table 6 11 (with parameters as given in Tables 6 1 to 6 5, with the 
exception of the parameter for the probability of infection through needle 
sharing)
Table 6.29 Predicted numbers with AIDS given model modification 
and intervention (i.e. |3 = 0.095 from 1989 onwards)
Heterosexual
Year Male Female Male Female
IVDU IVDU non-IVDU non-IVDU
1982 0 0 0 0
1984 0 0 0 0
1986 2 0 0 0
1988 10 3 0 1
1990 27 8 0 5
1992 49 15 0 12
1994 78 24 1 24
1996 111 35 2 42
1998 142 45 3 64
2000 163 52 4 90
2002 174 56 6 116
2004 177 57 8 140
2006 176 57 10 161
2008 174 57 11 177
2010 172 56 13 190
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It is clear that the effect of using the infection rate in the modified model 
gains on that for the model described by Table 6 11, and the corresponding 
epidemic spreads more quickly However, at least with these parameter 
values, the effect of the modification to the model is relatively small (The 
increase in the number of cases is 6% and 15% for IVDUs and non-IVDUs 
respectively by 2010)
6.8 Epidemiological implications and conclusions
6.8.1 Limitations of modelling AIDS by this approach
Much uncertainty surrounds the estimation of the epidemiological 
parameters used in this model, and this uncertainty is probably greater for the 
behavioural parameters than it is for the biological parameters
Values for certain key epidemiological parameters, such as variability in 
transmission probabilities have been assigned on the basis of published data 
relevant to developed countries (Bulatao, 1988, Padian et a l , 1991, Anderson 
et a l , 1992), with similar or at least comparable features to the Irish epidemic 
Quantitative data on transmission probabilities for heterosexual contact or for 
needle sharing activity are very limited at present We have again simply used 
the best published information available to us and from our own work It must 
be recognized however, that even modest improvement in the available 
information may be difficult if not impossible to achieve The obvious 
difficulties are those inherent in the study of the likelihood of transmission via 
intimate behaviour and the changes that are occurring in the incubation period 
of AIDS due to improvements in the management and treatment of patients 
before the development of AIDS A further complication is raised by changes in 
the case definition of AIDS (Brettle et a l , 1993, Centers for Disease Control, 
1987, 1993) Thus our understanding of the disease is changing with time as 
well as the parameters which descnbe its spread
Parameter values depicting patterns of sexual behaviour are even less 
reliable, though the surveys conducted by Dunne et al (1995), O’Hare and 
O’Brien (1992, 1993), Lansdowne Market Research (1992) and Irish Marketing 
Surveys (1993), (see Chapter 3) do help to provide plausible ranges for Irish 
estimates in terms of the rates of acquisition of needle sharing and sexual 
partners within the IVDU and heterosexual groups, and the sizes of the IVDU 
risk group Care must be exercised in the interpretation of the data, given that 
any survey of sexual behaviour records self-reported activity rather than
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observed-behaviours The compliance achieved in the Lansdowne Market 
Research Survey (1992) was acceptable given the sensitivity of the topic 
(43%), but the missing fraction of the designated sample may have behaviours 
that are atypical of the general population and possibly of great significance to 
the spread of HIV
An important determinant of the overall pattern of spread for a sexually 
transmitted infection within the general population is the degree of sexual 
contact within and between risk groups, but it is this area about which we know 
least because of the practical difficulties of ascertaining networks of sexual 
contact within human communities
In Ireland, we have no information to date on the patterns of mixing within 
specified risk groups (i e for IVDUs whether the mixing between different 
sexual activity classes (high / low activity) is assortative (like with like) or 
disassortative (like with unlike) In addition we have only very limited 
information on the degree of between risk group mixing ( i e for IVDUs what 
fraction of their sexual partners are IVDUs and what fraction non-IVDUs) 
Furthermore the model does not include the effects of variability over time or 
the effects of the non random nature of partner selection The non random 
selection and formation of interconnected pools of sexually active individuals 
would result in slower growth than that described in this chapter
Various assumptions on the probabilities involved and plausible 
parameter values make it clear that small changes in the values of key 
parameters induce significant changes in projected trends, particularly in the 
longer term up to the year 2010 (Tables 6 11,6 14 6 16-6 18, 6 20, 6 23-6 24)
The model presented here shows that under what currently appear to be 
reasonable hypotheses about transmission, epidemics of widely varying 
severity are consistent with available epidemiological data
6.8.2 Broad conclusions for transmission models
The following conclusions emerge however, even with the limitations 
indicated above
• Non-IVDU women are particularly susceptible to HIV infection.
This is an important finding and is due to women being biologically, 
epidemiologically and socially more vulnerable to the infection This is 
respectively because semen contains a far higher concentration of HIV than 
vaginal fluid, non-IVDU women are more likely to have a sexual partnership
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with an IVDU man than visa versa, and women are less inclined to protect 
themselves if in a long term relationship with an infected man
• It seems likely that heterosexual activity will account for more new 
cases of AIDS than IV drug use later on in the next century, particularly among 
females
In the early stages of the epidemic, IVDU transmission is more important 
than heterosexual transmission, however, the relative importance of 
heterosexual transmission increases, as the epidemic spreads from the IVDU 
to the bridge community As of December 1994 in Ireland, the ratio of 
IVDU heterosexual cases of AIDS is about 1 0 28 (Department of Health) 
Using figures generated by the preferred parametric choice for our model, the 
predicted ratio is about 1 0 24 for Dublin in 1994, but rises to 1 0 8 in 2010 
(The ratio of the prevalence of heterosexually acquired AIDS among women to 
the total prevalence of AIDS among men is about 1 0 95 when calculated from 
model projections in the year 2010) Nonetheless it is likely that differences in 
relevant^arameters that are too small to be detected in the next several years 
could have a serious impact on the epidemic in the more distant future The 
fact that the proportion of cases resulting from heterosexual contact is small 
and will probably remain so for the next several years does not appear to 
preclude the subsequent development of a major epidemic among 
heterosexuals
• The model serves to highlight both the urgency of implementation and 
the non-linear benefits that accrue from early introduction of behaviour 
changes, and the degree to which behaviour needs to be changed
However, it should be noted that small changes in behaviour can have 
very significant effects on projected trends, even if such changes are 
implemented ten or sixteen years after the introduction of the virus
• Transmission models are of limited use at present for predicting 
medium-to-long-term trends in the incidence of AIDS
Great uncertainty still surrounds future events (on the basis of current 
information), particularly within the heterosexual population, despite an ability 
to mirror accurately past trends in AIDS incidence Sometimes different 
parameter combinations which fit observed trends provide very different 
projections for the short or longer term
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Prediction more than a very short while ahead is therefore probably 
inadvisable due to the difficulty of validating model assumptions and of 
obtaining more precise parameter values The main role of such models is 
therefore to highlight the uncertainties in future trends given current 
epidemiological information A further major role is to illustrate how various 
assumptions affect projections
• Sensitivity analysis of the model revealed that the prediction imprecision 
is mainly due to the estimation uncertainty of the values of a few key variables 
Long-term precise predictions of AIDS cases will not be possible until 
these key variables have been determined accurately The results suggest that 
it is most important to measure the size of the IVDU population, the 
heterosexual transmission efficiencies, the rate of sexual partner change and 
the between-group mixing parameters accurately Interpretation of existing 
data on heterosexual transmission depends strongly on the size of the IVDU 
population and the magnitude of the between-group mixing parameter 
Reducing the uncertainty in these key parameters will have a considerable 
effect on increasing the accuracy of prediction estimates This knowledge 
should help to focus data collection efforts
The sensitivity analysis results have significant epidemiological 
implications The analysis revealed that many key variables are important in 
contributing to the prediction imprecision, but that only a few are significantly 
so Therefore, the results suggest that it is most important to quantify 
accurately these key variables, and hence the results can be used to suggest a 
strategic agenda to focus data collection efforts Reducing the estimation 
uncertainty in the key biological-behavioural transmission parameters will have 
a much greater effect on increasing the prediction precision of adult AIDS 
cases than accurately estimating any of the subgroup sizes
However, it is also necessary to develop more realistic mathematical 
models Behavioural changes and additional biological complexities, (such as 
variable transmission efficiencies, parameter changes due to intervention and 
age structure) should ideally be included in future models
The formulation of realistic mathematical models that link specific risk 
behaviours of individuals with the seroprevalence level of a population is 
essential to access the epidemiological significance of behavioural intervention 
strategies
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Chapter 7
Review of Results, Conclusions, and Final 
Recommendations
7.1 Review of aims and objectives
The main reason for formulating and exploring mathematical models such 
as that described in Chapter 6 is to investigate how the various parameters 
affect viral persistence and spread, and to help improve general understanding 
of the transmission dynamics of HIV infection The overall objective is of 
course to curb the growth of the epidemic Accurate estimates are important in 
this regard not only for developing effective strategies to prevent further spread
of HIV infection, but also for assessing the potentially enormous, future
demands on the health care system
7.2 Results of the numerical analysis
The use of deterministic models as predictive tools is still hampered by 
the uncertainties that surround key epidemiological parameters and processes 
It is still for example unclear how infectiousness varies over the incubation 
period of AIDS However such models do help us to understand the trends in 
the progress of the disease, give us important qualitative insight into the shape 
of the infection curve and provide a framework within which to evaluate the 
potential impact of different intervention programs
The results from the simulations presented in chapter 6 have strong 
implications for the prediction of the future course of the AIDS epidemic Even 
though they derive from a highly simplified model, the analyses presented here 
clearly show that the amount of sexual contact between the IVDUs and non- 
IVDU heterosexuals is a very important variable to consider when assessing 
the future of the epidemic in the Irish population The question as to whether 
the disease will become epidemic in the general population hinges critically on
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accurate estimation of the amount of sexual contact between the two groups 
and not only on the number of sexual partners Despite the current ratio of 
infecteds and AIDS cases for IVDUs and non-IVDUs this will not always remain 
the case
Women are particularly susceptible to HIV infection As more women 
become infected, so too do more infants through perinatal transmission (which 
is not dealt with in this work) The majonty of infected women are not aware of 
their condition They are often diagnosed after becoming pregnant or after 
giving birth According to a United Nations Development Programme (UNDP) 
study on AIDS, there are more than twice as many reported AIDS cases among 
15-25 year old women in Uganda than among men of the same age (UNDP, 
1994)
An appreciation of the points at which changes in sexual or drug using 
behaviour may dramatically reduce the burden of AIDS on its potential victims 
and on society at large is important Messages are more effective when they 
can be directed toward a specific target population Targeting education and 
condom distribution at high-risk groups will always be beneficial in the early 
stages of the epidemic, when infection in the general population is limited The 
projections recorded in Tables 6 26 and 6 27, which show the influence of the 
timing of behaviour change on the shape of the epidemic, provide a good 
illustration of this point With respect to data collection, they also highlight the 
importance of acquiring good quantitative information on sexual and drug using 
behaviour and temporal changes therein
7.3 Limitations of the model used. Developments and 
recommendations for future work
7.3.1 Data collection
The need for improved precision in estimating behavioural and population 
mixing variables is highlighted in Chapter 6 Data collection should therefore 
be extended in terms of frequency, detail and, most importantly, central 
collation, if rational implementation of intervention plans is to be achieved An 
immediate benefit would be a reduction in parameter estimation uncertainty 
with regard specifically to the behavioural parameters and hence improved 
prediction
Any worthwhile data collection presents difficulties and this is especially 
true in the context of research with IVDUs Nevertheless, repeat surveys of
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specific data subsets undertaken during drug use surveillance or monitoring 
schemes would sensibly improve parameter estimates, even though some of 
the parameters will be impossible to measure with complete accuracy
7.3.2 Extensions to risk groups
Any realistic model for the spread of HIV in the population must consider 
all risk groups Obvious extensions to risk groups considered include 
homosexual and bisexual men, haemophiliacs, recipients of blood products 
prior to 1985, sexual contacts of haemophiliacs and transfusion recipients, and 
children of infected individuals
7.3.3 Epidemiological factors
In addition to the risk groups themselves, a number of other factors 
should be considered These include
• The nature of the sexual behaviours and preventive measures taken
As mentioned earlier certain sexual behaviour behaviours involve a
higher risk of HIV transmission than others However obtaining this sort of 
sensitive information is not without its difficulties
• The age distribution of the population
Sexual behaviour is clearly age dependent, and the length of the 
incubation period tends to decrease with increasing age in adults Therefore a 
more realistic model needs to be stratified by age However this stratification 
involves model complications
• Geographic location
Chapter 1 offers a preliminary assessment of this area More 
interdisciplinary work is needed here as is extensive data collection
• The pattern of interaction of individuals within and between risk groups
Heterogeneity in contact rates and the duration of partnerships play an
important role in the spread of the HIV virus (Anderson, 1988) One should for 
example account for pair formation and pair separation, especially with regard 
to the spread of HIV in the heterosexual population There is also a need for 
the model to allow for proportional mixing within groups and between groups
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7.3.4 Aetiological factors
It is also necessary to consider three main factors associated with the 
natural history of the disease
• The pattern of mfectivity
This probably varies throughout the infectiousness period and the model 
should ideally account forjhis variability
• The progression of the disease within an individual
A more detailed calculation of the biological parameters would take into 
account the fact that the hazard of developing AIDS increases with time since 
infection There may also be a need, as suggested by Williams and Anderson 
(1994), to reduce the incubation rates progressively over 5 years from 1989 (by 
20%) to 80% of the original rates in order to mirror the observed lengthening of 
incubation periods brought about by improved care of patients
• The survival time of persons diagnosed with AIDS
The hazard of dying also increases with time from AIDS diagnosis In 
addition the survival time of persons diagnosed with AIDS is constantly 
changing due to improvements in the care of patients
7.4 Discussion
Studies have indicated that knowledge of HIV serostatus may help to 
reduce HIV transmission from HIV-positive IVDUs to others through safer 
injecting and sexual behaviour However, the proportion of IVDUs reporting 
high-risk behaviour remains substantial Desenclos et al (1993) in a study of 
European injecting drug users, found that IVDUs who knew that they were HIV- 
seropositive were 3 1 times (95% Cl, 2 3-4 2) more likely to always use 
condoms than were IVDUs who had never been tested (this effect was more 
pronounced for women and for those over 30 years of age) They also found 
that IVDUs with a negative test tended to inject drugs safely more often than 
those who had never been tested, but there was no significant difference in 
condom use in this regard (in fact condom use tended to be even less common 
among IVDUs who were negative at their last test than among never-tested 
IVDUs Regarding Irish IVDUs (150 respondents), they found that HIV-positive 
IVDUs in Ireland, were more likely to give their injecting equipment to other
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IVDUs than were HIV-positive respondents from any of the other twelve 
countries, and safe injection practices of HIV seropositive IVDUs were less 
likely in Ireland than in any other country with the exception of Italy Many 
studies have noted more change in injection risk behaviour than in sexual risk 
behaviour (Klee et a l , 1991a, Murphy et a l, 1993, Richardson et a l , 1993, Des 
Jarlais et a l , 1992) This is particularly true of those drug users who are in 
long term relationships
Unfortunately, however, neither drug-abuse treatment programmes nor 
safer injection programmes have been successful at reaching new injectors It 
appears that most individuals inject for several years before they perceive drug 
misuse or AIDS as personally relevant problems requiring special attention 
Some reports suggest that the highest prevalence of HIV infection and lowest 
rates of voluntary confidential testing are found in those who have no history of 
treatment for their drug-use (Donoghoe et a l , 1993)
In addition the availability of treatment is usually significantly less than the 
demand Expanding the treatment system could help to reduce IV drug 
injection and transmission of HIV among drug users Users who had not been 
exposed would reduce their chances of being exposed, and users who had 
already been exposed would reduce their chances of exposing others The 
cost of treating AIDS among drug users who are usually totally dependent on 
the state for their medical expenses is approximately £8,300, per case, per 
year for anti-viral therapy alone, (i e not including medical or hospital care or 
other drug costs) Therefore, the economics of the treatment of AIDS versus 
the provision of drug abuse treatment, also argues for expansion of the 
treatment network According to AIDS in the World (Mann et a l , 1992) the cost 
of AIDS inpatient care per year in the UK was $25, 000 to $30, 000 for the 
period 1987-1989 This represents approximately twice the UK per capita 
GNP for the period 1986-1988
However the decision to expand the treatment system is in the realm of 
the policy makers and AIDS is a difficult area for politicians because the 
wisdom of present policies will often not be validated for five or more years 
when they may no longer be in office In addition some of the necessary 
language of prevention is awkward to use in the delivery of speeches
The construction of transmission models highlights how little we know 
about the major epidemiological and behavioural determinants of the pattern of 
the HIV epidemic in Ireland This situation is not unique to Ireland As Knox 
has commented
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oThose who write the history of this disease will be intrigued by the 
contrasts which it displays the implacable deadlines of the biological hazard 
the still-primitive but rapidly-developing scientific foundation for 
understanding, predicting and controlling epidemics the urgent need to 
allocate resources, powers and responsibilities for its control’ and a disregard 
of all of them within a social response dominated by other concerns
(Knox et al 1993)
Our knowledge is not likely to improve rapidly because of the practical 
difficulties inherent in both the study of intimate human behaviour and the 
assessment of infectiousness and transmissibility for a disease with a long 
incubation period The many uncertainties argue strongly for a precautionary 
approach in the delivery of public health messages about HIV and AIDS The 
likely extent of the heterosexual epidemic in the future is uncertain, hence 
education must stress that the majonty are at risk while continuing to target 
most efforts at high risk groups
The need for continuous vigilance is also highlighted by Fitzpatrick et al 
(1992) in a study of 32 teenage girls attending a Dublin STD clinic which found 
that of 29 having intercourse without condoms, none considered themselves to 
be at risk of contracting HIV from their present partner As the Irish Times put 
it
There is now a need to reach out to the non-margmalised in society 
who may not believe that they are at nsk If only a small mmonty of those 
who have hitherto been easily recognisable as members of the marginalised 
groups at most nsk have been persuaded to change their nsk-takmg 
behaviour, how much more daunting is the task of altering the nsk behaviour 
of those who do not perceive themselves as being at nsk? There is a great 
deal more to be done to contain the spread of HIV than has been done to 
date
(Irish Times editorial, 30th Sept 1994)
More generally the key to reducing the spread of AIDS lies in accurate 
epidemiological surveillance which provides the factual base for education 
Transmission models produce a framework against which to interpret the 
factors that have generated past trends and the processes that will determine 
future events The stakes are very high
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Appendix A
HIV Transmission Survey of Drug Project 
Clients
A.1 Summary of principal features of AIDS in Ireland
The following represent notable features of AIDS in Ireland at present
• The proportion of AIDS case§ attributed to IVDU and heterosexual 
transmission continues to rise
• 408 cases of AIDS were reported by the end of June 1994
• 43 4% of cases occurred among IVDUs
• 11 % of cases are due to heterosexual transmission
• 31 % of female AIDS cases are due to heterosexual transmission
• 49 % of all AIDS cases attributed to heterosexual transmission are 
women
i
• Heterosexually acquired AIDS increased from 29% of all women with 
AIDS in 1993 to 31% in 1994
• The proportion of cases due to heterosexual sex is rising far more 
rapidly than that of any other route of transmission
• The number of reported cases of people infected through heterosexual 
sex rose by 80% in the past 2 years (June 1992-June 1994)
• Many of those who acquired the virus through heterosexual sex were 
the sexual partners of HIV-infected IVDUs
In our study we describe differences in high-risk sexual practices among 
IVDUs recruited from the Drug Treatment Centre (D T C ) and from the Ana 
Liffey Drug Project (A L ) Our primary objective is to investigate the variability 
in sexual and drug using practices among IVDUs and the associations between 
specific high-risk sexual and drug using practices and sex
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A.2 Subjects and Methods
A.2.1 Recruitment
Subjects were recruited from the D T C and the Ana Liffey Drug Project 
between 22 November 1993 and 23 August 1994 A common structured 
questionnaire was used with both groups A double-site strategy was 
employed to limit bias from single-site recruitment 133 persons were 
interviewed by the two different drug treatment agencies 117 of the 133 were 
IVDUs Of the 117, 96 were recruited by the DT C and 21 were recruited by 
the Ana Liffey Drug Project The D T C subjects were recruited sequentially 
but the Ana Liffey subjects were recruited on the threefold basis of HIV 
seropositive status, receptivity and lucidity Therefore the two groups are not 
strictly comparable The questions were designed to obtain data on the 
following age, sex, residence, attendance at a sexually transmitted disease 
clinic, use of intravenous drugs, sexual preference, number of sexual partners 
in the previous year, sexual contacts with intravenous drug users or 
seropositive partners, and use of condoms Individuals were asked about their 
injecting and drug using behaviours with IVDU and non-IVDU partners during 
the 12 months before interview The questionnaires were completed by trained 
interviewers during individual interviews Demographic details, recent drug 
use, syringe-sharing HIV risk behaviour, HIV testing, and awareness of HIV 
antibody status were compared across the two groups Given that the two 
groups were recruited on different bases and are not properly comparable they 
provide separate snapshots or cross-sectional views of the Irish HIV and drug 
problem Nevertheless, because numbers are small in the Ana Liffey sample, 
we have reported results together, indicating throughout, the likely bias 
introduced by the Ana Liffey group
A.2.1 Missing values
Midpoint intervals were assumed in year and month of birth and in year of 
last drug injection if data were missing This was the case for two subjects 
where only year of birth was recorded, for 21 subjects (all those recruited by 
the Ana Liffey Drug Project) where only year and month of birth were available 
and for 5 subjects where only year of last drug injection was recorded 
Midpoint intervals were also assumed in year of HIV seropositive diagnosis if 
data were missing (9 subjects and 4 partners of subjects), but it was assumed 
that the diagnosis occurred on the first of the month One of those whose age
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was missing and 12 whose number of sexual partners in the previous year was 
missing, were omitted from Tables A1, A2 and A3
A.2.2 Statistical analysis
Descriptive analyses of data on the 117 IVDUs were carried out, and the 
relation of each variable to serologic status was examined Data were 
analysed using the SAS system (SAS Institute, 1988) The procedure TTEST, 
was used for comparing means Pearson's %2, and Fisher's exact test (for 
when the sample size was small), were used for comparisons of proportions 
between groups In all cases a level of significance a= 0 05 was used unless 
otherwise stated
A.3 Results
A.3.1 Demographic characteristics
A summary of selected characteristics of the study population, by sex, is 
shown in Table A1
Three quarters of the study population were men and one quarter were 
women
The mean age of the participants was 25 years (S D 5 97) The age 
distribution ranged from 17-45 years The age distribution was similar for 
women and men
67 individuals from the total number of IVDUs (57%) reported having a 
regular sexual partner Women and men did not differ significantly in respect 
of having a regular partner
Men were more likely to have been using IV drugs at the time of the 
interview than women 38 (32 5%) men were currently using compared to only 
5 (4 3%) women ( %2=6 3, df=1, p=0 012)
The mean age of first intravenous drug use was 18 years (S D 3 6) The 
age of first needle use ranged from 12 to  32. 70 subjects out o f the 117 
in the sample had used IV drugs by 18 years of age (60%)
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Table A1. Selected characteristics of 117 IVDUs recruited from the 
D.T.C. and the Ana Liffey Drug Treatment Program 
by treatment centre and sex.
No (%)
Treatment centre 
_ P T C ______Anna Liffev_______Total
Men
No subjects 73 15 88
Age at interview
< 24 44 00 44
>24 28 15 43
Regular partner
No 37 04 41
Yes 36 11 47
IVDU at present
No 44 06 50
Yes 29 09 38
Women
No subjects 23 06 29
Age at interview
<24 13 00 13
>24 10 06 16
Regular partner
No 09 00 09
Yes 14 06 20
IVDU at present
No 21 03 24
Yes 02 03 05
A.3.2 Characteristics of sexual partners of subjects
26 (22%) of the sample reported having a sexual partner who was also, 
either at present or in the past, an IVDU
10 subjects (8 5%) reported that their regular sexual partner was 
seropositive, 52 (44 4%) had partners who were seronegative and 5 (4 3%) had 
partners whose status was unknown (42 7% had no regular partner)
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When questioned regarding the HIV status of their previous partner, 8 
(7 1%) reported that their previous sexual partner was seropositive, 71 (62 8%) 
had previous partners who were seronegative and 26 (23%) had previous 
partners whose status was unknown (8 (7 1%) had no previous partner)
Table A2. Treatment centre comparisons, demographics, recent 
drug use and HIV risk behaviour differences in drug users.
Treatment centre
P T C _____ Anna Liffev Total
n = 96 n = 21 n = 117
Demographics
Sex
Female (%) 19 7 5 1 24 8
Male (%) 62 4 128 75 2
Mean age (years) 24 31 25
Age group
<24 years (%) 49 1 0 49 1
24 years and over (%) 32 8 181 50 9
No years injecting
<5 years (%) 44 0 09 44 8
>5 years (%) 37 9 172 55 2
Mean number of years injecting 55 11 0 65
HIV risk behaviour
Mean injections (mth) 63 86 67
Sharing*
Sharing within prev 3 mths(%) 67 1 152 82 3
Injecting but not sharing (%) 165 1 3 177
Pata were missing for 38 subjects who had not injected in the previous 3 
months
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A.3.3 Demographic characteristics by treatment centre
Demographic characteristics, recent drug use and syringe-sharing HIV 
risk behaviours by treatment centre are shown in Table A2
There were no significant differences in gender between the treatment 
centres
IVDUs who were recruited by the D T C were younger (mean age = 24) 
than those recruited by A L  (mean age 31, t = -5 4, df =(94, 20), p< 0 0001) 
Significantly more IVDUs attending A L were 24 years of age and older (21 
(100%)) than those being treated by the D T C (38 out of 95 (40%), %2=24 8,
df= 1, p<0 0001)
Injectors attending AL also had longer injecting careers (mean = 11 years 
since first injection) than those attending the D T C (mean = 55 years, t = -4 6, 
df =(94,20), p< 0 0001) 51 of the IVDUs who attended the D T C  (data
missing for 1 subject) had less than 5 years experience of drug injecting, 
compared with only 1 of the 21 of those recruited by A L  (^2= 16 6, df =1,
p<0 0001)
The treatment centres did not differ with respect to age of first needle use
A.3.4 HIV risk behaviour
The study subjects were predominantly heterosexual 2 male and one 
female subjects were bisexual and one female subject was homosexual The 
proportions of women and men from each agency who had engaged in high- 
risk sexual and drug using practices are shown in Table A3
The mean age of first sexual intercourse for the total group was 15 7 
years (S D 2 4, range 9-29 years, median 15) 70% of the total group had
initiated sexual intercourse by age 16, and over half of the subjects in all 
agency/sex groups reported initiating sexual intercourse by age 15 51 7% of 
women (15 out of 29) and 52 3% of men (46 out of 88) had experienced 
intercourse by the time they were 15 years old There were no significant 
differences between the sexes, the recruiting centres, or between the different 
age groups regarding age of first sexual intercourse
In the group as a whole there were adequate data for 105 subjects 
regarding the total number of sexual partners in the previous year 46 (43 8%) 
of the respondents claimed to have had more than one sexual partner during 
the preceeding 12 months The mean number of sexual partners in the total 
group was 2 35 (S D 2 7, range 0-14) The median number of sexual partners 
was 1
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There were no significant differences between the sexes, the recruiting 
centres, or the age groups regarding whether subjects had had more than one 
sexual partner in the previous year
There was a significant difference between those with a regular partner 
and others regarding whether subjects had had more than one sexual partner 
in the previous year Subjects who had a regular partner were more likely to 
have had at most one partner in the previous year than those who did not have 
a regular partner (66 7% compared to 42 2%, x2=6 2, df =1, p=0 012)
The mean number of sexual partners for men was 2 5 (S D 2 8, range 0- 
14) The median number of sexual partners for men was 1 Men who did not 
have a regular partner were more likely than other men to have had more than 
one sexual partner in the previous year than those who had a regular partner 
(61 1 % compared to 36 6%, %2=4 6, df =1, p=0 032) This was not the case for
women
The mean number of sexual partners for women was 1 9 (S D 2 1, range 
0-8) The median number of sexual partners for women was 1 Women who 
had at most one sexual partner were more likely than other women to never 
use a condom (52 6% compared to 22 2%, p=0 056, Fisher's exact test)
The prevalence of sex with a non-IVDU was high in the group as a whole 
with 67% of subjects (n = 77, 2 missing values), reporting at least one partner 
who was a non-IVDU However, this differed widely between the sexes, the' 
age-groups and between the recruiting centres Men were far more likely than 
women to have had a non-IVDU sexual partner in the previous year 77 9% of 
men (n = 67) compared to only 34 5% of women (n = 10) had a sexual partner 
who was a non-IVDU (%2=18 5, df =1, p < 0 0001) Subjects recruited by the 
D T C were also more likely to have had a non-IVDU sexual partner in the 
previous year than were subjects recruited by A L 71 6% of D T C subjects 
compared to only 45% of A L subjects had a sexual partner who was a non- 
IVDU (%2= 5 3, df =1, p = 0 022) Younger subjects too were more likely to 
have a non-IVDU sexual partner than were those from the older age group 
75 4% of those under 24 had a non-IVDU sexual partner compared to 57 9% of 
those who were 24 years of age and older (%2= 3 9, df =1, p = 0 047)
However when those who were aged 24 years and older were analysed 
separately, there was no significant differences between the recruiting centres 
regarding sex with a non-IVDU This suggests that the significant difference 
found in this regard in the total group may be explained by the fact that the 
D T C subjects were younger than those recruited by A L
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On the other hand women tended to have more drug using sexual 
partners than men 75% of women had at least one IVDU sexual partner in the 
previous year compared to 41% of men (p = 0 014, Fisher's exact test) There 
was no significant difference between the recruiting centres regarding whether 
subjects had an IVDU sexual partner or not
The prevalence of anal sex was low in all agency/sex groups, with only 
12 8% of the total group reporting it There were no significant differences 
between the sexes or between the centres regarding anal sex
Of the total group only 28 (23 9%) subjects reported that they always use 
condoms 53 (45 3%) reported sometimes using them and 36 (30 8%) never 
use them Men were less likely than women to always use condoms (22% of 
men compared to 31% of women, x2= 7 1, df =2, p = 0 029) In the total group 
there were no significant differences between the recruiting centres, the age 
groups, the HIV status of subjects or between those who had a regular partner 
and others regarding condom use 29% of those with a regular sexual partner 
never use condoms, 46% sometimes use condoms and 25% always use 
condoms The corresponding proportions for those who do not have a regular 
partner are 33%, 45% and 22%
The use of condoms was also analysed by stratifying by number of sexual 
partners in the previous year and sexual contact with intravenous drug users 
There was no significant difference between those subjects who had had more 
than one partner in the previous year and others regarding condom use 
However a significantly higher proportion of women having had two or more 
sexual partners in the previous year reported the use of condoms, as compared 
with women with less than two partners (77 8% vs 47 4%, p = 0 056, Fishers 
exact test) In the total group no difference in condom use was seen between 
subjects who reported sexual contact with intravenous drug users and subjects 
who did not, nor between subjects who reported sexual contact with non-IVDUs 
and subjects who did not This also held true when the group was stratified by 
sex
There was a significant difference in condom use when measured against 
those who had been tested for HIV and those who had not been tested 26 7% 
of those who had been tested always use condoms compared to only 14 8% of 
those who had not been tested (x2= 6 47, df =2, p = 0 039)
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Table A3. HIV risk behaviour, by sex
No (%)
P T C  Anna Liffev
Men 73(83%) 15(17%)
Age at first intercourse
<15 _ 37(42%) 9(10%)
>15 36(41%) 6 ( 7 % )
Total no partners in 
previous year (missing 11)
< 1 33 (43%) 7 ( 9%)
> 1 32 (42%) 5 ( 6%)
Sex with an IVPU in
previous year (missing 9)
No 44 (56%) 3 ( 9%)
Yes 22(28%) 10(6%)
Sax with a non IVPU in 
previous year (missing 2)
No 11(13%) 8 ( 9 % )
Yes 61(71%) 6 ( 7 % )
Women 23(79%) 6(21%)
Age at first intercourse
<15 12(41%) 3(10%)
>15 11(38%) 3(10%)
Total no partners in 
previous year (missing 1)
<1 15(54%) 4(14%)
> 1 8 (29%) 1 ( 4%)
Sex with an IVPU in
previous year (missing 1)
No 4(14%) 3(11%)
Yes 19(68%) 2 ( 7%)
Sex with a non IVPU 
in previous year
No 16(55%) 3(10%)
Yes 7(24%) 3(10%)
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Total 
88 (100%)
46 (52%) 
42 (48%)
40 (52%) 
37 (48%)
47 (60%) 
32 (40%)
19 (22%) 
67 (78%)
29 (100%)
15 (52%) 
14(48%)
19 (68%) 
9 (32%)
7 (25%) 
21 (75%)
19 (65%) 
10 (34%)
A.3.5 Injecting practices
90 6% of the IVDUs had injected drugs in the 12 months before interview
and 67 5% had injected in the previous 3 months Intravenous drug users
recruited by A L who had injected in the previous three months had a higher 
number of mean injections per month (94) than those in the D T C (59, t=-3 33, 
df = (12, 65), p=0 0013)
All subjects whether currently injecting or not were questioned about the 
number of times they injected when they were injecting Those recruited by 
A L had a higher number of mean injections per month (86) than those
recruited by the D T C (63), (t=-2 43, df = (95, 20), p<0 017)
A.3.5.1 Sharing
Overall, 71 (60 7%) subjects had shared injecting equipment in the 
previous 6 months and 65 (55 6%) had shared in the previous 3 months There 
were no significant differences in needle-sharing risk behaviours by treatment 
centre, sex, age-group, or by the length of time that subjects were injecting
A.3.5.2 Cleaning of injecting equipment
The vast majority 93 (80 2%) of the total group reported that they always 
cleaned needles 21 (18 1%) said they sometimes cleaned and 2 reported that 
they never cleaned injecting equipment
However when questioned about the methods they employed in cleaning 
the equipment, only 60 (52 6%) subjects effectively cleaned the equipment
There were no significant differences in the cleaning of equipment or in 
the effectiveness of cleaning, between those who had shared in the previous 3 
months and others, nor between those who had shared in the previous 6 
months and others
Interestingly, while there was no significant difference between recruiting 
centres in the cleaning of equipment, they did differ regarding the effectiveness 
of cleaning Only 48% of those recruited by the D T C effectively cleaned 
injecting equipment compared to 71% of those recruited by A L (%2= 3 65, 
df=1, p = 0 056)
This was also the case for the different age groups While belonging to a 
particular age group did not affect whether subjects cleaned equipment or not, 
it did influence the effectiveness of cleaning In the total group older subjects 
were more likely to effectively clean equipment Only 42% of those aged under 
24 years effectively cleaned equipment compared to 62 5% of those aged 24 
years and older (%2= 4 7, df = 1, p = 0 03)
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fHowever when older subjects were taken separately, no significant 
difference was found between recruiting centres regarding the effective 
cleaning of equipment This suggests that the significant difference found with 
regard to the effective cleaning of equipment between the recruiting centres, in 
the total group can be explained by the difference in the age-groups between 
the two centres
A.3.6 Testing for HIV
Table A4 shows that 90 of the 117 (77%) IVDUs in the total sample had 
been tested for HIV Rates of HIV testing were obviously significantly lower in 
IVDUs recruited by the D T C  (69 out of 96, 71 9%) than those recruited by 
A L where all subjects had b^en tested and were seropositive This difference 
is an artificial one however, since A L purposely recruited seropositive clients
Table A4. HIV testing history of IVDUs by treatment centre.
Treatment centre
D TC Anna Liffey Total
Tested
n = 96 n = 21 n = 117
Yes 69 (59%) 21 (18%) 90 (77%)
No 27 (23%) 00 (0%) 27 (23%)
Serostatus
Positive 05 (6%) 21 (23%) 26 (29%)
Negative 54 (60%) 00 (0%) 54 (60%)
Unknown 10 (11%) 00 (0%) 10 (11%)
Missing data testing history, 27 cases
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A.3.7 Characteristics of those who claimed to be HIV seropositive
Overall 26 (29%) were seropositive, 54 (60%) were seronegative and HIV 
status was unknown in 10 (11%) Considering the different bases employed in 
the recruitment of the two samples there were, of course, significant differences 
in HIV status by treatment centre 7% (5 out of 69) of IVDUs recruited in the 
D T C  were HIV seropositive, whilst all 21 (100%) of those recruited by AL 
were HIV seropositive
The mean duration of time since diagnosis was 72 months, the range 
was from 3-116 months (S D 35 1) However with the exception of 2 
individuals, all subjects had been diagnosed at least one year previously
The majonty, 20 (76 9%) of those who were seropositive had a regular 
sexual partner, and 18 of the 20 (90%) had been with their regular partner for 4 
years or more Subjects who were HIV seropositive were more likely to have a 
regular partner than other subjects who had been tested 76 9% of those who 
were seropositive had a regular partner compared to 50% who were 
seronegative and 40% whose serostatus was unknown {%2= 6 4, df= 2, 
p=0 04)
12 (60%) of those seropositive subjects with a regular partner reported 
that their partner was an IVDU either at the time of the interview or in the past
9 of the 21 (45%) reported that their regular partner was also HIV 
seropositive
Those who reported being seropositive (N=26) were asked about their 
needle sharing and sexual activities since becoming seropositive
A.3.7.1 Sexual behaviour of subjects who reported being
seropositive
In the following sections it should be remembered that the numbers of HIV 
seropositive subjects are small The study subjects were predominantly 
heterosexual 22 seropositive individuals (84 6%) were sexually active in the 
previous year, the majority, 16 (72 7% of those who were seropositive and 
sexually active) with one partner only
A.3.7.2 Condom use
Of those who were seropositive 10 (38 5%) claimed they used condoms 
always and 10 (38 5%) said they use them sometimes Although 6 (23 1%) of 
those who were seropositive claimed they never used condoms, only 3 of the 6 
were sexually active in the previous year with a partner who was not
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seropositive and one of the 3 was female whose sexual partner was female 
There were two sexually active individuals (7 7%) therefore, who did not use 
condoms who were likely to contribute to further HIV transmission
A.3.7.3 Number of sexual partners
Since becoming HIV seropositive (n = 26), 9 (34 6%) claimed to have had 
fewer partners, 15 (57 7%) reported no change in the number of partners and 2 
(7 7%) claimed to have had more partners Table A5 shows the number of 
sexual partners of HIV seropositive subjects, by IVDU status
Table A5. Number of sexual partners by IVDU status (n = 26)
Number of sexual partners IVDU non-IVDU
0 8 (35%) 14(58%)
1 10 (43% 9 (37%)
2 2 (9%) 0 ( 0%)
3-9 2 (9%) 1 ( 4%)
10 or more 1 (4%) 0 ( 0%)
missing 3 2
A.3.7.4 Frequency of sexual activity
Since becoming HIV seropositive (n = 26), 17 subjects (65 4%) reported 
that their sexual activity was less frequent, 8 (30 8%) reported no change in the 
frequency of their sexual activity and 1 (3 8%) claimed that their sexual activity 
was more frequent
A.3.7.5 Injecting behaviour of subjects who reported being
seropositive
21 (80 8%) subjects claimed to have injected less often since becoming 
HIV seropositive 3 (11 5%) subjects said there was no change in their 
frequency of injecting and 2 (7 7%) said they inject more often since diagnosis 
of seropositive status
The average number of people shared with in a week when subjects were 
injecting, ranged from 0 to 48 with a mean of 2 9 and a standard deviation of 
7 1 For females the mean was found to be 2 24 (Std Dev =2 65) and the
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corresponding figure for males was 3 14 (Std Dev = 8 11) However this 
difference was not statistically significant
Despite being seropositive, 17 subjects (65 4%) admitted to having 
continued to share injecting equipment in the previous 6 months Of these, 
only one person said they limited sharing to one other person while 11 of the 
17 (64 7%) had shared with more than one other person (data were missing for 
5 subjects)
A.3.7.6 HIV status: treatment centre comparisons by age and length
of injecting career
Table A6 shows self reported HIV status by treatment centre and age All 
those who were HIV seropositive were 24 years of age or older Overall the 
HIV seropositive rate was therefore significantly higher in IVDUs aged 24 years 
and older (100%) than those aged < 24 years (0%, x2=30 7, df= 2, p<0 0001) 
This also held true when D T C  subjects were analysed separately (100%, 
compared to 0%, p= 0 009, Fisher's exact test)
Table A6. Self-reported HIV status treatment centre comparisons by 
age group and length of drug-injecting career.
Treatment centre
D TC  Anna Liffey Total
Age group in years (%)
<24 0 ( 0%) 0 ( 0%) 0 ( 0%)
>24 5(19%) 21(81%) 26 (100%)
No years injecting (%)
< 5 1 (4%) 1 (4%) 2 ( 8%)
>5  4(15%) 20(77%) 24(92%)
Table A6 also shows the HIV seropositive rates by treatment centre and 
length of injecting career In the total sample of those who were tested for HIV 
seropositivity (n = 90, see table A4), subjects injecting for 5 or more years (n = 
59), were more likely to be HIV seropositive than those injecting for less than 5 
years (n = 31 ) (40 7% compared to 6 5%, x2=11 7, df = 2, p=0 003)
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A.4 Discussion
Drug users recruited by D T C were younger and had shorter injecting 
careers than those recruited by Ana Liffey There was no difference in terms of 
sex, the majonty being men Levels of recent equipment sharing were similar 
for both groups
Sexual risks for HIV infection were common in this population The use of 
condoms was not common among the subjects In fact, only 23 9% of them 
reported consistent use of condoms However, women who had more than one 
sexual partner in the previous year were more likely to report consistent 
condom use than other women
A high proportion of men reported sexual contact with a non-IVDU 
woman, indicating the potential for widespread heterosexual transmission of 
HIV to women from infected male drug users
Our data show that most IVDUs in our survey had been tested for HIV 
antibodies HIV seropositivity was highest in IVDUs recruited by A L but this 
can be explained by the different recruiting strategy employed by A L In the 
total group higher seropositivity was associated with older IVDUs (> 24 years) 
Higher seropositivity was also associated with IVDUs with longer injecting 
careers (5 years or more) However when subjects recruited by the D T C 
were analysed separately there was no significant difference in seropositivity 
between those with longer and shorter injecting careers, which is not surprising 
given the numbers involved
A number of recent papers have reported on risk behaviour for HIV 
infection among different groups of IVDUs and commented on changes in such 
behaviour as a result of AIDS awareness or HIV diagnosis (Hart et a l , 1989, 
Robert et a l , 1990, O'Mahony & Barry, 1992 (and references therein), 
Comiskey et a l , 1993, Desenclos et a l , 1993, Rhodes et a l , 1993a, b) In 
particular Williams et al (1990) looked specifically at IVDUs receiving 
methadone maintenance and known to be seropositive (N = 48), and 
investigated whether they had altered their behaviour as a result of being 
infected They found that since diagnosis the cohort had made significant 
alterations in their at risk behaviour for HIV transmission Forty-two patients 
(88%) remained sexually active after diagnosis (the majonty, 64%, with one 
partner) and 16 (38%) claimed they used condoms always However, despite 
this positive change, there remained a high level of at risk behaviour for further 
HIV transmission Despite being seropositive 63% of the Williams et al. survey
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had continued to share injecting equipment (even if at a reduced risk level) 
and more than one third who remained sexually active, did not use condoms.
These results are very similar to those found in our HIV transmission 
survey described above. The similarity in the results of the two surveys 
suggests that they provide a reasonably accurate picture of the sexual and 
drug using behaviour of Dublin IVDUs who are in contact with a treatment 
centre. However, almost a third (31.6%) of IVDUs in our study were unaware of 
their antibody status, either because they had not sought testing at time of 
interview, or because they had not looked for the result once tested. This 
strongly indicates that only part of the problem is being assessed.
The probable levels of unreported HIV positivity in IVDU from the D.T.C., 
consequent upon the fact that 38.5% had either not been tested or had not 
sought the result if tested, has important implications for epidemiological 
indicators of epidemic spread. Accurate information is necessary to plan and 
target effective prevention initiatives, to evaluate existing prevention initiatives 
and to allocate resources, including those for future patient care.
Knowledge of HIV-positive status may prompt changes in drug-injecting 
behaviour and other HIV risk behaviours, and may facilitate early diagnosis of 
treatable conditions, such as pulmonary tuberculosis and other opportunistic 
infections. Testing, irrespective of result, provides an opportunity to encourage 
change in HIV risk behaviour. Some studies suggest that knowledge of HIV 
positivity may encourage reduced risk behaviour (Desenclos & Papaevangelou, 
1993).
The double-site sample discussed above included only drug users in a 
treatment setting. Consequently, data reported here reflect trends for only a 
proportion of all IVDUs in Dublin, and may not readily generalise to the large 
number of out-of-treatment IVDUs.
It is clear from the above that several sources of possible bias must be 
considered when interpreting these results. Recall and /or self-report bias may 
affect our conclusions on needle-sharing, frequency of injection and sexual 
behaviour. It is also possible that IVDUs in treatment may be more concerned 
about HIV risk behaviour, or may under-report what drug-treatment staff 
consider to be socially undesirable behaviour. This danger is less acute in the 
D.T.C. sample as 44.8% of this sample were drug free for at least one month 
and were questioned about their drug using behaviour retrospectively.
Our results emphasise that behavioural intervention programs targeted at 
IVDU in particular must focus equally on changes in risky sexual behaviours 
and drug-injection practices. The necessity of such a focus is emphasised by
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evidence suggesting that drug-related behaviour change is more readily 
achieved and maintained than sex-related behaviour change In addition, the 
high prevalence of subjects in our study who had engaged in sexual 
intercourse by 15 years of age emphasises the importance of educating young 
people about safer sexual practices at an early age, before they become 
sexually active
The high rates of equipment sharing and the low rates of consistent 
condom use reported in this high-risk population also indicates the need for 
new and more effective strategies designed to promote safer drug usage and 
sexual activity among intravenous drug users
Further research is urgently needed for understanding and characterising 
> the sexual behaviours in the populations currently at higher risk IVDUs and 
their partners This will aid the development of more effective and accessible 
intervention programs
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sAppendix B
Mathematica Program for Perturbation
Method
□  Clear Functions and Parameter Set
Clear[Pm, Pf, Xm ,Xf, Ym, Yf, Am, Af, Xmt ,Xft, Ymt, Yft, Amt, Aft], 
Clear[XxnTemp ,XfTemp, YmTemp, YfTemp, AmTemp, AfTemp],
Clear[XmnTemp ,XfnTemp, YmnTemp, YfnTemp, AmnTemp, AfnTemp],
Clear[a, del, eps, Lm, Lf, mm, mf, tmax, XmO, XfO, YmO, YfO, AmO, AfO] ,
Pm[n_] .= Pm[n] = Xm[n] + Ym[n] + Am[n];
Pf[n_] := Pf[n] = Xf[n] + Yf[n] + Af[n];
(* dummy variables for integration up to fifth order*)
Clear [tau, tauO], 
tau={tl,t2,t3,t4,t5},
□G enerate Series Procedure
Clear[GenSeries],
GenSeries[Xser_,n_] .= Module [{ans,tl},
if [n<3,
ans = Simplify[Xser],
(* n>=3 simplifying takes too long *) 
ans = Collect [Xser, eps], 
ans = Coefficient [ans, eps, 0], 
ans = Together[ans], 
t2 = Numerator[ans],
ans = Simplify[t2]/ Denominator [ans],],
Return[ans],],
■X m
Clear[Xmt, Xm, XmO, XmTemp, XmnTemp],
Xmt [0] = Lm - mm Xm[0],
Xmt[n_] •= Xmt[n] = 1/(epsAn *Pf[0]) (
- Sum[epsAk Sum[Xmt[k-j] Pf[n], {3,0,k}], {k,0,n-l}] - 
epsAn Sum[Xmt[n-j] Pf[j], {j,l,n}] +
Lm Sum[epsAk Pf[k], {k,0,n}] -
mm Sum[epsAk Sum[Xm[k-]] Pf[j], {j,0,k}], {k,0,n}] - 
eps Sum[epsAk Sum[Xm[k-j] Yf[j], {j,0,k}], {k,0,n-l}] ),
(* Anlyatical Solution n=0*)
XmTemp[0] = z[t] /
DSolve[{z' [t]==(Xmt[0] / {Xm[0]->z[t] }) , z[0]==XmO},
z[t],t] [[!]],
(* Exp[-mm t] XmO +
Integrate [Exp[-mm(t-tauO)] Lm, {tauO,0,t}],*)
(* Numerical Solution n>0*)
XmnTemp[n_] = z[t] /
NDSolve[{z'[t]==(Xmt[n] / {Xm[n]->z[t]}) ,z[0]==0 0}, 
z[t], {t,0 0,tmax}] [[1]],
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■  Xf
Clear[Xft, Xf, XfO, XfTemp, XfnTemp],
Xft [0] = Lf - mf Xf[0],
Xft[n_] •= Xft[n] = Xft[n] = 1/(epsAn *Pm[0]) (
- Sum[epsAk Sum[Xft[k-j] Pm[j], {j,0,k}], {k,0,n-l}] - 
epsAn Sum[Xft[n-j] Pm[j], {j,l,n}] +
Lf Sum[epsAk Pm[k] , {k,0,n}] -
mf Sum[epsAk Sum[Xf[k-j] Pm[]], {j,0,k}], {k,0,n}] - 
8 eps Sum[epsAk Sum[Xf[k-j] Ym[j], {j,0,k}], {k,0,n-l}] ),
(* Anlyatical Solution n=0 *)
XfTemp[0] = z[t] /
DSolve[{z1[t]==(Xft[0] /. {Xf[0]->z[t]}) ,z[0]==Xf0}, 
z[t], t] [[1]],
(* Exp[-mf t] XfO +
Integrate [Exp[-mf(t-tauO)] Lf, {tau0,0,t}], *)
(* Numerical Solution n>0*)
XfnTemp[n_] •= z[t] /
NDSolve[{z’[t]==(Xft[n] / {Xf[n]->z[t] } ) ,z[0]==0 0}, 
z[t], {t,0 0,tmax}] [ [1]] ,
■Ym
Clear[Ymt, Ym, YmO, YmTemp, YmnTemp],
Ymt[0] = - (a+mm) Ym[0],
Ymt[n_] = 1/(epsAn *Pf[0]) (
- Sum[epsAk Sum[Ymt[k-]] Pf[j], <:,0,k}], {k,0,n-l}] - 
epsAn Sum[Ymt[n-j] Pf[j], {j,l,n}] -
(a+mm) Sum[epsAk Sum[Ym[k-j] Pf[j], {j,0,k}], {k,0,n}] + 
eps Sum[epsAk Sum[Xm[k-j] Yf[j], {],0,k}], {k,0,n-l}] ),
(* Anlyatical Solution n=0 *)
YmTemp[0] = Exp[-(a+mm) t] YmO,
(* Numerical Solution n>0*)
YmnTemp[n_] = z[t] /
NDSolve[{z'[t]==(Ymt[n] / {Ym[n]->z[t]}) ,z[0]==0 0},
z[t], {t,0 0,tmax}] [[1]],
■ Y f
Clear[Yft, Yf, YfO, YfTemp, YfnTemp],
Yft[0] = - (afmf) Yf[0],
Yft[n_] = Yft[n] = 1/(epsAn *Pm[0]) (
- Sum[epsAk Sum[Yft[k-j] Pm[j], {j,0,k}], {k,0,n-l}] - 
epsAn Sum[Yft[n-j] Pm[j], {j,l,n}] - 
» (a+mf) Sum[epsAk Sum[Yf[k-j] Pm[j], {j,0,k}], {k,0,n}] +
8 eps Sum[epsAk Sum[Xf[k-j] Ym[:], {j,0,k}], {k,0,n-l}] );
(* Anyatical Solution n=0*)
YfTemp[0] = Exp[-(a+mf) t] YfO ,
(* Numerical Solution n>0*)
YfnTemp[n_] .= z[t] /
NDSolve[{z'[t]==(Yft[n] / {Yf[n]->z[t]}) ,z[0]==0 0), 
z[t], {t,0.0,tmax}] [ [ 1]];
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■Am
Clear[Amt, Am, AmO, AmTemp, AmnTemp] ,
Amt[n_] = a Ym[n] - (del+itim) Am[n],
(* Anlyatical Solution n=0*)
AmTemp[0] = z[t] /
DSolve[{z'[t]==(Amt[0] / {Ym[0]->YmTemp[0], Am[0]->z[t]}) ,
z[0]==AmO}, z[t], t] [[1]],
(*Exp[-(del+mm) t] AmO + _
Integrate [Exp[-(del+mm) (t-tauO)] * a *
(Ym[0] / (t->tau0)), {tauO,0,t}],*)
(* Numerical Solution n>0*)
AmnTemp[n_] = z[t] /.
NDSolve[{z'[t]==(Amt[n] / {Am[n]->z[t]}) ,z[0]==0 0}, 
z [t] , {t, 0 0, tmax} ] [ [1] ] ,
■ A f
Clear[Aft, Af, AfO, AfTemp, AfnTemp],
Aft[n_] = a Yf[n] - (del+mf) Af[n],
(* Anlyatical Solution *)
AfTemp[0] = z[t] /
DSolve[{z'[t]==(Aft[0] / {Yf[0]->YfTemp[0], Af[0]->z[t]}) ,
z[0]==Af0}, z[t], t] [[1]],
(* Exp[-(del+mf) t] AfO +
Integrate [Exp[-(del+mf) (t-tau0)] * a *
(Yf[0] / [t->tau0)), {tauO,0,t}], *)
(* Numerical Solution *)
AfnTemp[n_] .= AfnTemp[n] = z[t] /
NDSolve[{z'[t]==(Aft[n] / {Af[n]->z[t]}) ,z[0]==0 0}, 
z[t], {t,0 0,tmax}] [[!]],
□  Calculate Series Expansions
(* 'remember' expansions up 
n=0,
Xmt[n]=GenSeries[Xmt [n],n], 
Ymt[n]=GenSeries[Ymt[n], n], 
Amt [n], Aft[n];
n=l,
Xmt [n] =GenSenes [Xmt [n] , n] , 
Ymt[n]=GenSeries[Ymt[n],n], 
Amt[n], Aft[n],
n=2,
Xmt[n]=GenSeries[Xmt[n],n] , 
Ymt [n] =GenSenes [Ymt [n] , n], 
Amt[n], Aft[n],
n=3;
Xmt [n] =GenSeries [Xmt [n] , n] ; 
Ymt[n]=GenSeries[Ymt[n],n], 
Amt[n], Aft[n],
to order 3 *)
Xft[n]=GenSeries[Xft[n],n], 
Yft[n]=GenSèries[Yft[n],n],
Xft[n]=GenSeries[Xft[n],n], 
Yft[n]=GenSeries[Yft[n],n],
Xft [n] =GenSenes [Xft [n] , n], 
Yft[n]=GenSeries[Yft[n],n],
Xft[n]=GenSeries[Xft[n],n]; 
Yft[n]=GenSeries[Yft[n],n],
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□  Remember Series Expansions 
Zero order
Xmt[0] = Lm - mm*Xm[0],
Xft[0] = Lf - mf*Xf[0] ,
Ymt[0] = -((a + mm)*Ym[0]),
Yft[0] = -((a + mf)*Yf[0]),
Amt[0] = - ((del + mm)*Am[0_]) + a*Ym[0] ,
Aft[0] = -((del + mf)*Af[0]) + a*Yf[0];
First order
Xmt [1] = -((mm*Af[0]*Xm[l] + mm*Xf[0]*Xm[l] + Xm[0]*Yf[0] + mm*Xm[l]*Yf| 
(Af[0] + Xf[0] + Yf[0])) ,
Xft[l] = -((mf*Am[0]*Xf[1] + mf*Xf[1]*Xm[0] + 8*Xf[0]*Ym[0] + mf*Xf[l]*} 
(Am[0] + Xm[0] + Ym[0])),
Ymt[1] = (Xm[0]*Yf[0] - a*Af[0]*Ym[l] - mm*Af[0]*Ym[l] - a*Xf[0]*Ym[l] - 
mm*Xf[0]*Ym[l] - a*Yf[0]*Ym[l] - mm*Yf[0]*Ym[l])/
(Af[0] + Xf[0] + Yf[0]),
Yft[1] = (-(a*Am[0]*Yf[1]) - mf*Am[0]*Yf[1] - a*Xm[0]*Yf[1] -
mf*Xm[0]*Yf[1] + 8*Xf[0]*Ym[0] - a*Yf[1]*Ym[0] - mf*Yf[1]*Ym[0])/ 
(Am[0] + Xm[0] + Ym[0]),
Amt[l] = -((del + mm)*Am[l]) + a*Ym[l],
Aft[1] = -((del + mf)*Af[1]) + a*Yf[l],
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Second order
Xmt[2] = (-(mm*Af[0]A2*Xm[2]) - 2*rran*Af[0]*Xf[0]*Xm[2] - mm*Xf[0]A2*Xm[i 
Af[l]*Xm[0]*Yf[0] + Xf[l]*Xm[0]*Yf[0] - Af[0]*Xm[l]*Yf[0] - 
Xf[0]*Xm[l]*Yf[0] - 2*mm*Af[0]*Xm[2]*Yf[0] - 
2*iran*Xf[0]*Xm[2]*Yf[0] - Xm[l]*Yf[0]A2 - mm*Xm[2]*Yf[0]A2 - 
Af[0]*Xm[0]*Yf[1] - Xf[0]*Xm[0]*Yf[1])/(Af[0] +Xf[0] +Yf[0])A2,
Xft[2] = (-(mf*Am[0]A2*Xf[2]) - 2*mf*Am[0]*Xf[2]*Xra[0] - mf*Xf[2]*Xm[0]' 
8*Am[l]*Xf[0]*Ym[0] - -8*Am[0]*Xf[1]*Ym[0] - 
2*mf*Am[0]*Xf[2]*Ym[0] - 8*Xf[1]*Xm[0]*Ym[0] - 
2*mf*Xf[2]*Xm[0]*Ym[0] + 8*Xf[0]*Xm[l]*Ym[0] - 
8*Xf[1]*Ym[0]A2 - mf*Xf[2]*Ym[0]A2 - 8*Am[0]*Xf[0]*Ym[l] - 
8*Xf[0]*Xm[0]*Ym[l])/(Am[0] +Xm[0] +Ym[0])A2,
Ymt [2] = (-(Af[1]*Xm[0]*Yf[0]) - Xf[1]*Xm[0]*Yf[0] + Af[0]*Xm[l]*Yf[0] H 
Xf[0]*Xm[l]*Yf[0] + Xm[l]*Yf[0]A2 + Af[0]*Xm[0]*Yf[1] +
Xf[0]*Xm[0]*Yf[1] - a*Af[0]A2*Ym[2] - mm*Af[0]A2*Ym[2] -
2*a*Af[0]*Xf[0]*Ym[2] - 2*iran*Af[0]*Xf[0]*Ym[2] -
a*Xf[0]A2*Ym[2] - mm*Xf[0]A2*Ym[2] - 2*a*Af[0]*Yf[0]*Ym[2] -
2*mm*Af[0]*Yf[0]*Ym[2] - 2*a*Xf[0]*Yf[0]*Ym[2] -
2*mm*Xf[0]*Yf[0]*Ym[2] - a*Yf[0]A2*Ym[2] - mm*Yf[0]A2*Ym[2])/
(Af[0] + Xf [0] + Yf[0])A2,
Yft[2] = (-(a*Am[0]A2*Yf[2]) - mf*Am[0]A2*Yf[2] - 2*a*Am[0]*Xm[0]*Yf[2] 
2*mf*AmtO]*Xm[0]*Yf[2] - a*Xm[0]A2*Yf[2] - mf*Xm[0]A2*Yf[2] - 
8*Am[l]*Xf[0]*Ym[0] + 8*Am[0]*Xf[1]*Ym[0] +
8*Xf[1]*Xm[0]*Ym[0] - 8*Xf[0]*Xm[l]*Ym[0] - 
2*a*Am[0]*Yf[2]*Ym[0] - 2*mf*Am[0]*Yf[2]*Ym[0] - 
2*a*Xm[0]*Yf[2]*Ym[0] - 2*mf*Xm[0]*Yf[2]*Ym[0] +
8*Xf[1]*Ym[0]A2 - a*Yf[2]*Ym[0]A2 - mf*Yf[2]*Ym[0]A2 +
8*Am[0]*Xf[0]*Ym[l] + 8*Xf[0]*Xm[0]*Ym[l])/
(Am[0] + Xm[0] + Ym[0])A2,
Amt [2] = - ((del + mm)*Am[2]) + a*Ym[2], 
Aft[2] = -((del + mf)*Af[2]) + a*Yf[2],
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□  Parameter Set 1
a = 0 1, 
del = 0 6329, 
eps = 0 0104,
Lm = 9577.0,
Lf = 9568.0, 
mm = 0 04; 
mf = 0 04,
(* initial conditions *)
XmO = 214257 0;
XfO = 223764 0,
YmO = 1 83691,
YfO = 59.0501,
AmO = 0 146069;
AfO = 5.01905,
(* maximum time interval *) 
tmax = 30.0,
□ Z e ro  order - Anlyatical
(* anlyatical *) 
n=0,
Xm[n] = XmTempfn], Xf[n]
Ym[n] = YmTemp[n]; Yf[n]
Am[n] = AmTemp[n], Af[n]
□  First order - Numerical
(* numerical *) 
n=l,
Xm[n] = XmnTemp[n], Xf[n]
Ym[n] = YmnTemp[n], Yf[n]
Am[n] = AmnTemp[n], Af[n]
□  Second order - Numerical
(* numerical *) 
n=2,
Xm[n] = XmnTemp[n], Xf[n]
Ym[n] = YmnTemp[ n j , Yf[n]
Am[n] = AmnTemp[n], Af[n]
XfTemp[n], 
YfTemp[n], 
AfTemp[n],
XfnTemp[n], 
YfnTemp [n], 
AfnTemp[n],
XfnTemp[n], 
YfnTemp[n], 
AfnTemp[n],
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Appendix C
Numerical Analysis
The NAG library routine D02EBF was used to solve the system of non­
linear differential equations described in Chapter 6 The fortran program which 
calls on the NAG routine follows
C IVDU/HETERO HIV TRANSMISSION MODEL SOLVER, D02EBF
C Ni LOW, DUBL POP ESTIMATES, Pi MIX WITH IV, 1980 TO
2005
C
IMPLICIT NONE 
C SCALARS IN COMMON
REAL*8 H, XEND 
INTEGER I
C
C LOCAL SCALARS
REAL*8 TOL, X
INTEGER IFAIL, IR, IW, J, MPED, N, NOUT
C
C LOCAL ARRAYS
REAL*8 W(16,498), Y(16)
C
C SUBROUTINE REFERENCES
C D02EBF
C
EXTERNAL FCN, OUT, PEDERV 
COMMON XEND, H, I 
DATA NOUT 121 
WRITE (NOUT, 99996)
WRITE (NOUT, 99994)
N=16
C-1
IW=498
MPED=0
IR=0
DO 20 J=10,12 
TOL=10 0D0**(-J)
WRITE (NOUT,99999) TOL 
WRITE (NOUT,99998)
X=0 0D0 
XEND=250D0 
Y(1)=2999 0D0 
Y(2)=1000 0D0 
Y(3)=205363 0D0 
Y(4)=218663 0D0 
Y(5)=1 0D0 
Y(6)=0 0D0 
Y(7)=0.0D0 
Y(8)=0 ODO 
Y(9)=0 ODO 
Y(10)=0 ODO 
Y(11)=0 ODO 
Y(12)=0 ODO 
Y(13)=3000 ODO 
Y(14)=1000 ODO 
Y(15)=205363 ODO 
Y(16)=218663 ODO 
H=1 ODO 
1=24 
IFAIL=0
CALL D02EBF(X, XEND, N, Y, TOL, IR, FCN, MPED, PEDERV, 
+ OUT, W, IW, IFAIL)
WRITE (NOUT,99997) IFAIL
IF (TOL LT 0 ODO) WRITE (NOUT, 99995)
20 CONTINUE 
STOP
C
99999 FORMAT (1X/CALCULATION WITH TOL=\ 1PD11 4)
99998 FORMAT (1 X,’X AND SOLUTION AT EQUALLY SPACED 
POINTS’)
99997 FORMAT (1X,'IFAIL=M2)
99996 FORMAT (4(1 X/),1 X/D02EBF HIVSYS2 PROGRAM RESULTS',/) 
99995 FORMAT (1X,'RANGE TOO SHORT FOR TOL’)
99994 FORMAT (1X,'CALCULATING JACOBIAN INTERNALLY')
C
END
C
SUBROUTINE FCN(T, Y, F)
C
IMPLICIT NONE 
C SCALAR ARGUMENTS
REAL*8 T
C
C ARRAY ARGUMENTS
REAL*8 F(16), Y(16)
C
REAL*8BETA12.BETA14.BETA21 ,BETA23,BETA32,BETA34,BETA41, 
BETA43,
+ BETAHT,N1 ,N2,C12,C14,C21 ,C23,C32,C34,C41 ,C43,
+ LAMDA1 ,LAMDA2,LAMDA3,LAMDA4,MU1 ,MU2,MU3,MU4,GA,
+ ALPHA,D
C
BETA12=0 007D0 
BETA14=0 007D0 
BETA32=0 007D0 
BETA34=0 0054D0 
BETA21=0 1015D0 
BETA23=01015D0 
BETA41=01015D0 
BETA43=0 0783D0 
BETAHT=019D0 
N1=6 280D0 
N2=4 48D0 
C12=0 72D0 
C14=1 76D0 
C21=1 29D0 
C23=0 59D0 
C32=0 0046D0
C-3
C34=1 9254D0 
C41=0 0148D0 
C43=1 1152D0 
LAMDA1 =396 ODO 
LAMDA2=132 ODO 
LAMDA3=9577 ODO 
LAMDA4=9568 ODO 
MU1=015D0 
MU2=015D0 
MU3=0 0333D0 
MU4=0 0333D0 
GA=0 007D0 
ALPHA=01 DO 
D=0 6329D0
F(1 )=LAMDA1 -N1*BETAHT*Y(1 )*(Y(5)+Y(6))/(Y(13)+Y(14))
-C12*BETA12*Y(1)*Y(6)/Y(14)-C14*BETA14*Y(1)*Y(8)/Y(16)
-(MU1+GA)*Y(1)
F(2)= LAMDA2-N2*BETAHT*Y(2)*(Y(5)+Y(6))/(Y(13)+Y(14)) 
-C21*BETA21 *Y(2)*Y(5)/Y(13)-C23*BETA23*Y(2)*Y(7)/Y(15) 
-(MU2+GA)*Y(2)
F(3)=LAMDA3-C32*BETA32*Y(3)*Y(6)/Y(14) 
-C34*BETA34*Y(3)*Y(8)/Y (16)
-(MU3+GA)*Y(3)
F(4)=LAMDA4-C41 *BETA41 *Y(4)*Y(5)/Y(13) 
-C43*BETA43*Y(4)*Y(7)/Y (15)
-(MU4+GA)*Y(4)
F(5)=N1 *BETAHT*Y(1 )*(Y(5)+Y(6))/(Y(13)+Y(14))
+C12*BETA12*Y(1 )*Y(6)/Y(14)+C14*BETA14*Y(1 )*Y(8)/Y(16) 
-(MU1 +GA+ALPHA)*Y(5) 
F(6)=N2*BETAHT*Y(2)*(Y(5)+Y(6))/(Y(13)+Y(14))
+C21 *BETA21 *Y(2)*Y(5)/Y(13)+C23*BETA23*Y(2)*Y(7)A'(15) 
-(MU2+GA+ALPHA)*Y(6)
F(7)=C32*BETA32*Y(3)*Y(6)/Y(14) 
+C34*BETA34*Y(3)*Y(8)/Y(16)
-(MU3+GA+ALPHA)*Y(7)
F(8)=C41 *BETA41 *Y(4)*Y(5)A'(13) 
+C43*BETA43*Y(4)*Y(7)/Y (15)
C-4
+ -(MU4+GA+ALPHA)*Y (8)
C
F(9)=ALPH A*Y (5)-(D+GA)*Y (9)
F(10)=ALPH A*Y (6)-(D+GA)*Y(10)
F(11 )=ALPHA*Y (7)-(D+GA)*Y (11 )
F(12)=ALPH A*Y (8)-(D+GA)*Y(12)
C
F(13)=F(1 )+F(5)+F(9)
F(14)=F(2)+F(6)+F(10)
F(15)=F(3)+F(7)+F(11 )
F(16)=F(4)+F(8)+F(12)
RETURN
END
C
SUBROUTINE PEDERV(X, Y, PW)
C CAN OMIT THIS SECTION 
RETURN 
END
C
SUBROUTINE OUT(X, Y)
IMPLICIT NONE 
C SCALAR ARGUMENTS
REAL*8 X 
C ARRAY ARGUMENTS
REAL*8 Y(16)
C SCALARS IN COMMON
REAL*8 H, XEND 
INTEGER I 
C LOCAL SCALARS
INTEGER J, NOUT 
COMMON XEND, H, I 
DATA NOUT 121
WRITE (NOUT,99999) X, (Y(J), J=1,16) 
X=XEND - FLOAT(l)*H 
1= 1-1
RETURN
99999 FORMAT (1 X,1 PD11 4,/,4(4(2X,1 PE12 5)/)) 
END
C-5
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